Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
achromatopsia 2 | CNGA3* | Cnga3* | 3 models | Alliance of Genome Resources | |||
achromatopsia 3 | CNGB3* | Cngb3* | 2 models | Alliance of Genome Resources | |||
achromatopsia 4 | GNAT2* | Gnat2* | 2 models | Alliance of Genome Resources | |||
achromatopsia 7 | ATF6* | Atf6* | 1 model | Alliance of Genome Resources | |||
adrenoleukodystrophy | ABCD1* | Abcd1* | 9 models | Alliance of Genome Resources | |||
adult-onset autosomal dominant demyelinating leukodystrophy | LMNB1* | Lmnb1* | 1 model | Alliance of Genome Resources | |||
agenesis of the corpus callosum with peripheral neuropathy | SLC12A6* | Slc12a6* | 3 models | Alliance of Genome Resources | |||
age related macular degeneration 12 | CX3CR1* | Cx3cr1* | 2 models | Alliance of Genome Resources | |||
age related macular degeneration 4 | CFH* | Cfh*, Cfhr4 | 1 model | Alliance of Genome Resources | |||
Alexander disease | GFAP* | Gfap* | 4 models | Alliance of Genome Resources | |||
alternating hemiplegia of childhood | ATP1A3* | Atp1a3* | 4 models | Alliance of Genome Resources | |||
Alzheimer's disease | APP* | App* | 24 models | Alliance of Genome Resources | |||
Alzheimer's disease | LRP1* | Lrp1* | 2 models | Alliance of Genome Resources | |||
Alzheimer's disease | MME* | Mme* | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease | PLAU* | Plau* | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease | PSEN1* | Psen1* | 19 models | Alliance of Genome Resources | |||
Alzheimer's disease 3 | PSEN1* | Psen1* | 6 models | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | SOD1* | Sod1* | 2 models | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 10 | TARDBP* | Tardbp* | 7 models | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 21 | MATR3* | Matr3* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 4 | SETX* | Setx* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 6 | FUS* | Fus* | 1 model | Alliance of Genome Resources | |||
aniridia | PAX6* | Pax6* | 2 models | Alliance of Genome Resources | |||
anterior segment dysgenesis | PITX3* | Pitx3* | 1 model | Alliance of Genome Resources | |||
arteriovenous malformations of the brain | ENG* | Eng* | 1 model | Alliance of Genome Resources | |||
arteriovenous malformations of the brain | KRAS* | Kras* | 2 models | Alliance of Genome Resources | |||
ataxia telangiectasia | ATM* | Atm* | 9 models | Alliance of Genome Resources | |||
Athabaskan brainstem dysgenesis syndrome | HOXA1* | Hoxa1* | 1 model | Alliance of Genome Resources | |||
atypical teratoid rhabdoid tumor | SMARCB1* | Smarcb1* | 3 models | Alliance of Genome Resources | |||
autosomal dominant auditory neuropathy 1 | DIAPH3* | Diaph3* | 2 models | Alliance of Genome Resources | |||
autosomal dominant distal hereditary motor neuronopathy 2 | HSPB8* | Hspb8* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nocturnal frontal lobe epilepsy 3 | CHRNB2* | Chrnb2* | 2 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 12 | TECTA* | Tecta* | 4 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 13 | COL11A2* | Col11a2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 22 | MYO6* | Myo6* | 2 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 25 | SLC17A8* | Slc17a8* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 36 | TMC1* | Tmc1* | 3 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 41 | P2RX2* | P2rx2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 67 | OSBPL2* | Osbpl2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 9 | COCH* | Coch* | 1 model | Alliance of Genome Resources | |||
autosomal recessive distal hereditary motor neuronopathy 1 | IGHMBP2* | Ighmbp2* | 2 models | Alliance of Genome Resources | |||
autosomal recessive isolated ectopia lentis 2 | ADAMTSL4* | Adamtsl4* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2A | CAPN3* | Capn3* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2B | DYSF* | Dysf* | 5 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2C | SGCG* | Sgcg* | 2 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2D | SGCA* | Sgca* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2E | SGCB* | Sgcb* | 2 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2F | SGCD* | Sgcd* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2G | TCAP* | Tcap* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2H | TRIM32* | Trim32* | 2 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2I | FKRP* | Fkrp* | 4 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2J | TTN* | Ttn* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2L | ANO5* | Ano5* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2P | DAG1* | Dag1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2U | CRPPA* | Crppa* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 12 | CDH23* | Cdh23* | 3 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 16 | STRC*, STRCP1 | Strc* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 18A | USH1C* | Ush1c* | 3 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 18B | OTOG* | Otog* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 1A | GJB6* | Gjb6* | 3 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 1A | GJB2* | Gjb2* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 2 | MYO7A* | Myo7a* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 22 | OTOA* | Otoa* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 23 | PCDH15* | Pcdh15* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 28 | TRIOBP* | Triobp* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 29 | CLDN14* | Cldn14* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 3 | MYO15A* | Myo15a* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 30 | MYO3A* | Myo3a* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 31 | WHRN* | Whrn* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 32 | CDC14A* | Cdc14a* | 4 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 37 | MYO6* | Myo6* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 39 | HGF* | Hgf* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 42 | ILDR1* | Ildr1* | 3 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 48 | CIB2* | Cib2* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 49 | MARVELD2* | Marveld2* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 59 | PJVK* | Pjvk* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 63 | LRTOMT*, LRRC51, TOMT | Tomt*, Lrrc51 | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 68 | S1PR2* | S1pr2* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 7 | TMC1* | Tmc1* | 6 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 74 | MSRB3* | Msrb3* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 79 | TPRN* | Tprn* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 88 | ELMOD3* | Elmod3* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 9 | OTOF* | Otof* | 2 models | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 93 | CABP2* | Cabp2* | 1 model | Alliance of Genome Resources | |||
autosomal recessive spinocerebellar ataxia 12 | WWOX* | Wwox* | 1 model | Alliance of Genome Resources | |||
autosomal recessive spinocerebellar ataxia 13 | GRM1* | Grm1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive spinocerebellar ataxia 16 | STUB1* | Stub1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive spinocerebellar ataxia 18 | GRID2* | Grid2* | 2 models | Alliance of Genome Resources | |||
Axenfeld-Rieger syndrome type 1 | PITX2* | Pitx2* | 6 models | Alliance of Genome Resources | |||
basal ganglia calcification | PDGFRB* | Pdgfrb* | 1 model | Alliance of Genome Resources | |||
basal ganglia calcification | SLC20A2* | Slc20a2* | 1 model | Alliance of Genome Resources | |||
Becker muscular dystrophy | DMD* | Dmd* | 1 model | Alliance of Genome Resources | |||
benign neonatal seizures | KCNQ3* | Kcnq3* | 5 models | Alliance of Genome Resources | |||
benign neonatal seizures | KCNQ2* | Kcnq2* | 5 models | Alliance of Genome Resources | |||
bestrophinopathy | BEST1* | Best1* | 2 models | Alliance of Genome Resources | |||
Bethlem myopathy | COL6A1* | Col6a1* | 1 model | Alliance of Genome Resources | |||
Bietti crystalline corneoretinal dystrophy | CYP4V2* | Cyp4v3* | 2 models | Alliance of Genome Resources | |||
biotin-responsive basal ganglia disease | SLC19A3* | Slc19a3* | 2 models | Alliance of Genome Resources | |||
blue cone monochromacy | OPN1LW*, OPN1MW*, OPN1MW2, OPN1MW3 | Opn1mw* | 1 model | Alliance of Genome Resources | |||
Bothnia retinal dystrophy | RLBP1* | Rlbp1* | 1 model | Alliance of Genome Resources | |||
brain small vessel disease 1 | COL4A1* | Col4a1* | 1 model | Alliance of Genome Resources | |||
brittle cornea syndrome 1 | ZNF469* | Zfp469* | 1 model | Alliance of Genome Resources | |||
buphthalmos | CYP1B1* | Cyp1b1* | 4 models | Alliance of Genome Resources | |||
CADASIL 1 | NOTCH3* | Notch3* | 6 models | Alliance of Genome Resources | |||
Canavan disease | ASPA* | Aspa* | 5 models | Alliance of Genome Resources | |||
cataract | LIM2* | Lim2* | 1 model | Alliance of Genome Resources | |||
cataract | LSS* | Lss* | 1 model | Alliance of Genome Resources | |||
cataract | PANK4* | Pank4* | 1 model | Alliance of Genome Resources | |||
cataract | PAX6* | Pax6* | 1 model | Alliance of Genome Resources | |||
cataract | TRPM3* | Trpm3* | 2 models | Alliance of Genome Resources | |||
cataract 10 multiple types | CRYBA1* | Cryba1* | 2 models | Alliance of Genome Resources | |||
cataract 14 multiple types | GJA3* | Gja3* | 2 models | Alliance of Genome Resources | |||
cataract 15 multiple types | MIP* | Mip* | 7 models | Alliance of Genome Resources | |||
cataract 16 multiple types | CRYAB* | Cryab* | 1 model | Alliance of Genome Resources | |||
cataract 19 multiple types | LIM2* | Lim2* | 4 models | Alliance of Genome Resources | |||
cataract 1 multiple types | GJA8* | Gja8* | 4 models | Alliance of Genome Resources | |||
cataract 20 multiple types | CRYGS* | Crygs* | 3 models | Alliance of Genome Resources | |||
cataract 21 multiple types | MAF* | Maf* | 1 model | Alliance of Genome Resources | |||
cataract 2 multiple types | CRYGC* | Crygc* | 2 models | Alliance of Genome Resources | |||
cataract 30 | VIM* | Vim* | 1 model | Alliance of Genome Resources | |||
cataract 39 multiple types | CRYGB* | Crygb* | 6 models | Alliance of Genome Resources | |||
cataract 3 multiple types | CRYBB2* | Crybb2* | 3 models | Alliance of Genome Resources | |||
cataract 4 multiple types | CRYGD* | Crygd*, Cryge, Crygf | 2 models | Alliance of Genome Resources | |||
cataract 5 multiple types | HSF4* | Hsf4* | 2 models | Alliance of Genome Resources | |||
cataract 6 multiple types | EPHA2* | Epha2* | 1 model | Alliance of Genome Resources | |||
cataract 9 multiple types | CRYAA* | Cryaa* | 9 models | Alliance of Genome Resources | |||
Cayman type cerebellar ataxia | ATCAY* | Atcay* | 3 models | Alliance of Genome Resources | |||
cerebellar ataxia type 42 | CACNA1G* | Cacna1g* | 2 models | Alliance of Genome Resources | |||
cerebral cavernous malformation | KRIT1* | Krit1* | 1 model | Alliance of Genome Resources | |||
cerebral cavernous malformation 2 | CCM2* | Ccm2* | 4 models | Alliance of Genome Resources | |||
cerebral cavernous malformation 3 | PDCD10* | Pdcd10* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2K | GDAP1* | Gdap1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2O | DYNC1H1* | Dync1h1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2P | LRSAM1* | Lrsam1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2Q | DHTKD1* | Dhtkd1* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2S | IGHMBP2* | Ighmbp2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2Z | MORC2* | Morc2a*, Morc2b | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease dominant intermediate C | YARS1* | Yars1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease recessive intermediate D | COX6A1* | Cox6a1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1A | PMP22* | Pmp22* | 6 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1B | MPZ* | Mpz* | 10 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1C | LITAF* | Litaf* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1E | PMP22* | Pmp22* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2A1 | KIF1B* | Kif1b* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2A2A | MFN2* | Mfn2* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2B | RAB7A* | Rab7* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2B1 | LMNA* | Lmna* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2D | GARS1* | Gars1* | 4 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2E | NEFL* | Nefl* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 3 | PMP22* | Pmp22* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 3 | MPZ* | Mpz* | 3 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4B1 | MTMR2* | Mtmr2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4B2 | SBF2* | Sbf2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4B3 | SBF1* | Sbf1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4C | SH3TC2* | Sh3tc2* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4D | NDRG1* | Ndrg1* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4E | EGR2* | Egr2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4H | FGD4* | Fgd4* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4J | FIG4* | Fig4* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease X-linked dominant 1 | GJB1* | Gjb1* | 4 models | Alliance of Genome Resources | |||
Charlevoix-Saguenay spastic ataxia | SACS* | Sacs* | 2 models | Alliance of Genome Resources | |||
choreaacanthocytosis | VPS13A* | Vps13a* | 1 model | Alliance of Genome Resources | |||
choroideremia | CHM* | Chm* | 4 models | Alliance of Genome Resources | |||
complex cortical dysplasia with other brain malformations 4 | TUBG1* | Tubg1* | 1 model | Alliance of Genome Resources | |||
complex cortical dysplasia with other brain malformations 7 | TUBB2B* | Tubb2b* | 1 model | Alliance of Genome Resources | |||
cone-rod dystrophy 16 | CFAP418* | Cfap418* | 1 model | Alliance of Genome Resources | |||
cone-rod dystrophy 18 | RAB28* | Rab28* | 2 models | Alliance of Genome Resources | |||
cone-rod dystrophy 2 | CRX* | Crx* | 2 models | Alliance of Genome Resources | |||
cone-rod dystrophy 3 | ABCA4* | Abca4* | 2 models | Alliance of Genome Resources | |||
cone-rod dystrophy 6 | GUCY2D* | Gucy2e* | 1 model | Alliance of Genome Resources | |||
cone-rod dystrophy 9 | ADAM9* | Adam9* | 1 model | Alliance of Genome Resources | |||
congenital central hypoventilation syndrome | PHOX2B* | Phox2b* | 2 models | Alliance of Genome Resources | |||
congenital hereditary endothelial dystrophy of cornea | SLC4A11* | Slc4a11* | 1 model | Alliance of Genome Resources | |||
congenital merosin-deficient muscular dystrophy 1A | LAMA2* | Lama2* | 10 models | Alliance of Genome Resources | |||
congenital muscular dystrophy due to integrin alpha-7 deficiency | ITGA7* | Itga7* | 1 model | Alliance of Genome Resources | |||
congenital muscular dystrophy due to LMNA mutation | LMNA* | Lmna* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 10 | DOK7* | Dok7* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 11 | RAPSN* | Rapsn* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 12 | GFPT1* | Gfpt1* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 19 | COL13A1* | Col13a1* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 3A | CHRND* | Chrnd* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 4A | CHRNE* | Chrne* | 2 models | Alliance of Genome Resources | |||
congenital myasthenic syndrome 4C | CHRNE* | Chrne* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 5 | COLQ* | Colq* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 6 | CHAT* | Chat* | 2 models | Alliance of Genome Resources | |||
congenital myasthenic syndrome 8 | AGRN* | Agrn* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 9 | MUSK* | Musk* | 3 models | Alliance of Genome Resources | |||
congenital nystagmus 1 | FRMD7* | Frmd7* | 2 models | Alliance of Genome Resources | |||
congenital stationary night blindness 1A | NYX* | Nyx* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness 1B | GRM6* | Grm6* | 2 models | Alliance of Genome Resources | |||
congenital stationary night blindness 1C | TRPM1* | Trpm1* | 2 models | Alliance of Genome Resources | |||
congenital stationary night blindness 1D | SLC24A1* | Slc24a1* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness 1E | GPR179* | Gpr179* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness 1F | LRIT3* | Lrit3* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness 2A | CACNA1F* | Cacna1f* | 12 models | Alliance of Genome Resources | |||
congenital stationary night blindness autosomal dominant 1 | RHO* | Rho* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness autosomal dominant 2 | PDE6B* | Pde6b* | 14 models | Alliance of Genome Resources | |||
congenital stromal corneal dystrophy | DCN* | Dcn* | 1 model | Alliance of Genome Resources | |||
corneal dystrophy | TGFBI* | Tgfbi* | 1 model | Alliance of Genome Resources | |||
cornea plana | KERA* | Kera* | 1 model | Alliance of Genome Resources | |||
cortical dysplasia-focal epilepsy syndrome | CNTNAP2* | Cntnap2* | 1 model | Alliance of Genome Resources | |||
Creutzfeldt-Jakob disease | PRNP* | Prnp* | 8 models | Alliance of Genome Resources | |||
Dandy-Walker syndrome | ZIC1* | Zic1* | 1 model | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 14 | KCNT1* | Kcnt1* | 2 models | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 16 | TBC1D24* | Tbc1d24* | 1 model | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 17 | GNAO1* | Gnao1* | 3 models | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 2 | CDKL5* | Cdkl5* | 2 models | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 39 | SLC25A12* | Slc25a12* | 1 model | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 54 | HNRNPU* | Hnrnpu* | 1 model | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 7 | KCNQ2* | Kcnq2* | 1 model | Alliance of Genome Resources | |||
dopamine beta-hydroxylase deficiency | DBH* | Dbh* | 1 model | Alliance of Genome Resources | |||
Doyne honeycomb retinal dystrophy | EFEMP1* | Efemp1* | 4 models | Alliance of Genome Resources | |||
Dravet syndrome | SCN1A* | Scn1a* | 8 models | Alliance of Genome Resources | |||
dry eye syndrome | MUC5AC* | Muc5ac* | 1 model | Alliance of Genome Resources | |||
Duane retraction syndrome | CHN1* | Chn1* | 1 model | Alliance of Genome Resources | |||
Duane retraction syndrome | MAFB* | Mafb* | 2 models | Alliance of Genome Resources | |||
Duchenne muscular dystrophy | DMD* | Dmd* | 30 models | Alliance of Genome Resources | |||
Emery-Dreifuss muscular dystrophy | LMNA* | Lmna* | 2 models | Alliance of Genome Resources | |||
enhanced S-cone syndrome | NR2E3* | Nr2e3* | 2 models | Alliance of Genome Resources | |||
episodic ataxia type 1 | KCNA1* | Kcna1* | 1 model | Alliance of Genome Resources | |||
episodic ataxia type 2 | CACNA1A* | Cacna1a* | 3 models | Alliance of Genome Resources | |||
episodic kinesigenic dyskinesia 1 | PRRT2* | Prrt2* | 2 models | Alliance of Genome Resources | |||
exfoliation syndrome | LOXL1* | Loxl1* | 1 model | Alliance of Genome Resources | |||
familial encephalopathy with neuroserpin inclusion bodies | SERPINI1* | Serpini1* | 1 model | Alliance of Genome Resources | |||
familial episodic pain syndrome 3 | SCN11A* | Scn11a* | 1 model | Alliance of Genome Resources | |||
familial hemiplegic migraine 2 | ATP1A2* | Atp1a2* | 2 models | Alliance of Genome Resources | |||
familial temporal lobe epilepsy 1 | LGI1* | Lgi1* | 4 models | Alliance of Genome Resources | |||
fatal familial insomnia | PRNP* | Prnp* | 1 model | Alliance of Genome Resources | |||
foveal hypoplasia 2 | SLC38A8* | Slc38a8* | 1 model | Alliance of Genome Resources | |||
fragile X-associated tremor/ataxia syndrome | FMR1* | Fmr1* | 1 model | Alliance of Genome Resources | |||
Friedreich ataxia | FXN* | Fxn* | 8 models | Alliance of Genome Resources | |||
frontotemporal dementia | CHMP2B* | Chmp2b* | 1 model | Alliance of Genome Resources | |||
Fuchs' endothelial dystrophy | COL8A2* | Col8a2* | 3 models | Alliance of Genome Resources | |||
Fukuyama congenital muscular dystrophy | FKTN* | Fktn* | 6 models | Alliance of Genome Resources | |||
generalized epilepsy with febrile seizures plus | SCN1A* | Scn1a* | 5 models | Alliance of Genome Resources | |||
Gerstmann-Straussler-Scheinker syndrome | PRNP* | Prnp* | 7 models | Alliance of Genome Resources | |||
giant axonal neuropathy 1 | GAN* | Gan* | 2 models | Alliance of Genome Resources | |||
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | GRN* | Grn* | 3 models | Alliance of Genome Resources | |||
gyrate atrophy | OAT* | Oat* | 3 models | Alliance of Genome Resources | |||
hereditary neuropathy with liability to pressure palsies | PMP22* | Pmp22* | 3 models | Alliance of Genome Resources | |||
hereditary sensory and autonomic neuropathy type 6 | DST* | Dst* | 1 model | Alliance of Genome Resources | |||
hereditary sensory neuropathy | NTRK1* | Ntrk1* | 2 models | Alliance of Genome Resources | |||
hereditary spastic paraplegia 11 | SPG11* | Spg11* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 13 | HSPD1* | Hspd1* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 15 | ZFYVE26* | Zfyve26* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 2 | PLP1* | Plp1* | 2 models | Alliance of Genome Resources | |||
hereditary spastic paraplegia 30 | KIF1A* | Kif1a* | 2 models | Alliance of Genome Resources | |||
hereditary spastic paraplegia 31 | REEP1* | Reep1* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 35 | FA2H* | Fa2h* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 4 | SPAST* | Spast* | 3 models | Alliance of Genome Resources | |||
hereditary spastic paraplegia 48 | AP5Z1* | Ap5z1* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 54 | DDHD2* | Ddhd2* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 7 | SPG7* | Spg7* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 80 | UBAP1* | Ubap1* | 1 model | Alliance of Genome Resources | |||
holoprosencephaly 11 | CDON* | Cdon* | 8 models | Alliance of Genome Resources | |||
holoprosencephaly 2 | SIX3* | Six3* | 4 models | Alliance of Genome Resources | |||
holoprosencephaly 3 | SHH* | Shh* | 3 models | Alliance of Genome Resources | |||
holoprosencephaly 5 | ZIC2* | Zic2* | 3 models | Alliance of Genome Resources | |||
Huntington's disease | HTT* | Htt* | 21 models | Alliance of Genome Resources | |||
hydrocephalus | TRIM71* | Trim71* | 1 model | Alliance of Genome Resources | |||
hyperekplexia 1 | GLRA1* | Glra1* | 4 models | Alliance of Genome Resources | |||
hyperekplexia 2 | GLRB* | Glrb* | 1 model | Alliance of Genome Resources | |||
hyperekplexia 3 | SLC6A5* | Slc6a5* | 2 models | Alliance of Genome Resources | |||
hypomyelinating leukodystrophy 2 | GJC2* | Gjc2* | 3 models | Alliance of Genome Resources | |||
hypomyelinating leukodystrophy 6 | TUBB4A* | Tubb4a* | 3 models | Alliance of Genome Resources | |||
isolated microphthalmia 6 | PRSS56* | Prss56* | 3 models | Alliance of Genome Resources | |||
Joubert syndrome 17 | CPLANE1* | Cplane1* | 1 model | Alliance of Genome Resources | |||
Joubert syndrome 26 | KATNIP* | Katnip* | 1 model | Alliance of Genome Resources | |||
Joubert syndrome 3 | AHI1* | Ahi1* | 1 model | Alliance of Genome Resources | |||
Joubert syndrome 5 | CEP290* | Cep290* | 2 models | Alliance of Genome Resources | |||
Joubert syndrome 6 | TMEM67* | Tmem67* | 1 model | Alliance of Genome Resources | |||
Joubert syndrome 7 | RPGRIP1L* | Rpgrip1l* | 1 model | Alliance of Genome Resources | |||
juvenile myoclonic epilepsy | EFHC1* | Efhc1* | 2 models | Alliance of Genome Resources | |||
juvenile spinal muscular atrophy | SMN1*, SMN2* | Smn1* | 2 models | Alliance of Genome Resources | |||
Kufor-Rakeb syndrome | ATP13A2* | Atp13a2* | 1 model | Alliance of Genome Resources | |||
L-2-hydroxyglutaric aciduria | L2HGDH* | L2hgdh* | 1 model | Alliance of Genome Resources | |||
late-onset retinal degeneration | C1QTNF5* | C1qtnf5* | 1 model | Alliance of Genome Resources | |||
Leber congenital amaurosis 1 | GUCY2D* | Gucy2e* | 3 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 10 | CEP290* | Cep290* | 3 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 12 | RD3* | Rd3* | 1 model | Alliance of Genome Resources | |||
Leber congenital amaurosis 14 | LRAT* | Lrat* | 1 model | Alliance of Genome Resources | |||
Leber congenital amaurosis 19 | USP45* | Usp45* | 1 model | Alliance of Genome Resources | |||
Leber congenital amaurosis 2 | RPE65* | Rpe65* | 4 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 3 | SPATA7* | Spata7* | 2 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 4 | AIPL1* | Aipl1* | 5 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 5 | LCA5* | Lca5* | 1 model | Alliance of Genome Resources | |||
Leber congenital amaurosis 6 | RPGRIP1* | Rpgrip1* | 3 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 7 | CRX* | Crx* | 4 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 8 | CRB1* | Crb1* | 3 models | Alliance of Genome Resources | |||
Leber congenital amaurosis 9 | NMNAT1* | Nmnat1* | 2 models | Alliance of Genome Resources | |||
Leber hereditary optic neuropathy | ND6* | mt-Nd6* | 1 model | Alliance of Genome Resources | |||
leukoencephalopathy with vanishing white matter | EIF2B5* | Eif2b5* | 7 models | Alliance of Genome Resources | |||
lissencephaly | PAFAH1B1* | Pafah1b1* | 5 models | Alliance of Genome Resources | |||
lissencephaly | TUBA1A* | Tuba1a* | 1 model | Alliance of Genome Resources | |||
low tension glaucoma | OPTN* | Optn* | 1 model | Alliance of Genome Resources | |||
Marfan syndrome | FBN1* | Fbn1* | 8 models | Alliance of Genome Resources | |||
MASA syndrome | L1CAM* | L1cam* | 1 model | Alliance of Genome Resources | |||
Mast syndrome | SPG21* | Spg21* | 1 model | Alliance of Genome Resources | |||
megaconial type congenital muscular dystrophy | CHKB* | Chkb* | 1 model | Alliance of Genome Resources | |||
megalencephalic leukoencephalopathy with subcortical cysts 1 | MLC1* | Mlc1* | 1 model | Alliance of Genome Resources | |||
microcephaly | CDK5RAP2* | Cdk5rap2* | 2 models | Alliance of Genome Resources | |||
microcephaly | MCPH1* | Mcph1* | 1 model | Alliance of Genome Resources | |||
microcephaly | ASPM* | Aspm* | 3 models | Alliance of Genome Resources | |||
microphthalmia | HCCS* | Hccs* | 3 models | Alliance of Genome Resources | |||
multiple sclerosis | PRF1* | Prf1* | 1 model | Alliance of Genome Resources | |||
multiple sclerosis | TNF* | Tnf* | 2 models | Alliance of Genome Resources | |||
muscular dystrophy | FKRP* | Fkrp* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | POMT1* | Pomt1* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B5 | FKRP* | Fkrp* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B6 | LARGE1* | Large1* | 1 model | Alliance of Genome Resources | |||
myoclonic dystonia 11 | SGCE* | Sgce* | 2 models | Alliance of Genome Resources | |||
myotonic dystrophy type 1 | DMPK* | Dmpk* | 2 models | Alliance of Genome Resources | |||
neurodegeneration with brain iron accumulation 2a | PLA2G6* | Pla2g6* | 4 models | Alliance of Genome Resources | |||
neurodegeneration with brain iron accumulation 5 | WDR45* | Wdr45* | 2 models | Alliance of Genome Resources | |||
neurodegeneration with brain iron accumulation 6 | COASY* | Coasy* | 1 model | Alliance of Genome Resources | |||
neurodevelopmental disorder with involuntary movements | GNAO1* | Gnao1* | 1 model | Alliance of Genome Resources | |||
normal pressure hydrocephalus | CFAP43* | Cfap43* | 1 model | Alliance of Genome Resources | |||
ocular albinism 1 | GPR143* | Gpr143* | 1 model | Alliance of Genome Resources | |||
Oguchi disease-2 | GRK1* | Grk1* | 1 model | Alliance of Genome Resources | |||
open-angle glaucoma | MYOC* | Myoc* | 1 model | Alliance of Genome Resources | |||
optic atrophy | OPA1* | Opa1* | 3 models | Alliance of Genome Resources | |||
Parkinson's disease | EN1* | En1* | 3 models | Alliance of Genome Resources | |||
Parkinson's disease | NR4A2* | Nr4a2* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | PPARGC1A* | Ppargc1a* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | TFAM* | Tfam* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | VPS35* | Vps35* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease 1 | SNCA* | Snca* | 6 models | Alliance of Genome Resources | |||
Parkinson's disease 14 | PLA2G6* | Pla2g6* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease 17 | VPS35* | Vps35* | 2 models | Alliance of Genome Resources | |||
Parkinson's disease 2 | PRKN* | Prkn* | 9 models | Alliance of Genome Resources | |||
Parkinson's disease 4 | SNCA* | Snca* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease 6 | PINK1* | Pink1* | 4 models | Alliance of Genome Resources | |||
Parkinson's disease 7 | PARK7* | Park7* | 4 models | Alliance of Genome Resources | |||
Parkinson's disease 8 | LRRK2* | Lrrk2* | 1 model | Alliance of Genome Resources | |||
paroxysmal nonkinesigenic dyskinesia 1 | PNKD* | Pnkd* | 2 models | Alliance of Genome Resources | |||
patterned macular dystrophy 1 | PRPH2* | Prph2* | 4 models | Alliance of Genome Resources | |||
patterned macular dystrophy 2 | CTNNA1* | Ctnna1* | 2 models | Alliance of Genome Resources | |||
Pelizaeus-Merzbacher disease | PLP1* | Plp1* | 8 models | Alliance of Genome Resources | |||
periventricular nodular heterotopia | FLNA* | Flna* | 1 model | Alliance of Genome Resources | |||
pontocerebellar hypoplasia type 10 | CLP1* | Clp1* | 3 models | Alliance of Genome Resources | |||
pontocerebellar hypoplasia type 14 | PPIL1* | Ppil1* | 2 models | Alliance of Genome Resources | |||
primary autosomal recessive microcephaly 2 with or without cortical malformations | WDR62* | Wdr62* | 1 model | Alliance of Genome Resources | |||
progressive myoclonus epilepsy 1B | PRICKLE1* | Prickle1* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa | CNGB1* | Cngb1* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 1 | RP1* | Rp1* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 11 | PRPF31* | Prpf31* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 12 | CRB1* | Crb1* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 13 | PRPF8* | Prpf8* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 14 | TULP1* | Tulp1* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 18 | PRPF3* | Prpf3* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 19 | ABCA4* | Abca4* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 2 | RP2* | Rp2* | 4 models | Alliance of Genome Resources | |||
retinitis pigmentosa 20 | RPE65* | Rpe65* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 26 | CERKL* | Cerkl* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 28 | FAM161A* | Fam161a* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 3 | RPGR* | Rpgr* | 4 models | Alliance of Genome Resources | |||
retinitis pigmentosa 30 | FSCN2* | Fscn2* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 4 | RHO* | Rho* | 13 models | Alliance of Genome Resources | |||
retinitis pigmentosa 40 | PDE6B* | Pde6b* | 9 models | Alliance of Genome Resources | |||
retinitis pigmentosa 41 | PROM1* | Prom1* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 49 | CNGA1* | Cnga1* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 54 | PCARE* | Pcare* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 56 | IMPG2* | Impg2* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 59 | DHDDS* | Dhdds* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 7 | PRPH2* | Prph2* | 3 models | Alliance of Genome Resources | |||
retinitis pigmentosa 77 | REEP6* | Reep6* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa with or without situs inversus | ARL2BP* | Arl2bp* | 1 model | Alliance of Genome Resources | |||
rigid spine muscular dystrophy 1 | SELENON* | Selenon* | 1 model | Alliance of Genome Resources | |||
Riley-Day syndrome | ELP1* | Elp1* | 5 models | Alliance of Genome Resources | |||
Schnyder corneal dystrophy | UBIAD1* | Ubiad1* | 2 models | Alliance of Genome Resources | |||
Sorsby's fundus dystrophy | TIMP3* | Timp3* | 2 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 1 | ATXN1* | Atxn1* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 14 | PRKCG* | Prkcg* | 2 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 17 | TBP* | Tbp* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 2 | ATXN2* | Atxn2* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 28 | AFG3L2* | Afg3l2* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 5 | SPTBN2* | Sptbn2* | 2 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 6 | CACNA1A* | Cacna1a* | 3 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 7 | ATXN7* | Atxn7* | 5 models | Alliance of Genome Resources | |||
spinocerebellar ataxia with axonal neuropathy 1 | TDP1* | Tdp1* | 1 model | Alliance of Genome Resources | |||
subcortical band heterotopia | EML1* | Eml1* | 2 models | Alliance of Genome Resources | |||
syndromic microphthalmia 2 | BCOR*, BCORP1 | Bcor* | 1 model | Alliance of Genome Resources | |||
tibial muscular dystrophy | TTN* | Ttn* | 1 model | Alliance of Genome Resources | |||
torsion dystonia 1 | TOR1A* | Tor1a* | 4 models | Alliance of Genome Resources | |||
torsion dystonia 6 | THAP1* | Thap1* | 2 models | Alliance of Genome Resources | |||
Troyer syndrome | SPART* | Spart* | 1 model | Alliance of Genome Resources | |||
Unverricht-Lundborg syndrome | CSTB* | Cstb* | 1 model | Alliance of Genome Resources | |||
vitelliform macular dystrophy | IMPG2* | Impg2* | 1 model | Alliance of Genome Resources | |||
vitelliform macular dystrophy | BEST1* | Best1* | 2 models | Alliance of Genome Resources | |||
Walker-Warburg syndrome | POMGNT1* | Pomgnt1* | 2 models | Alliance of Genome Resources | |||
Werdnig-Hoffmann disease | SMN1*, SMN2 | Smn1* | 17 models | Alliance of Genome Resources | |||
X-linked cone-rod dystrophy 1 | RPGR* | Rpgr* | 2 models | Alliance of Genome Resources | |||
X-linked deafness 4 | SMPX* | Smpx* | 6 models | Alliance of Genome Resources | |||
X-linked distal spinal muscular atrophy 3 | ATP7A* | Atp7a* | 2 models | Alliance of Genome Resources | |||
X-linked juvenile retinoschisis 1 | RS1* | Rs1* | 8 models | Alliance of Genome Resources | |||
achromatopsia | PDE6C | Pde6c* | 2 models | Alliance of Genome Resources | |||
achromatopsia | GNAT2 | Gnat2* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration | CD46 | Cd46* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration | CCR2 | Ccr2* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration | CCL2, CCL13 | Ccl2*, Ccl12 | 3 models | Alliance of Genome Resources | |||
age related macular degeneration | PPARGC1A | Ppargc1a* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 1 | VLDLR | Vldlr* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 1 | CRYBA1 | Cryba1* | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease | PIN1 | Pin1*, Pin1rt1 | 2 models | Alliance of Genome Resources | |||
Alzheimer's disease | CAV1 | Cav1* | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease | PLCB1 | Plcb1* | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease | IL33 | Il33* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis | ADARB1 | Adarb1* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis | EPG5 | Epg5* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis | PSMC4 | Psmc4* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis | STMN2 | Stmn2* | 2 models | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis | ZNF106 | Zfp106* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | SNCG | Sncg* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | SOD2 | Sod2* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | VEGFA | Vegfa* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | VPS54 | Vps54* | 1 model | Alliance of Genome Resources | |||
anencephaly | CECR2 | Cecr2* | 3 models | Alliance of Genome Resources | |||
anencephaly | EFNA5 | Efna5* | 1 model | Alliance of Genome Resources | |||
anencephaly | LMO4 | Lmo4* | 1 model | Alliance of Genome Resources | |||
angle-closure glaucoma | TFAP2B | Tfap2b* | 1 model | Alliance of Genome Resources | |||
anterior segment dysgenesis | TSC1 | Tsc1* | 1 model | Alliance of Genome Resources | |||
arteriovenous malformations of the brain | NOTCH4 | Notch4* | 1 model | Alliance of Genome Resources | |||
arteriovenous malformations of the brain | ACVRL1 | Acvrl1* | 1 model | Alliance of Genome Resources | |||
auditory system disease | FSCN2 | Fscn2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 25 | TRPV4 | Trpv4* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 4A | CEACAM16 | Ceacam16* | 1 model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness | ATP6V1B1 | Atp6v1b1* | 1 model | Alliance of Genome Resources | |||
Axenfeld-Rieger syndrome type 1 | HMGN2 | Hmgn2*, Hmgn2-ps | 1 model | Alliance of Genome Resources | |||
Axenfeld-Rieger syndrome type 3 | BMP4 | Bmp4* | 1 model | Alliance of Genome Resources | |||
blindness | SLC7A14 | Slc7a14* | 1 model | Alliance of Genome Resources | |||
brain disease | PTEN | Pten* | 1 model | Alliance of Genome Resources | |||
buphthalmos | FOXC1 | Foxc1* | 2 models | Alliance of Genome Resources | |||
buphthalmos | TYR | Tyr* | 3 models | Alliance of Genome Resources | |||
Canavan disease | SOD2 | Sod2* | 1 model | Alliance of Genome Resources | |||
cataract | Acc* | 1 model | |||||
cataract | Alm* | 1 model | |||||
cataract | Apo* | 1 model | |||||
cataract | Apoca* | 1 model | |||||
cataract | Cat2* | 1 model | |||||
cataract | Cat4* | 3 models | |||||
cataract | Ccw* | 1 model | |||||
cataract | Coc* | 2 models | |||||
cataract | CRYGA | Cryga* | 1 model | Alliance of Genome Resources | |||
cataract | CRYGD | Cryge*, Crygd, Crygf | 2 models | Alliance of Genome Resources | |||
cataract | DNASE2B | Dnase2b* | 1 model | Alliance of Genome Resources | |||
cataract | Enc* | 1 model | |||||
cataract | GCLC | Gclc* | 1 model | Alliance of Genome Resources | |||
cataract | Iac* | 1 model | |||||
cataract | Idc* | 1 model | |||||
cataract | Nuca* | 1 model | |||||
cataract | SORD | Sord* | 1 model | Alliance of Genome Resources | |||
cataract | Tcm* | 1 model | |||||
cataract | VPS13B | Vps13b* | 1 model | Alliance of Genome Resources | |||
cataract 2 multiple types | CRYGD | Crygd*, Cryge, Crygf | 1 model | Alliance of Genome Resources | |||
cerebellar ataxia | CACNA1A | Cacna1a* | 1 model | Alliance of Genome Resources | |||
cerebellar disease | ZNF423 | Zfp423* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease intermediate type | CFAP276 | Cfap276* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 6 | SLC25A46 | Slc25a46* | 1 model | Alliance of Genome Resources | |||
Charlevoix-Saguenay spastic ataxia | ANKFY1 | Ankfy1* | 1 model | Alliance of Genome Resources | |||
childhood electroclinical syndrome | CACNA1A | Cacna1a* | 1 model | Alliance of Genome Resources | |||
chromosome 1q41-q42 deletion syndrome | TP53BP2 | Trp53bp2* | 3 models | Alliance of Genome Resources | |||
coloboma | NF2 | Nf2* | 1 model | Alliance of Genome Resources | |||
coloboma | Opr1* | 1 model | |||||
coloboma | opr2* | 2 models | |||||
coloboma | Opr3* | 1 model | |||||
cone dystrophy | YAP1 | Yap1* | 1 model | Alliance of Genome Resources | |||
cone-rod dystrophy | TLCD3B | Tlcd3b* | 1 model | Alliance of Genome Resources | |||
cone-rod dystrophy | DRAM2 | Dram2* | 1 model | Alliance of Genome Resources | |||
cone-rod dystrophy 19 | rd22* | 1 model | |||||
congenital aphakia | FOXE3 | Foxe3* | 1 model | Alliance of Genome Resources | |||
congenital central hypoventilation syndrome | TLX3 | Tlx3* | 1 model | Alliance of Genome Resources | |||
congenital fibrosis of the extraocular muscles | KIF21A | Kif21a* | 3 models | Alliance of Genome Resources | |||
congenital fibrosis of the extraocular muscles | TUBB3 | Tubb3* | 1 model | Alliance of Genome Resources | |||
congenital muscular dystrophy | COL6A3 | Col6a3* | 1 model | Alliance of Genome Resources | |||
congenital nervous system abnormality | TUBA1A | Tuba1a* | 3 models | Alliance of Genome Resources | |||
congenital nervous system abnormality | EML1 | Eml1* | 3 models | Alliance of Genome Resources | |||
congenital nystagmus | AHR | Ahr* | 1 model | Alliance of Genome Resources | |||
Dandy-Walker syndrome | ZNF423 | Zfp423* | 1 model | Alliance of Genome Resources | |||
Dandy-Walker syndrome | ZIC4 | Zic4* | 1 model | Alliance of Genome Resources | |||
degenerative myopia | LRP2 | Lrp2* | 1 model | Alliance of Genome Resources | |||
diabetic retinopathy | INSR | Insr* | 1 model | Alliance of Genome Resources | |||
distal myopathy | DYSF | Dysf* | 4 models | Alliance of Genome Resources | |||
distal myopathy | DNAJB4 | Dnajb4* | 2 models | Alliance of Genome Resources | |||
dry eye syndrome | SOD1 | Sod1* | 1 model | Alliance of Genome Resources | |||
dry eye syndrome | PLTP | Pltp* | 1 model | Alliance of Genome Resources | |||
dry eye syndrome | FAR2 | Far2* | 1 model | Alliance of Genome Resources | |||
dry eye syndrome | AWAT2 | Awat2* | 2 models | Alliance of Genome Resources | |||
dry eye syndrome | AQP5 | Aqp5* | 1 model | Alliance of Genome Resources | |||
Duchenne muscular dystrophy | CTSS | Ctss* | 1 model | Alliance of Genome Resources | |||
early infantile epileptic encephalopathy | SCN8A | Scn8a* | 1 model | Alliance of Genome Resources | |||
early infantile epileptic encephalopathy | GOT2 | Got2* | 2 models | Alliance of Genome Resources | |||
early infantile epileptic encephalopathy | ARX | Arx* | 7 models | Alliance of Genome Resources | |||
Emery-Dreifuss muscular dystrophy | ZMPSTE24 | Zmpste24* | 1 model | Alliance of Genome Resources | |||
Emery-Dreifuss muscular dystrophy | SYNE1 | Syne1* | 1 model | Alliance of Genome Resources | |||
encephalomyelitis | IKZF4 | Ikzf4* | 1 model | Alliance of Genome Resources | |||
enhanced S-cone syndrome | NRL | Nrl* | 1 model | Alliance of Genome Resources | |||
enlarged vestibular aqueduct | ATP6V1B1 | Atp6v1b1* | 1 model | Alliance of Genome Resources | |||
epilepsy | SYN2 | Syn2* | 2 models | Alliance of Genome Resources | |||
epilepsy | SLC12A5 | Slc12a5* | 1 model | Alliance of Genome Resources | |||
epilepsy | SCN8A | Scn8a* | 1 model | Alliance of Genome Resources | |||
epilepsy | SCAMP5 | Scamp5* | 1 model | Alliance of Genome Resources | |||
epilepsy | KCNA1 | Kcna1* | 1 model | Alliance of Genome Resources | |||
epilepsy | GAD2 | Gad2* | 1 model | Alliance of Genome Resources | |||
epilepsy | CDYL | Cdyl* | 1 model | Alliance of Genome Resources | |||
epilepsy | CACNA2D2 | Cacna2d2* | 1 model | Alliance of Genome Resources | |||
epilepsy | ALDH5A1 | Aldh5a1* | 1 model | Alliance of Genome Resources | |||
epilepsy | ATP6V1B2 | Atp6v1b2* | 1 model | Alliance of Genome Resources | |||
epilepsy | BSN | Bsn* | 1 model | Alliance of Genome Resources | |||
epilepsy | C1QA | C1qa* | 1 model | Alliance of Genome Resources | |||
exfoliation syndrome | LYST | Lyst* | 1 model | Alliance of Genome Resources | |||
exudative vitreoretinopathy | NDP | Ndp* | 1 model | Alliance of Genome Resources | |||
exudative vitreoretinopathy | LRP5, LRP5L | Lrp5* | 4 models | Alliance of Genome Resources | |||
exudative vitreoretinopathy | FZD4 | Fzd4* | 2 models | Alliance of Genome Resources | |||
exudative vitreoretinopathy | TSPAN12 | Tspan12* | 1 model | Alliance of Genome Resources | |||
exudative vitreoretinopathy | CDH5 | Cdh5* | 1 model | Alliance of Genome Resources | |||
exudative vitreoretinopathy | CTNNB1 | Ctnnb1* | 1 model | Alliance of Genome Resources | |||
facioscapulohumeral muscular dystrophy | FAT1 | Fat1* | 3 models | Alliance of Genome Resources | |||
facioscapulohumeral muscular dystrophy | LARGE1 | Large1* | 1 model | Alliance of Genome Resources | |||
familial hemiplegic migraine | CACNA1A | Cacna1a* | 5 models | Alliance of Genome Resources | |||
focal dystonia | TOR1A | Tor1a* | 1 model | Alliance of Genome Resources | |||
frontotemporal dementia | TARDBP | Tardbp* | 2 models | Alliance of Genome Resources | |||
frontotemporal dementia | TREM2 | Trem2* | 1 model | Alliance of Genome Resources | |||
frontotemporal dementia | VCP | Vcp* | 1 model | Alliance of Genome Resources | |||
fundus albipunctatus | MFRP | Mfrp* | 2 models | Alliance of Genome Resources | |||
generalized dystonia | CACNA1A | Cacna1a* | 2 models | Alliance of Genome Resources | |||
generalized epilepsy with febrile seizures plus | GABRG2 | Gabrg2* | 1 model | Alliance of Genome Resources | |||
generalized epilepsy with febrile seizures plus | SCN1B | Scn1b* | 1 model | Alliance of Genome Resources | |||
glaucoma | LGR4 | Lgr4* | 1 model | Alliance of Genome Resources | |||
glaucoma | SH3PXD2B | Sh3pxd2b* | 1 model | Alliance of Genome Resources | |||
glaucoma | PITX2 | Pitx2* | 1 model | Alliance of Genome Resources | |||
glaucoma | METTL23 | Mettl23* | 4 models | Alliance of Genome Resources | |||
glioblastoma | TP53 | Trp53* | 2 models | Alliance of Genome Resources | |||
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | TARDBP | Tardbp* | 1 model | Alliance of Genome Resources | |||
Guillain-Barre syndrome | CD86 | Cd86* | 1 model | Alliance of Genome Resources | |||
Guillain-Barre syndrome | AIRE | Aire* | 1 model | Alliance of Genome Resources | |||
hereditary ataxia | SCYL1 | Scyl1* | 1 model | Alliance of Genome Resources | |||
hereditary ataxia | RNF170 | Rnf170* | 1 model | Alliance of Genome Resources | |||
hereditary sensory neuropathy | DST | Dst* | 1 model | Alliance of Genome Resources | |||
hereditary sensory neuropathy | SCN11A | Scn11a* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia | BORCS7 | Borcs7* | 1 model | Alliance of Genome Resources | |||
holoprosencephaly | PIGN | Pign* | 1 model | Alliance of Genome Resources | |||
holoprosencephaly | NOSIP | Nosip* | 1 model | Alliance of Genome Resources | |||
holoprosencephaly | PGAP1 | Pgap1* | 1 model | Alliance of Genome Resources | |||
Huntington's disease | ZDHHC17 | Zdhhc17* | 1 model | Alliance of Genome Resources | |||
Huntington's disease | PPARD | Ppard* | 1 model | Alliance of Genome Resources | |||
Huntington's disease | ZDHHC13 | Zdhhc13* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | SOX3 | Sox3* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | STK36 | Stk36* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | KIF27 | Kif27* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | HYDIN | Hydin* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | E2F5 | E2f5* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | DPCD | Dpcd* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | CELSR2 | Celsr2* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | CCDC85C | Ccdc85c* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | CCDC39 | Ccdc39* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | AK8 | Ak8* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | AK7 | Ak7* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | ADD1 | Add1* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | MBOAT7 | Mboat7* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | ULK4 | Ulk4* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | NME5 | Nme5* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | NME7 | Nme7* | 1 model | Alliance of Genome Resources | |||
hydrocephalus | POMK | Pomk* | 1 model | Alliance of Genome Resources | |||
hyperekplexia | GLRA1 | Glra1* | 1 model | Alliance of Genome Resources | |||
idiopathic generalized epilepsy | GABRA1 | Gabra1* | 3 models | Alliance of Genome Resources | |||
idiopathic generalized epilepsy | DNM1 | Dnm1* | 2 models | Alliance of Genome Resources | |||
Joubert syndrome | ZIC1 | Zic1* | 1 model | Alliance of Genome Resources | |||
juvenile glaucoma | PAX6 | Pax6* | 1 model | Alliance of Genome Resources | |||
Lafora disease | EPM2A | Epm2a* | 1 model | Alliance of Genome Resources | |||
Lafora disease | NHLRC1 | Nhlrc1* | 3 models | Alliance of Genome Resources | |||
Lambert-Eaton myasthenic syndrome | CACNA1A | Cacna1a* | 1 model | Alliance of Genome Resources | |||
Leber congenital amaurosis | CCT2 | Cct2* | 1 model | Alliance of Genome Resources | |||
Leber congenital amaurosis | PALS1 | Pals1* | 1 model | Alliance of Genome Resources | |||
Lennox-Gastaut syndrome | DGKD | Dgkd* | 1 model | Alliance of Genome Resources | |||
lens disease | ADAMTSL4 | Adamtsl4* | 1 model | Alliance of Genome Resources | |||
leukodystrophy | CLCN2 | Clcn2* | 1 model | Alliance of Genome Resources | |||
leukoencephalopathy with vanishing white matter | EIF2B4 | Eif2b4* | 4 models | Alliance of Genome Resources | |||
limb-girdle muscular dystrophy | SGCG | Sgcg* | 1 model | Alliance of Genome Resources | |||
lissencephaly | DCX | Dcx* | 1 model | Alliance of Genome Resources | |||
lissencephaly | DAG1 | Dag1* | 2 models | Alliance of Genome Resources | |||
lissencephaly | ARX | Arx* | 2 models | Alliance of Genome Resources | |||
low tension glaucoma | SOD1 | Sod1* | 1 model | Alliance of Genome Resources | |||
low tension glaucoma | SLC1A3 | Slc1a3* | 1 model | Alliance of Genome Resources | |||
low tension glaucoma | SLC1A1 | Slc1a1* | 1 model | Alliance of Genome Resources | |||
malignant astrocytoma | HRAS | Hras* | 1 model | Alliance of Genome Resources | |||
Marfan syndrome | MUS81 | Mus81* | 1 model | Alliance of Genome Resources | |||
medulloblastoma | IFNG | Ifng* | 2 models | Alliance of Genome Resources | |||
medulloblastoma | PTCH1 | Ptch1* | 12 models | Alliance of Genome Resources | |||
medulloblastoma | SMO | Smo* | 8 models | Alliance of Genome Resources | |||
megalencephalic leukoencephalopathy with subcortical cysts | HEPACAM | Hepacam* | 1 model | Alliance of Genome Resources | |||
microcephaly | PPIL1 | Ppil1* | 2 models | Alliance of Genome Resources | |||
microcephaly | COPB2 | Copb2* | 1 model | Alliance of Genome Resources | |||
microcephaly | TUBB | Tubb5* | 2 models | Alliance of Genome Resources | |||
microcephaly | KIF20B | Kif20b* | 1 model | Alliance of Genome Resources | |||
microphthalmia | RALBP1 | Ralbp1* | 1 model | Alliance of Genome Resources | |||
microphthalmia | ARHGAP6 | Arhgap6* | 3 models | Alliance of Genome Resources | |||
microphthalmia | TRPM3 | Trpm3* | 3 models | Alliance of Genome Resources | |||
microphthalmia | MID1 | Mid1* | 3 models | Alliance of Genome Resources | |||
motor neuron disease | RHOT1 | Rhot1* | 1 model | Alliance of Genome Resources | |||
motor peripheral neuropathy | STMN2 | Stmn2* | 2 models | Alliance of Genome Resources | |||
motor peripheral neuropathy | SLC12A6 | Slc12a6* | 1 model | Alliance of Genome Resources | |||
movement disease | EFNB3 | Efnb3* | 1 model | Alliance of Genome Resources | |||
multiple sclerosis | LRCH1 | Lrch1* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | FKRP | Fkrp* | 2 models | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | LARGE1 | Large1* | 3 models | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | POMGNT1 | Pomgnt1* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | B4GAT1 | B4gat1* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | FKTN | Fktn* | 3 models | Alliance of Genome Resources | |||
myopia | ADORA2A | Adora2a* | 1 model | Alliance of Genome Resources | |||
myotonic disease | MBNL1 | Mbnl1* | 2 models | Alliance of Genome Resources | |||
neuroaxonal dystrophy | BORCS7 | Borcs7* | 1 model | Alliance of Genome Resources | |||
neuroblastoma | LIN28B | Lin28b* | 1 model | Alliance of Genome Resources | |||
neurodegeneration with brain iron accumulation 2a | nad* | 1 model | |||||
neurodegeneration with brain iron accumulation 2a | gnd* | 1 model | |||||
neurodegeneration with brain iron accumulation 2a | inad* | 1 model | |||||
neurodegenerative disease | HPDL | Hpdl* | 1 model | Alliance of Genome Resources | |||
neurodegenerative disease | CLEC16A | Clec16a* | 1 model | Alliance of Genome Resources | |||
neurogenic-type arthrogryposis multiplex congenita-2 | pma* | 1 model | |||||
neuromuscular disease | NEMF | Nemf* | 3 models | Alliance of Genome Resources | |||
neuropathy | STMN2 | Stmn2* | 1 model | Alliance of Genome Resources | |||
neuropathy | NEMF | Nemf* | 3 models | Alliance of Genome Resources | |||
neuropathy | MPZ | Mpz* | 2 models | Alliance of Genome Resources | |||
nonsyndromic deafness | m12Anu* | 1 model | |||||
nonsyndromic deafness | WFS1 | Wfs1* | 1 model | Alliance of Genome Resources | |||
nonsyndromic deafness | PPIP5K2 | Ppip5k2* | 1 model | Alliance of Genome Resources | |||
nonsyndromic deafness | KLC2 | Klc2* | 1 model | Alliance of Genome Resources | |||
nonsyndromic deafness | ALG10, ALG10B | Alg10b* | 1 model | Alliance of Genome Resources | |||
normal pressure hydrocephalus | CWH43 | Cwh43* | 3 models | Alliance of Genome Resources | |||
normal pressure hydrocephalus | p23-ST1* | 1 model | |||||
normal pressure hydrocephalus | AK9 | Ak9* | 1 model | Alliance of Genome Resources | |||
obstructive hydrocephalus | MYO9A | Myo9a* | 1 model | Alliance of Genome Resources | |||
ocular albinism 1 | SLC24A5 | Slc24a5* | 1 model | Alliance of Genome Resources | |||
ocular albinism with sensorineural deafness | MITF | Mitf* | 14 models | Alliance of Genome Resources | |||
optic atrophy | RPL24 | Rpl24* | 1 model | Alliance of Genome Resources | |||
otitis media | BPIFA1 | Bpifa1*, Bpifa5 | 1 model | Alliance of Genome Resources | |||
otitis media | CBY1 | Cby1* | 1 model | Alliance of Genome Resources | |||
otitis media | DNAH5 | Dnah5* | 1 model | Alliance of Genome Resources | |||
otitis media | E2F4 | E2f4* | 1 model | Alliance of Genome Resources | |||
otitis media | ENPP1 | Enpp1* | 1 model | Alliance of Genome Resources | |||
otitis media | EYA4 | Eya4* | 1 model | Alliance of Genome Resources | |||
otitis media | FBXO11 | Fbxo11* | 3 models | Alliance of Genome Resources | |||
otitis media | FGFR1 | Fgfr1* | 2 models | Alliance of Genome Resources | |||
otitis media | IDUA | Idua* | 1 model | Alliance of Genome Resources | |||
otitis media | LMNA | Lmna* | 1 model | Alliance of Genome Resources | |||
otitis media | MECOM | Mecom* | 2 models | Alliance of Genome Resources | |||
otitis media | NAGLU | Naglu* | 1 model | Alliance of Genome Resources | |||
otitis media | NF2 | Nf2* | 3 models | Alliance of Genome Resources | |||
otitis media | NISCH | Nisch* | 1 model | Alliance of Genome Resources | |||
otitis media | PHEX | Phex* | 1 model | Alliance of Genome Resources | |||
otitis media | RPL38 | Rpl38* | 1 model | Alliance of Genome Resources | |||
otitis media | SALL4 | Sall4* | 1 model | Alliance of Genome Resources | |||
otitis media | SH3PXD2B | Sh3pxd2b* | 1 model | Alliance of Genome Resources | |||
otitis media | TBX1 | Tbx1* | 1 model | Alliance of Genome Resources | |||
otitis media | TGIF1 | Tgif1* | 1 model | Alliance of Genome Resources | |||
otitis media | TP73 | Trp73* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | ATG7 | Atg7* | 2 models | Alliance of Genome Resources | |||
Parkinson's disease | COX10 | Cox10* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | DRD2 | Drd2* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | KCNN2 | Kcnn2* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | MINAR2 | Minar2* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | nm3* | 1 model | |||||
Parkinson's disease | PITX3 | Pitx3* | 3 models | Alliance of Genome Resources | |||
Parkinson's disease | RRN3, RRN3P1, RRN3P2 | Rrn3* | 2 models | Alliance of Genome Resources | |||
Parkinson's disease | SPR | Spr* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | TWNK | Twnk* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | ADCY5 | Adcy5* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | ADH7 | Adh7* | 1 model | Alliance of Genome Resources | |||
partial central choroid dystrophy | PRPH2 | Prph2* | 2 models | Alliance of Genome Resources | |||
Peters anomaly | PAX6 | Pax6* | 5 models | Alliance of Genome Resources | |||
pigment dispersion syndrome | COL18A1 | Col18a1* | 1 model | Alliance of Genome Resources | |||
pigment dispersion syndrome | GPNMB | Gpnmb* | 5 models | Alliance of Genome Resources | |||
porencephaly | COL4A1 | Col4a1* | 1 model | Alliance of Genome Resources | |||
primary open angle glaucoma | GUCY1A1 | Gucy1a1* | 1 model | Alliance of Genome Resources | |||
progressive myoclonus epilepsy | SCARB2 | Scarb2* | 1 model | Alliance of Genome Resources | |||
pyridoxine-dependent epilepsy | ALDH7A1 | Aldh7a1* | 1 model | Alliance of Genome Resources | |||
restless legs syndrome | DRD3 | Drd3* | 1 model | Alliance of Genome Resources | |||
restless legs syndrome | MEIS1 | Meis1* | 1 model | Alliance of Genome Resources | |||
restless legs syndrome | BTBD9 | Btbd9* | 4 models | Alliance of Genome Resources | |||
retinal degeneration | MDM1 | Mdm1* | 1 model | Alliance of Genome Resources | |||
retinal degeneration | FSCN2 | Fscn2* | 1 model | Alliance of Genome Resources | |||
retinal degeneration | rd21* | 1 model | |||||
retinal degeneration | PDE6B | Pde6b* | 1 model | Alliance of Genome Resources | |||
retinal degeneration | NMNAT1 | Nmnat1* | 1 model | Alliance of Genome Resources | |||
retinal degeneration | IFT172 | Ift172* | 1 model | Alliance of Genome Resources | |||
retinal detachment | PRKCQ | Prkcq* | 2 models | Alliance of Genome Resources | |||
retinal vein occlusion | NRP1 | Nrp1* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa | AGTPBP1 | Agtpbp1* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa | CCDC66 | Ccdc66* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa | PDE6G | Pde6g* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa | SLC6A6 | Slc6a6* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa | CEP250 | Cep250* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa | CFAP418 | Cfap418* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa | CRB2 | Crb2* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa | CWC27 | Cwc27* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa | EPG5 | Epg5* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa | PDE6A | Pde6a* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa | PDE6B | Pde6b* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 2 | ARL3 | Arl3* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 49 | rd24* | 1 model | |||||
retinoschisis | mrs1* | 1 model | |||||
scapuloperoneal myopathy | FHL1 | Fhl1* | 1 model | Alliance of Genome Resources | |||
sclerocornea | RAD54L | Rad54l* | 1 model | Alliance of Genome Resources | |||
sensorineural hearing loss | GAS2 | Gas2* | 1 model | Alliance of Genome Resources | |||
sensorineural hearing loss | SLC7A8 | Slc7a8* | 1 model | Alliance of Genome Resources | |||
sensorineural hearing loss | SLC7A14 | Slc7a14* | 2 models | Alliance of Genome Resources | |||
sensorineural hearing loss | SLITRK6 | Slitrk6* | 1 model | Alliance of Genome Resources | |||
severe nonproliferative diabetic retinopathy | PDGFRB | Pdgfrb* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 27 | FGF14 | Fgf14* | 1 model | Alliance of Genome Resources | |||
Stargardt disease | ABCA4 | Abca4* | 5 models | Alliance of Genome Resources | |||
Stargardt disease | ELOVL4 | Elovl4* | 2 models | Alliance of Genome Resources | |||
Stiff-Person syndrome | TRAK1 | Trak1* | 1 model | Alliance of Genome Resources | |||
temporal lobe epilepsy | GLUL | Glul* | 1 model | Alliance of Genome Resources | |||
temporal lobe epilepsy | SLC32A1 | Slc32a1* | 1 model | Alliance of Genome Resources | |||
temporal lobe epilepsy | KCNA1 | Kcna1* | 1 model | Alliance of Genome Resources | |||
trigeminal neuralgia | GABRG1 | Gabrg1* | 1 model | Alliance of Genome Resources | |||
tropical spastic paraparesis | ZEB1 | Zeb1* | 1 model | Alliance of Genome Resources | |||
tympanosclerosis | ENPP1 | Enpp1* | 1 model | Alliance of Genome Resources | |||
Ullrich congenital muscular dystrophy | COL6A1 | Col6a1* | 1 model | Alliance of Genome Resources | |||
Ullrich congenital muscular dystrophy | COL6A3 | Col6a3* | 1 model | Alliance of Genome Resources | |||
uveal melanoma | GRM1 | Grm1* | 1 model | Alliance of Genome Resources | |||
vestibular disease | KCNA10 | Kcna10* | 1 model | Alliance of Genome Resources | |||
Walker-Warburg syndrome | COL4A1 | Col4a1* | 1 model | Alliance of Genome Resources | |||
Werdnig-Hoffmann disease | VPS54 | Vps54* | 1 model | Alliance of Genome Resources | |||
acoustic neuroma | CYP2E1* | Cyp2e1 | Alliance of Genome Resources | ||||
acoustic neuroma | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
acoustic neuroma | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
acute disseminated encephalomyelitis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
acute disseminated encephalomyelitis | HLA-DRB1*, HLA-DRB5*, HLA-DRB3, HLA-DRB4 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
acute retinal necrosis syndrome | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
adult-onset leukoencephalopathy with axonal spheroids and pigmented glia | CSF1R* | Csf1r | Alliance of Genome Resources | ||||
adult spinal muscular atrophy | SMN1*, SMN2 | Smn1 | Alliance of Genome Resources | ||||
age related macular degeneration | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
age related macular degeneration | FBLN5* | Fbln5 | Alliance of Genome Resources | ||||
age related macular degeneration 1 | HMCN1* | Hmcn1 | Alliance of Genome Resources | ||||
age related macular degeneration 1 | CFHR3* | Cfhr2 | Alliance of Genome Resources | ||||
age related macular degeneration 1 | CFHR1*, CFHR2 | Cfhr1 | Alliance of Genome Resources | ||||
age related macular degeneration 1 | APOE* | Apoe | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 11 | CST3* | Cst3 | Alliance of Genome Resources | ||||
age related macular degeneration 13 | CFI* | Cfi | Alliance of Genome Resources | ||||
age related macular degeneration 14 | CFB* | Cfb | Alliance of Genome Resources | ||||
age related macular degeneration 14 | C2* | C2 | Alliance of Genome Resources | ||||
age related macular degeneration 15 | C9* | C9 | Alliance of Genome Resources | ||||
age related macular degeneration 2 | ABCA4* | Abca4 | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 5 | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
age related macular degeneration 6 | RAX2* | ||||||
age related macular degeneration 7 | C3* | C3 | Alliance of Genome Resources | ||||
age related macular degeneration 7 | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
age related macular degeneration 8 | ARMS2* | ||||||
age related macular degeneration 9 | C3* | C3 | Alliance of Genome Resources | ||||
Aland Island eye disease | CACNA1F* | Cacna1f | Alliance of Genome Resources | ||||
allergic conjunctivitis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
allergic conjunctivitis | TNC* | Tnc | Alliance of Genome Resources | ||||
allergic conjunctivitis | IL4R* | Il4ra | Alliance of Genome Resources | ||||
allergic conjunctivitis | IL13* | Il13 | Alliance of Genome Resources | ||||
alternating hemiplegia of childhood | ATP1A2* | Atp1a2 | Alliance of Genome Resources | ||||
alveolar echinococcosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
alveolar echinococcosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
Alzheimer's disease | PSEN2* | Psen2 | 3 models | Alliance of Genome Resources | |||
Alzheimer's disease | PPP3R1* | Ppp3r1 | Alliance of Genome Resources | ||||
Alzheimer's disease | PPP2R2B* | Ppp2r2b | Alliance of Genome Resources | ||||
Alzheimer's disease | PPARG* | Pparg | Alliance of Genome Resources | ||||
Alzheimer's disease | PPARA* | Ppara | Alliance of Genome Resources | ||||
Alzheimer's disease | PON3* | Pon3 | Alliance of Genome Resources | ||||
Alzheimer's disease | PON2* | Pon2 | Alliance of Genome Resources | ||||
Alzheimer's disease | PON1* | Pon1 | Alliance of Genome Resources | ||||
Alzheimer's disease | PNMT* | Pnmt | Alliance of Genome Resources | ||||
Alzheimer's disease | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
Alzheimer's disease | PCK1* | Pck1 | Alliance of Genome Resources | ||||
Alzheimer's disease | PARP1* | Parp1 | Alliance of Genome Resources | ||||
Alzheimer's disease | NTRK2* | Ntrk2 | Alliance of Genome Resources | ||||
Alzheimer's disease | NTRK1* | Ntrk1 | Alliance of Genome Resources | ||||
Alzheimer's disease | NTF3* | Ntf3 | Alliance of Genome Resources | ||||
Alzheimer's disease | NOS3* | Nos3 | Alliance of Genome Resources | ||||
Alzheimer's disease | NOS1* | Nos1 | Alliance of Genome Resources | ||||
Alzheimer's disease | NGFR* | Ngfr | Alliance of Genome Resources | ||||
Alzheimer's disease | NFE2L2* | Nfe2l2 | Alliance of Genome Resources | ||||
Alzheimer's disease | NEFM* | Nefm | Alliance of Genome Resources | ||||
Alzheimer's disease | NECTIN2* | Nectin2 | Alliance of Genome Resources | ||||
Alzheimer's disease | NCSTN* | Ncstn | Alliance of Genome Resources | ||||
Alzheimer's disease | NCF2* | Ncf2 | Alliance of Genome Resources | ||||
Alzheimer's disease | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
Alzheimer's disease | MT3* | Mt3 | Alliance of Genome Resources | ||||
Alzheimer's disease | MCM2* | Mcm2 | Alliance of Genome Resources | ||||
Alzheimer's disease | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
Alzheimer's disease | MAPT* | Mapt | 2 models | Alliance of Genome Resources | |||
Alzheimer's disease | MAOB* | Maob | Alliance of Genome Resources | ||||
Alzheimer's disease | MAOA* | Maoa | Alliance of Genome Resources | ||||
Alzheimer's disease | LRPAP1* | Lrpap1 | Alliance of Genome Resources | ||||
Alzheimer's disease | LRP8* | Lrp8 | Alliance of Genome Resources | ||||
Alzheimer's disease | LPL* | Lpl | Alliance of Genome Resources | ||||
Alzheimer's disease | LIPC* | Lipc | Alliance of Genome Resources | ||||
Alzheimer's disease | LDLR* | Ldlr | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease | KLK6* | Klk6 | Alliance of Genome Resources | ||||
Alzheimer's disease | KLC1* | Klc1 | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease | KCNMA1* | Kcnma1 | Alliance of Genome Resources | ||||
Alzheimer's disease | IRS1* | Irs1 | Alliance of Genome Resources | ||||
Alzheimer's disease | IREB2* | Ireb2 | Alliance of Genome Resources | ||||
Alzheimer's disease | IL10* | Il10 | Alliance of Genome Resources | ||||
Alzheimer's disease | IL6R* | Il6ra | Alliance of Genome Resources | ||||
Alzheimer's disease | IL4* | Il4 | Alliance of Genome Resources | ||||
Alzheimer's disease | IL2* | Il2 | Alliance of Genome Resources | ||||
Alzheimer's disease | IL1B* | Il1b | Alliance of Genome Resources | ||||
Alzheimer's disease | IL1A* | Il1a | Alliance of Genome Resources | ||||
Alzheimer's disease | IGFBP3* | Igfbp3 | Alliance of Genome Resources | ||||
Alzheimer's disease | IGF1* | Igf1 | Alliance of Genome Resources | ||||
Alzheimer's disease | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
Alzheimer's disease | HTR6* | Htr6 | Alliance of Genome Resources | ||||
Alzheimer's disease | HSPA1A*, HSPA1B* | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
Alzheimer's disease | HMGCR* | Hmgcr | Alliance of Genome Resources | ||||
Alzheimer's disease | HFE* | Hfe | Alliance of Genome Resources | ||||
Alzheimer's disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
Alzheimer's disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
Alzheimer's disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
Alzheimer's disease | GSTO2* | Gsto2 | Alliance of Genome Resources | ||||
Alzheimer's disease | GSTO1* | Gsto1 | Alliance of Genome Resources | ||||
Alzheimer's disease | GSTM3* | Gstm5 | Alliance of Genome Resources | ||||
Alzheimer's disease | GSS* | Gss | Alliance of Genome Resources | ||||
Alzheimer's disease | GSK3B* | Gsk3b | Alliance of Genome Resources | ||||
Alzheimer's disease | GRN* | Grn | Alliance of Genome Resources | ||||
Alzheimer's disease | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
Alzheimer's disease | GLUL* | Glul | Alliance of Genome Resources | ||||
Alzheimer's disease | GCG* | Gcg | Alliance of Genome Resources | ||||
Alzheimer's disease | GAPDHS* | Gapdhs | Alliance of Genome Resources | ||||
Alzheimer's disease | GAPDH* | Gapdh, Gapdh-ps15, Gapdhrt, Gapdhrt2 | Alliance of Genome Resources | ||||
Alzheimer's disease | FYN* | Fyn | Alliance of Genome Resources | ||||
Alzheimer's disease | FAS* | Fas | Alliance of Genome Resources | ||||
Alzheimer's disease | ESR2* | Esr2 | Alliance of Genome Resources | ||||
Alzheimer's disease | ESR1* | Esr1 | Alliance of Genome Resources | ||||
Alzheimer's disease | EPO* | Epo | Alliance of Genome Resources | ||||
Alzheimer's disease | ENO1* | Eno1, Eno1b | Alliance of Genome Resources | ||||
Alzheimer's disease | EIF2S1* | Eif2s1 | Alliance of Genome Resources | ||||
Alzheimer's disease | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
Alzheimer's disease | ECE1* | Ece1 | Alliance of Genome Resources | ||||
Alzheimer's disease | DLST* | Dlst | Alliance of Genome Resources | ||||
Alzheimer's disease | CYP46A1* | Cyp46a1 | Alliance of Genome Resources | ||||
Alzheimer's disease | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
Alzheimer's disease | CTSD* | Ctsd | Alliance of Genome Resources | ||||
Alzheimer's disease | CLOCK* | Clock | Alliance of Genome Resources | ||||
Alzheimer's disease | CHAT* | Chat | Alliance of Genome Resources | ||||
Alzheimer's disease | CDK5R1* | Cdk5r1 | Alliance of Genome Resources | ||||
Alzheimer's disease | CDK5* | Cdk5 | Alliance of Genome Resources | ||||
Alzheimer's disease | CASP7* | Casp7 | Alliance of Genome Resources | ||||
Alzheimer's disease | C3* | C3 | Alliance of Genome Resources | ||||
Alzheimer's disease | C2* | C2 | Alliance of Genome Resources | ||||
Alzheimer's disease | BDNF* | Bdnf | Alliance of Genome Resources | ||||
Alzheimer's disease | BCHE* | Bche | Alliance of Genome Resources | ||||
Alzheimer's disease | BACE2* | Bace2 | Alliance of Genome Resources | ||||
Alzheimer's disease | BACE1* | Bace1 | Alliance of Genome Resources | ||||
Alzheimer's disease | APOE* | Apoe | 4 models | Alliance of Genome Resources | |||
Alzheimer's disease | APOC1* | Apoc1 | Alliance of Genome Resources | ||||
Alzheimer's disease | APOA4* | Apoa4 | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease | APOA1* | Apoa1 | Alliance of Genome Resources | ||||
Alzheimer's disease | APBB2* | Apbb2 | Alliance of Genome Resources | ||||
Alzheimer's disease | APBB1* | Apbb1 | Alliance of Genome Resources | ||||
Alzheimer's disease | ALDH2* | Aldh2 | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
Alzheimer's disease | AGER* | Ager | Alliance of Genome Resources | ||||
Alzheimer's disease | ADRB3* | Adrb3 | Alliance of Genome Resources | ||||
Alzheimer's disease | ADRA1A* | Adra1a | Alliance of Genome Resources | ||||
Alzheimer's disease | ADAM17* | Adam17 | Alliance of Genome Resources | ||||
Alzheimer's disease | ACHE* | Ache | Alliance of Genome Resources | ||||
Alzheimer's disease | ABCA1* | Abca1 | Alliance of Genome Resources | ||||
Alzheimer's disease | ABAT* | Abat | Alliance of Genome Resources | ||||
Alzheimer's disease | A2M* | A2m | Alliance of Genome Resources | ||||
Alzheimer's disease | XRN1* | Xrn1 | Alliance of Genome Resources | ||||
Alzheimer's disease | WT1* | Wt1 | Alliance of Genome Resources | ||||
Alzheimer's disease | VLDLR* | Vldlr | Alliance of Genome Resources | ||||
Alzheimer's disease | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
Alzheimer's disease | UQCRC1* | Uqcrc1 | Alliance of Genome Resources | ||||
Alzheimer's disease | UCHL1* | Uchl1 | Alliance of Genome Resources | ||||
Alzheimer's disease | TTR* | Ttr | Alliance of Genome Resources | ||||
Alzheimer's disease | TPH1* | Tph1 | Alliance of Genome Resources | ||||
Alzheimer's disease | TNF* | Tnf | Alliance of Genome Resources | ||||
Alzheimer's disease | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
Alzheimer's disease | TFAM* | Tfam | Alliance of Genome Resources | ||||
Alzheimer's disease | TAP2* | Tap2 | Alliance of Genome Resources | ||||
Alzheimer's disease | STAT3* | Stat3 | Alliance of Genome Resources | ||||
Alzheimer's disease | SORL1* | Sorl1 | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease | SOD2* | Sod2 | Alliance of Genome Resources | ||||
Alzheimer's disease | SNCA* | Snca | Alliance of Genome Resources | ||||
Alzheimer's disease | SERPINE2* | Serpine2 | Alliance of Genome Resources | ||||
Alzheimer's disease | S100B* | S100b | Alliance of Genome Resources | ||||
Alzheimer's disease | RCAN1* | Rcan1 | Alliance of Genome Resources | ||||
Alzheimer's disease 1 | MPO* | Mpo | Alliance of Genome Resources | ||||
Alzheimer's disease 1 | APP* | App | Alliance of Genome Resources | ||||
Alzheimer's disease 1 | PLAU* | Plau | Alliance of Genome Resources | ||||
Alzheimer's disease 18 | ADAM10* | Adam10 | Alliance of Genome Resources | ||||
Alzheimer's disease 2 | APOE* | Apoe | Alliance of Genome Resources | ||||
Alzheimer's disease 3 | APOE* | Apoe | Alliance of Genome Resources | ||||
Alzheimer's disease 4 | PSEN2* | Psen2 | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease 9 | ABCA7* | Abca7 | Alliance of Genome Resources | ||||
aminoglycoside-induced deafness | TRMU* | Trmu | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | VDR* | Vdr | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | AOX1* | Aox1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | APOE* | Apoe | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | CCS* | Ccs | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | CHMP2B* | Chmp2b | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | DPP6* | Dpp6 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | FUS* | Fus | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | GOT1* | Got1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | GRN* | Grn | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | GSK3A* | Gsk3a | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | GSK3B* | Gsk3b | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | HMGB1* | Hmgb1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | ITPR2* | Itpr2 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | NEFH* | Nefh | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | NEFL* | Nefl | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | OPTN* | Optn | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | PON2* | Pon2 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | PON3* | Pon3 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | PPARGC1A* | Ppargc1a | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | SLC11A2* | Slc11a2 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | SOD1* | Sod1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | TARDBP* | Tardbp | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | TFAM* | Tfam | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | TXNRD1* | Txnrd1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | UBQLN2* | Ubqln2 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | UNC13A* | Unc13a | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | VAPB* | Vapb | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis | ALS2* | Als2 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 | TRPM7* | Trpm7 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 1 | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 1 | NEFH* | Nefh | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 1 | PRPH* | Prph | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 11 | FIG4* | Fig4 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 12 | OPTN* | Optn | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 15 | UBQLN2* | Ubqln2 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 16 | SIGMAR1* | Sigmar1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 18 | PFN1* | Pfn1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 19 | ERBB4* | Erbb4 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 2 | ALS2* | Als2 | 3 "NOT" models | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 20 | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 22 | TUBA4A* | Tuba4a | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 23 | ANXA11* | Anxa11 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 24 | NEK1* | Nek1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 25 | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 26 | TIA1* | Tia1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 28 | LRP12* | Lrp12 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 5 | SPG11* | Spg11 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 8 | VAPB* | Vapb | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 9 | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
anencephaly | RPGRIP1L* | Rpgrip1l | Alliance of Genome Resources | ||||
anencephaly | MTRR* | Mtrr | Alliance of Genome Resources | ||||
anencephaly | NUAK2* | Nuak2 | Alliance of Genome Resources | ||||
anencephaly | TRIM36* | Trim36 | Alliance of Genome Resources | ||||
angle-closure glaucoma | HGF* | Hgf | Alliance of Genome Resources | ||||
angle-closure glaucoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
angle-closure glaucoma | CAT* | Cat | Alliance of Genome Resources | ||||
angle-closure glaucoma | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
angle-closure glaucoma | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
angle-closure glaucoma | NOS3* | Nos3 | Alliance of Genome Resources | ||||
angle-closure glaucoma | APOE* | Apoe | Alliance of Genome Resources | ||||
aniridia | TRIM44* | Trim44 | Alliance of Genome Resources | ||||
aniridia | ELP4* | Elp4 | Alliance of Genome Resources | ||||
aniridia 1 | PAX6* | Pax6 | Alliance of Genome Resources | ||||
anterior ischemic optic neuropathy | CSF3* | Csf3 | Alliance of Genome Resources | ||||
anterior ischemic optic neuropathy | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
anterior ischemic optic neuropathy | NOS3* | Nos3 | Alliance of Genome Resources | ||||
anterior segment dysgenesis | FOXE3* | Foxe3 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 1 | PITX3* | Pitx3 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 2 | FOXE3* | Foxe3 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 3 | FOXC1* | Foxc1 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 4 | PITX2* | Pitx2 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 5 | PAX6* | Pax6 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 6 | CYP1B1* | Cyp1b1 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 7 | PXDN* | Pxdn | Alliance of Genome Resources | ||||
anterior segment dysgenesis 8 | CPAMD8* | ||||||
anterior uveitis | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
anterior uveitis | TNF* | Tnf | Alliance of Genome Resources | ||||
anterior uveitis | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
anterior uveitis | CCL2*, CCL13 | Ccl2, Ccl12 | Alliance of Genome Resources | ||||
anterior uveitis | CFB* | Cfb | Alliance of Genome Resources | ||||
anterior uveitis | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
anterior uveitis | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
anterior uveitis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
arcus senilis | KERA* | Kera | Alliance of Genome Resources | ||||
arteriovenous malformations of the brain | IL6* | Il6 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita | VPS33B* | Vps33b | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita | TNNI2* | Tnni2 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita | MYH8* | Myh8 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita-1 | LGI4* | Lgi4 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita-3 | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita-4 | SCYL2* | Scyl2 | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita-5 | TOR1A* | Tor1a | Alliance of Genome Resources | ||||
arthrogryposis multiplex congenita-6 | NEB* | Neb | Alliance of Genome Resources | ||||
astroblastoma | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
ataxia-oculomotor apraxia type 4 | PNKP* | Pnkp | Alliance of Genome Resources | ||||
ataxia telangiectasia | BAK1* | Bak1 | Alliance of Genome Resources | ||||
ataxia telangiectasia | IL2* | Il2 | Alliance of Genome Resources | ||||
ataxia telangiectasia | IFNG* | Ifng | Alliance of Genome Resources | ||||
ataxia telangiectasia | HDAC4* | Hdac4 | Alliance of Genome Resources | ||||
ataxia telangiectasia | BIK* | Bik | Alliance of Genome Resources | ||||
ataxia telangiectasia | BAX* | Bax | Alliance of Genome Resources | ||||
ataxia-telangiectasia-like disorder-1 | MRE11* | Mre11a | Alliance of Genome Resources | ||||
ataxia-telangiectasia-like disorder-2 | PCNA* | Pcna | Alliance of Genome Resources | ||||
ataxia with oculomotor apraxia type 1 | APTX* | Aptx | Alliance of Genome Resources | ||||
ataxia with oculomotor apraxia type 3 | PIK3R5* | Pik3r5 | Alliance of Genome Resources | ||||
autoimmune disease of the nervous system | ANXA5* | Anxa5 | Alliance of Genome Resources | ||||
autoimmune disease of the nervous system | ALDOC* | Aldoc | Alliance of Genome Resources | ||||
autoimmune uveitis | CXCL8* | ||||||
autosomal dominant adult-onset proximal spinal muscular atrophy | VAPB* | Vapb | Alliance of Genome Resources | ||||
autosomal dominant auditory neuropathy 3 | TMEM43* | Tmem43 | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia | NPTX1* | Nptx1 | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia | FGF14* | Fgf14 | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia | SAMD9L* | Samd9l | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia, deafness and narcolepsy | DNMT1* | Dnmt1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 10 | EMILIN1* | Emilin1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 11 | SPTAN1* | Sptan1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 12 | REEP1* | Reep1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 13 | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 14 | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 3 | HSPB1* | Hspb1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 4 | HSPB3* | Hspb3 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 5 | GARS1* | Gars1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 6 | FBXO38* | Fbxo38 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 7 | SLC5A7* | Slc5a7 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 8 | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 9 | WARS1* | Wars1 | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | LMNA* | Lmna | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 4 | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 5 | SYNE2* | Syne2 | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 7 | TMEM43* | Tmem43 | Alliance of Genome Resources | ||||
autosomal dominant isolated ectopia lentis 1 | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
autosomal dominant keratitis | PAX6* | Pax6 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy | CAPN3* | Capn3 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 1 | DNAJB6* | Dnajb6 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 2 | TNPO3* | Tnpo3 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 3 | HNRNPDL* | Hnrnpdl | Alliance of Genome Resources | ||||
autosomal dominant nocturnal frontal lobe epilepsy | CHRNB2* | Chrnb2 | Alliance of Genome Resources | ||||
autosomal dominant nocturnal frontal lobe epilepsy 1 | CHRNA4* | Chrna4 | 1 "NOT" model | Alliance of Genome Resources | |||
autosomal dominant nocturnal frontal lobe epilepsy 4 | CHRNA2* | Chrna2 | Alliance of Genome Resources | ||||
autosomal dominant nocturnal frontal lobe epilepsy 5 | KCNT1* | Kcnt1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | PI4KB* | Pi4kb | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | COL11A1* | Col11a1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ELMOD3* | Elmod3 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | EPHA10* | Epha10 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | GREB1L* | Greb1l | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | MAP1B* | Map1b | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | MYO3A* | Myo3a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | THOC1* | Thoc1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | USP48* | Usp48 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ATP11A* | Atp11a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ATP2B2* | Atp2b2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ATOH1* | Atoh1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 1 | DIAPH1* | Diaph1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 10 | EYA4* | Eya4 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 11 | MYO7A* | Myo7a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 15 | POU4F3* | Pou4f3 | 1 "NOT" model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 17 | MYH9* | Myh9 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 20 | ACTG1* | Actg1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 21 | RIPOR2* | Ripor2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 23 | SIX1* | Six1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 27 | REST* | Rest | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 28 | GRHL2* | Grhl2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 2A | KCNQ4* | Kcnq4 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 2B | GJB3* | Gjb3 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 34 | NLRP3* | Nlrp3 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 3A | GJB2* | Gjb2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 3B | GJB6* | Gjb6 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 40 | CRYM* | Crym | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 44 | CCDC50* | Ccdc50 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 4A | MYH14* | Myh14 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 4B | CEACAM16* | Ceacam16 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 5 | GSDME* | Gsdme | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 50 | MIR96* | Mir96 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 56 | TNC* | Tnc | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 6 | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 64 | DIABLO* | Diablo | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 65 | TBC1D24* | Tbc1d24 | 2 "NOT" models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 66 | CD164* | Cd164 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 68 | HOMER2* | Homer2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 69 | KITLG* | Kitl | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 7 | LMX1A* | Lmx1a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 70 | MCM2* | Mcm2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 71 | DMXL2* | Dmxl2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 72 | SLC44A4* | Slc44a4 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 73 | PTPRQ* | Ptprq | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 74 | PDE1C* | Pde1c | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 75 | TRRAP* | Trrap | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 76 | PLS1* | Pls1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 77 | ABCC1* | Abcc1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 78 | SLC12A2* | Slc12a2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 79 | SCD5* | ||||||
autosomal dominant sensory ataxia 1 | RNF170* | Rnf170 | Alliance of Genome Resources | ||||
autosomal dominant vitreoretinochoroidopathy | BEST1* | Best1 | Alliance of Genome Resources | ||||
autosomal recessive congenital nystagmus | ROBO1* | Robo1 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 10 | VRK1* | Vrk1 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 2 | SIGMAR1* | Sigmar1 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 4 | PLEKHG5* | Plekhg5 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 5 | DNAJB2* | Dnajb2 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 6 | REEP1* | Reep1 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 7 | VWA1* | Vwa1 | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 8 | SORD* | Sord | Alliance of Genome Resources | ||||
autosomal recessive distal hereditary motor neuronopathy 9 | COQ7* | Coq7 | Alliance of Genome Resources | ||||
autosomal recessive Emery-Dreifuss muscular dystrophy 3 | LMNA* | Lmna | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | JAG2* | Jag2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | HMGCR* | Hmgcr | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | POPDC3* | Popdc3 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | LAMA2* | Lama2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2D | DAG1* | Dag1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2K | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2L | FKTN* | Fktn | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2M | FKTN* | Fktn | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2N | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2O | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2Q | PLEC* | Plec | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2S | TRAPPC11* | Trappc11 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2T | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2W | LIMS2* | Lims2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2X | POPDC1* | Popdc1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2Y | TOR1AIP1* | Tor1aip1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2Z | POGLUT1* | Poglut1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | STX4* | Stx4a | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | AFG2B* | Afg2b | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | CDH23* | Cdh23 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | CLRN2* | Clrn2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | GPR156* | Gpr156 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | MINAR2* | Minar2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | PKHD1L1* | Pkhd1l1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness | TMTC4* | Tmtc4 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 100 | PPIP5K2* | Ppip5k2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 101 | GRXCR2* | Grxcr2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 102 | EPS8* | Eps8 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 103 | CLIC5* | Clic5 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 104 | RIPOR2* | Ripor2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 106 | EPS8L2* | Eps8l2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 107 | WBP2* | Wbp2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 108 | ROR1* | Ror1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 109 | ESRP1* | Esrp1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 110 | COCH* | Coch | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 111 | MPZL2* | Mpzl2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 112 | BDP1* | Bdp1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 113 | CEACAM16* | Ceacam16 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 114 | GRAP*, GRAPL | Grap | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 115 | SPNS2* | Spns2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 116 | CLDN9* | Cldn9 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 12 | ATP2B2* | Atp2b2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 15 | GIPC3* | Gipc3 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 1A | GJB3* | Gjb3 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 1B | GJB6* | Gjb6 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 21 | TECTA* | Tecta | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 24 | RDX* | Rdx | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 25 | GRXCR1* | Grxcr1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 26 | GAB1* | Gab1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 35 | ESRRB* | Esrrb | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 36 | ESPN* | Espn | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 4 | FOXI1* | Foxi1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 4 | KCNJ10* | Kcnj10 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 4 | SLC26A4* | Slc26a4 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 44 | ADCY1* | Adcy1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 53 | COL11A2* | Col11a2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 57 | PDZD7* | Pdzd7 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 6 | TMIE* | Tmie | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 61 | SLC26A5* | Slc26a5 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 66 | DCDC2* | Dcdc2a | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 67 | LHFPL5* | Lhfpl5 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 70 | PNPT1* | Pnpt1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 76 | SYNE4* | Syne4 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 77 | LOXHD1* | Loxhd1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 8 | TMPRSS3* | Tmprss3 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 84A | PTPRQ* | Ptprq | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 84B | OTOGL* | Otogl | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 86 | TBC1D24* | Tbc1d24 | 1 "NOT" model | Alliance of Genome Resources | |||
autosomal recessive nonsyndromic deafness 89 | KARS1* | Kars1 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 91 | SERPINB6* | Serpinb6a, Serpinb6b, Serpinb6c, Serpinb6d, Serpinb6e | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 94 | NARS2* | Nars2 | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 97 | MET* | Met | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 98 | TSPEAR* | Tspear | Alliance of Genome Resources | ||||
autosomal recessive nonsyndromic deafness 99 | TMEM132E* | Tmem132e | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 10 | ANO10* | Ano10 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 11 | SYT14* | Syt14 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 14 | SPTBN2* | Sptbn2 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 15 | RUBCN* | Rubcn | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 17 | CWF19L1* | Cwf19l1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 19 | SLC9A1* | Slc9a1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 2 | PMPCA* | Pmpca | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 20 | SNX14* | Snx14 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 21 | SCYL1* | Scyl1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 22 | VWA3B* | Vwa3b | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 23 | TDP2* | Tdp2 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 24 | UBA5* | Uba5 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 25 | ATG5* | Atg5 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 26 | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 27 | GDAP2* | Gdap2 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 28 | THG1L* | Thg1l | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 29 | VPS41* | Vps41 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 30 | PITRM1* | Pitrm1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 31 | ATG7* | Atg7 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 32 | PRDX3* | Prdx3 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 33 | RNU12* | ||||||
autosomal recessive spinocerebellar ataxia 4 | VPS13D* | Vps13d | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 7 | TPP1* | Tpp1 | Alliance of Genome Resources | ||||
autosomal recessive spinocerebellar ataxia 8 | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
Axenfeld-Rieger syndrome | FOXC1* | Foxc1 | Alliance of Genome Resources | ||||
Axenfeld-Rieger syndrome | PITX2* | Pitx2 | Alliance of Genome Resources | ||||
Axenfeld-Rieger syndrome type 3 | FOXC1* | Foxc1 | Alliance of Genome Resources | ||||
background diabetic retinopathy | A2M* | A2m | Alliance of Genome Resources | ||||
bacterial meningitis | PARP1* | Parp1 | Alliance of Genome Resources | ||||
bacterial meningitis | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
basal ganglia calcification | XPR1* | Xpr1 | Alliance of Genome Resources | ||||
basal ganglia calcification | JAM2* | Jam2 | Alliance of Genome Resources | ||||
basal ganglia calcification | MYORG* | Myorg | Alliance of Genome Resources | ||||
basal ganglia calcification | PDGFB* | Pdgfb | Alliance of Genome Resources | ||||
basal ganglia disease | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
basal laminar drusen | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
Behr syndrome | OPA1* | Opa1 | Alliance of Genome Resources | ||||
benign familial infantile seizures 2 | PRRT2* | Prrt2 | Alliance of Genome Resources | ||||
benign familial infantile seizures 3 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
benign familial infantile seizures 5 | SCN8A* | Scn8a | Alliance of Genome Resources | ||||
benign familial infantile seizures 6 | CHRNA2* | Chrna2 | Alliance of Genome Resources | ||||
benign neonatal seizures | ATP1A2* | Atp1a2 | Alliance of Genome Resources | ||||
Bethlem myopathy | COL12A1* | Col12a1 | Alliance of Genome Resources | ||||
Bethlem myopathy | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
Bethlem myopathy | COL6A2* | Col6a2 | Alliance of Genome Resources | ||||
bilateral frontoparietal polymicrogyria | ADGRG1* | Adgrg1 | Alliance of Genome Resources | ||||
bilateral optic nerve hypoplasia | PAX6* | Pax6 | Alliance of Genome Resources | ||||
bilateral parasagittal parieto-occipital polymicrogyria | FIG4* | Fig4 | Alliance of Genome Resources | ||||
bilateral perisylvian polymicrogyria | ADGRG1* | Adgrg1 | Alliance of Genome Resources | ||||
birdshot chorioretinopathy | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
blepharospasm | DRD5* | Drd5 | Alliance of Genome Resources | ||||
blindness | VSX2* | Vsx2 | Alliance of Genome Resources | ||||
blindness | AIPL1* | Aipl1 | Alliance of Genome Resources | ||||
blindness | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
blue color blindness | OPN1SW* | Opn1sw | Alliance of Genome Resources | ||||
brachial plexus neuritis | SEPTIN9* | Septin9 | Alliance of Genome Resources | ||||
bradyopsia 1 | RGS9* | Rgs9 | Alliance of Genome Resources | ||||
bradyopsia 2 | RGS9BP* | Rgs9bp | Alliance of Genome Resources | ||||
brain cancer | TERT* | Tert | Alliance of Genome Resources | ||||
brain cancer | CCDC26* | ||||||
brain cancer | CDKN2B-AS1* | ||||||
brain disease | NUP214* | Nup214 | Alliance of Genome Resources | ||||
brain disease | IRF3* | Irf3 | Alliance of Genome Resources | ||||
brain disease | TRAF3* | Traf3 | Alliance of Genome Resources | ||||
brain disease | UNC93B1* | Unc93b1 | Alliance of Genome Resources | ||||
brain disease | PPP2R2B* | Ppp2r2b | Alliance of Genome Resources | ||||
brain disease | CPT2* | Cpt2 | Alliance of Genome Resources | ||||
brain disease | DBR1* | Dbr1 | Alliance of Genome Resources | ||||
brain disease | MFF* | Mff | Alliance of Genome Resources | ||||
brain disease | TBK1* | Tbk1 | Alliance of Genome Resources | ||||
brain disease | SNORA31* | ||||||
brain disease | RANBP2*, RGPD1, RGPD2, RGPD3, RGPD4, RGPD5, RGPD6, RGPD8 | Ranbp2 | Alliance of Genome Resources | ||||
brain disease | TICAM1* | Ticam1 | Alliance of Genome Resources | ||||
brain edema | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
brain glioma | PTPRB* | Ptprb | Alliance of Genome Resources | ||||
brain glioma | XRCC3* | Xrcc3 | Alliance of Genome Resources | ||||
brain glioma | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
brain glioma | ADAM3A* | Adam3 | Alliance of Genome Resources | ||||
brain infarction | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
brain infarction | ALOX5AP* | Alox5ap | Alliance of Genome Resources | ||||
brain infarction | ALDH2* | Aldh2 | Alliance of Genome Resources | ||||
brain infarction | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
brain infarction | CYP2R1* | Cyp2r1 | Alliance of Genome Resources | ||||
brain infarction | ADM* | Adm | Alliance of Genome Resources | ||||
brain ischemia | PGF* | Pgf | Alliance of Genome Resources | ||||
brain ischemia | ANGPT1* | Angpt1 | Alliance of Genome Resources | ||||
brain ischemia | ANXA1* | Anxa1 | Alliance of Genome Resources | ||||
brain ischemia | CSF3* | Csf3 | Alliance of Genome Resources | ||||
brain ischemia | FGF1* | Fgf1 | Alliance of Genome Resources | ||||
brain ischemia | HSPA1B*, HSPA1A | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
brain ischemia | IGF1* | Igf1 | Alliance of Genome Resources | ||||
brain ischemia | MDK* | Mdk | Alliance of Genome Resources | ||||
brain ischemia | PROZ* | Proz | Alliance of Genome Resources | ||||
brain ischemia | SELE* | Sele | Alliance of Genome Resources | ||||
brain small vessel disease | FGA* | Fga | Alliance of Genome Resources | ||||
brain small vessel disease | NR1D1* | Nr1d1 | Alliance of Genome Resources | ||||
brain small vessel disease | FGG* | Fgg | Alliance of Genome Resources | ||||
brain small vessel disease 2 | COL4A2* | Col4a2 | Alliance of Genome Resources | ||||
brain small vessel disease 3 | COLGALT1* | Colgalt1 | Alliance of Genome Resources | ||||
brittle cornea syndrome 2 | PRDM5* | Prdm5 | Alliance of Genome Resources | ||||
Brody myopathy | ATP2A1* | Atp2a1 | Alliance of Genome Resources | ||||
CADASIL | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
CADASIL 2 | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
carotid artery disease | SOD2* | Sod2 | Alliance of Genome Resources | ||||
carotid artery disease | MMP8* | Mmp8 | Alliance of Genome Resources | ||||
carotid artery disease | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
carotid artery disease | SREBF2* | Srebf2 | Alliance of Genome Resources | ||||
carotid artery disease | AGT* | Agt | Alliance of Genome Resources | ||||
carotid artery disease | FGB* | Fgb | Alliance of Genome Resources | ||||
carotid artery disease | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
carotid artery disease | PPARG* | Pparg | Alliance of Genome Resources | ||||
carotid artery disease | PRL* | Prl | Alliance of Genome Resources | ||||
carotid artery disease | PTGDS* | Ptgds | Alliance of Genome Resources | ||||
carotid artery disease | SELPLG* | Selplg | Alliance of Genome Resources | ||||
carotid artery disease | UCP2* | Ucp2 | Alliance of Genome Resources | ||||
carotid artery disease | XDH* | Xdh | Alliance of Genome Resources | ||||
carotid artery disease | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
carotid artery disease | LUM* | Lum | Alliance of Genome Resources | ||||
carotid artery disease | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
carotid artery disease | LTA* | Lta | Alliance of Genome Resources | ||||
carotid artery disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
carotid artery disease | GNB3* | Gnb3 | Alliance of Genome Resources | ||||
carotid artery disease | CD14* | Cd14 | Alliance of Genome Resources | ||||
carotid artery disease | CETP* | ||||||
carotid artery disease | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
carotid artery thrombosis | THBD* | Thbd | Alliance of Genome Resources | ||||
carotid stenosis | FABP2* | Fabp2 | Alliance of Genome Resources | ||||
carotid stenosis | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
carotid stenosis | PTGIS* | Ptgis | Alliance of Genome Resources | ||||
carotid stenosis | MT2A*, MT1A, MT1B, MT1E, MT1F, MT1G, MT1H, MT1L, MT1M, MT1X | Mt1, Mt2 | Alliance of Genome Resources | ||||
carotid stenosis | F2* | F2 | Alliance of Genome Resources | ||||
carotid stenosis | MMP3* | Mmp3 | Alliance of Genome Resources | ||||
carotid stenosis | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
carpal tunnel syndrome 1 | TTR* | Ttr | Alliance of Genome Resources | ||||
carpal tunnel syndrome 2 | COMP* | Comp | Alliance of Genome Resources | ||||
cataract | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
cataract | AKR1B1* | Akr1b1 | Alliance of Genome Resources | ||||
cataract | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
cataract | BCOR*, BCORP1 | Bcor | Alliance of Genome Resources | ||||
cataract | BFSP2* | Bfsp2 | Alliance of Genome Resources | ||||
cataract | CRYBA1* | Cryba1 | Alliance of Genome Resources | ||||
cataract | CRYBB1* | Crybb1 | Alliance of Genome Resources | ||||
cataract | CRYBB2* | Crybb2 | Alliance of Genome Resources | ||||
cataract | CRYGC* | Crygc | Alliance of Genome Resources | ||||
cataract | GALK1* | Galk1 | Alliance of Genome Resources | ||||
cataract | GCNT2* | Gcnt2 | Alliance of Genome Resources | ||||
cataract | GJA8* | Gja8 | Alliance of Genome Resources | ||||
cataract | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
cataract | HSF4* | Hsf4 | Alliance of Genome Resources | ||||
cataract | MAF* | Maf | Alliance of Genome Resources | ||||
cataract | MIP* | Mip | Alliance of Genome Resources | ||||
cataract | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
cataract | NFE2L2* | Nfe2l2 | Alliance of Genome Resources | ||||
cataract | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
cataract | PITX3* | Pitx3 | Alliance of Genome Resources | ||||
cataract | SOD1* | Sod1 | Alliance of Genome Resources | ||||
cataract 11 multiple types | PITX3* | Pitx3 | Alliance of Genome Resources | ||||
cataract 12 multiple types | BFSP2* | Bfsp2 | Alliance of Genome Resources | ||||
cataract 13 with adult i phenotype | GCNT2* | Gcnt2 | Alliance of Genome Resources | ||||
cataract 17 multiple types | CRYBB1* | Crybb1 | Alliance of Genome Resources | ||||
cataract 18 | FYCO1* | Fyco1 | Alliance of Genome Resources | ||||
cataract 22 multiple types | CRYBB3* | Crybb3 | Alliance of Genome Resources | ||||
cataract 23 | CRYBA4* | Cryba4 | Alliance of Genome Resources | ||||
cataract 27 | PAX6* | Pax6 | Alliance of Genome Resources | ||||
cataract 31 multiple types | CHMP4B* | Chmp4b | Alliance of Genome Resources | ||||
cataract 33 | BFSP1* | Bfsp1 | Alliance of Genome Resources | ||||
cataract 34 multiple types | FOXE3* | Foxe3 | Alliance of Genome Resources | ||||
cataract 36 | TDRD7* | Tdrd7 | Alliance of Genome Resources | ||||
cataract 38 | AGK* | Agk | Alliance of Genome Resources | ||||
cataract 40 | NHS* | Nhs | Alliance of Genome Resources | ||||
cataract 41 | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
cataract 42 | CRYBA2* | Cryba2 | Alliance of Genome Resources | ||||
cataract 43 | UNC45B* | Unc45b | Alliance of Genome Resources | ||||
cataract 44 | LSS* | Lss | Alliance of Genome Resources | ||||
cataract 45 | SIPA1L3* | Sipa1l3 | Alliance of Genome Resources | ||||
cataract 46 juvenile-onset | LEMD2* | Lemd2 | Alliance of Genome Resources | ||||
cataract 47 | SLC16A12* | Slc16a12 | Alliance of Genome Resources | ||||
cataract 48 | DNMBP* | Dnmbp | Alliance of Genome Resources | ||||
cataract 7 | CRYGD* | Crygd, Cryge, Crygf | Alliance of Genome Resources | ||||
cataract 9 multiple types | PITX3* | Pitx3 | Alliance of Genome Resources | ||||
central nervous system cancer | XRCC3* | Xrcc3 | Alliance of Genome Resources | ||||
central nervous system cancer | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
central nervous system lymphoma | BTK* | Btk | Alliance of Genome Resources | ||||
central nervous system lymphoma | IL10* | Il10 | Alliance of Genome Resources | ||||
central nervous system lymphoma | MYD88* | Myd88 | Alliance of Genome Resources | ||||
central nervous system lymphoma | CD79B* | Cd79b | Alliance of Genome Resources | ||||
central nervous system vasculitis | HLA-A*, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
central retinal vein occlusion | PROC* | Proc | Alliance of Genome Resources | ||||
cerebellar ataxia | RPGRIP1L* | Rpgrip1l | Alliance of Genome Resources | ||||
cerebellar ataxia | ATCAY* | Atcay | Alliance of Genome Resources | ||||
cerebellar ataxia | L2HGDH* | L2hgdh | Alliance of Genome Resources | ||||
cerebellar ataxia | POLG* | Polg | Alliance of Genome Resources | ||||
cerebellar ataxia | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
cerebellar ataxia type 41 | TRPC3* | Trpc3 | Alliance of Genome Resources | ||||
cerebellar ataxia type 43 | MME* | Mme | Alliance of Genome Resources | ||||
cerebellar ataxia type 47 | PUM1* | Pum1 | Alliance of Genome Resources | ||||
cerebellar ataxia type 48 | STUB1* | Stub1 | Alliance of Genome Resources | ||||
cerebral cavernous malformation | PON1* | Pon1 | Alliance of Genome Resources | ||||
cerebral cavernous malformation | PIK3CA* | Pik3ca | Alliance of Genome Resources | ||||
cerebral cavernous malformation 1 | KRIT1* | Krit1 | Alliance of Genome Resources | ||||
cerebral cavernous malformation 1 | PTGIS* | Ptgis | Alliance of Genome Resources | ||||
cerebral infarction | TOMM40* | Tomm40 | Alliance of Genome Resources | ||||
cerebral infarction | TYMS* | Tyms | Alliance of Genome Resources | ||||
cerebral infarction | ALOX5AP* | Alox5ap | Alliance of Genome Resources | ||||
cerebral infarction | AGXT2* | Agxt2 | Alliance of Genome Resources | ||||
cerebral infarction | ACE* | Ace | Alliance of Genome Resources | ||||
cerebral infarction | APOA5* | Apoa5 | Alliance of Genome Resources | ||||
cerebral infarction | APOE* | Apoe | Alliance of Genome Resources | ||||
cerebral infarction | BHMT* | Bhmt, Bhmt1b | Alliance of Genome Resources | ||||
cerebral infarction | CBS* | Cbs | Alliance of Genome Resources | ||||
cerebral infarction | F2* | F2 | Alliance of Genome Resources | ||||
cerebral infarction | F5* | F5 | Alliance of Genome Resources | ||||
cerebral infarction | F7* | F7 | Alliance of Genome Resources | ||||
cerebral infarction | FOLH1*, FOLH1B | Folh1 | Alliance of Genome Resources | ||||
cerebral infarction | GCH1* | Gch1 | Alliance of Genome Resources | ||||
cerebral infarction | GPX3* | Gpx3 | Alliance of Genome Resources | ||||
cerebral infarction | GRIN1* | Grin1 | Alliance of Genome Resources | ||||
cerebral infarction | HLA-A*, HLA-B*, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
cerebral infarction | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
cerebral infarction | H19* | ||||||
cerebral infarction | HNF1A* | Hnf1a | Alliance of Genome Resources | ||||
cerebral infarction | IFNB1* | Ifnb1 | Alliance of Genome Resources | ||||
cerebral infarction | ITGA9* | Itga9 | Alliance of Genome Resources | ||||
cerebral infarction | KALRN* | Kalrn | Alliance of Genome Resources | ||||
cerebral infarction | KCNN4* | Kcnn4 | Alliance of Genome Resources | ||||
cerebral infarction | LIPG* | Lipg | Alliance of Genome Resources | ||||
cerebral infarction | LTA* | Lta | Alliance of Genome Resources | ||||
cerebral infarction | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
cerebral infarction | MTR* | Mtr | Alliance of Genome Resources | ||||
cerebral infarction | MYRF* | Myrf | Alliance of Genome Resources | ||||
cerebral infarction | NR1H3* | Nr1h3 | Alliance of Genome Resources | ||||
cerebral infarction | PARK7* | Park7 | Alliance of Genome Resources | ||||
cerebral infarction | PDX1* | Pdx1 | Alliance of Genome Resources | ||||
cerebral infarction | PHACTR1* | Phactr1 | Alliance of Genome Resources | ||||
cerebral infarction | PON1* | Pon1 | Alliance of Genome Resources | ||||
cerebral infarction | PON2* | Pon2 | Alliance of Genome Resources | ||||
cerebral infarction | PRKCH* | Prkch | Alliance of Genome Resources | ||||
cerebral infarction | PROS1* | Pros1 | Alliance of Genome Resources | ||||
cerebral infarction | PTGIS* | Ptgis | Alliance of Genome Resources | ||||
cerebral infarction | SERPING1* | Serping1 | Alliance of Genome Resources | ||||
cerebral infarction | TBXAS1* | Tbxas1 | Alliance of Genome Resources | ||||
cerebral infarction | THBD* | Thbd | Alliance of Genome Resources | ||||
cerebral infarction | TNF* | Tnf | Alliance of Genome Resources | ||||
cerebral palsy | ALOX5AP* | Alox5ap | Alliance of Genome Resources | ||||
cerebrovascular disease | P2RY12* | P2ry12 | Alliance of Genome Resources | ||||
cerebrovascular disease | SELE* | Sele | Alliance of Genome Resources | ||||
cerebrovascular disease | AGT* | Agt | Alliance of Genome Resources | ||||
cerebrovascular disease | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
cerebrovascular disease | APOE* | Apoe | Alliance of Genome Resources | ||||
cerebrovascular disease | G6PD* | G6pd2, G6pdx | Alliance of Genome Resources | ||||
cerebrovascular disease | GLCE* | Glce | Alliance of Genome Resources | ||||
cerebrovascular disease | LMNA* | Lmna | Alliance of Genome Resources | ||||
cerebrovascular disease | NR1H3* | Nr1h3 | Alliance of Genome Resources | ||||
cervical dystonia | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | CADM3* | Cadm3 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | ITPR3* | Itpr3 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | POLR3B* | Polr3b | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | JAG1* | Jag1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | MFN2* | Mfn2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | NEFL* | Nefl | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | PMP22* | Pmp22 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | SLC12A6* | Slc12a6 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | FBLN5* | Fbln5 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2C | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2C | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2CC | NEFH* | Nefh | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2F | HSPB1* | Hspb1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2K | JPH1* | Jph1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2L | HSPB8* | Hspb8 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2N | AARS1* | Aars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2T | MME* | Mme | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2U | MARS1* | Mars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2V | NAGLU* | Naglu | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease, axonal type 2W | HARS1* | Hars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2X | SPG11* | Spg11 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate A | GBF1* | Gbf1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate B | DNM2* | Dnm2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate D | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate E | INF2* | Inf2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate F | GNB4* | Gnb4 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate G | NEFL* | Nefl | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease recessive intermediate A | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease recessive intermediate B | KARS1* | Kars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease recessive intermediate C | PLEKHG5* | Plekhg5 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1D | EGR2* | Egr2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1F | NEFL* | Nefl | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1G | PMP2* | Pmp2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2A2B | MFN2* | Mfn2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2B2 | PNKP* | Pnkp | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2DD | ATP1A1* | Atp1a1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2EE | MPV17* | Mpv17 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2I | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2J | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2R | TRIM2* | Trim2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2Y | VCP* | Vcp | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 3 | PRX* | Prx | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 3 | EGR2* | Egr2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4A | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4F | PRX* | Prx | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4G | HK1* | Hk1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4K | SURF1* | Surf1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 6 | MFN2* | Mfn2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease X-linked dominant 6 | PDK3* | Pdk3 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease X-linked recessive 4 | AIFM1* | Aifm1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease X-linked recessive 5 | PRPS1* | Prps1 | Alliance of Genome Resources | ||||
childhood absence epilepsy | GABRG2* | Gabrg2 | Alliance of Genome Resources | ||||
childhood absence epilepsy | GABRB3* | Gabrb3 | Alliance of Genome Resources | ||||
childhood absence epilepsy | CACNG3* | Cacng3 | Alliance of Genome Resources | ||||
childhood absence epilepsy | GRIK1* | Grik1 | Alliance of Genome Resources | ||||
childhood absence epilepsy | LGI4* | Lgi4 | Alliance of Genome Resources | ||||
childhood absence epilepsy | NPY* | Npy | Alliance of Genome Resources | ||||
childhood absence epilepsy | CACNA1H* | Cacna1h | Alliance of Genome Resources | ||||
childhood absence epilepsy | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
childhood astrocytic tumor | RTEL1* | Rtel1 | Alliance of Genome Resources | ||||
childhood-onset dystonia with optic atrophy and basal ganglia abnormalities | MECR* | Mecr | Alliance of Genome Resources | ||||
childhood-onset neurodegeneration with brain atrophy | UBTF* | Ubtf | Alliance of Genome Resources | ||||
cholesteatoma of middle ear | IL2* | Il2 | Alliance of Genome Resources | ||||
chordoid glioma | PRKCA* | Prkca | Alliance of Genome Resources | ||||
choreatic disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
choreatic disease | VPS13A* | Vps13a | Alliance of Genome Resources | ||||
choreatic disease | NKX2-1* | Nkx2-1 | Alliance of Genome Resources | ||||
choreatic disease | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
choreatic disease | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
chorioretinitis | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
choroidal sclerosis | GUCY2D* | Gucy2e | Alliance of Genome Resources | ||||
choroidal sclerosis | PRPH2* | Prph2 | Alliance of Genome Resources | ||||
choroid disease | IL10* | Il10 | Alliance of Genome Resources | ||||
classic dopamine transporter deficiency syndrome | SLC6A3* | Slc6a3 | Alliance of Genome Resources | ||||
coloboma | MAB21L2* | Mab21l2 | Alliance of Genome Resources | ||||
coloboma | SALL2* | Sall2 | Alliance of Genome Resources | ||||
coloboma | TMEM67* | Tmem67 | Alliance of Genome Resources | ||||
coloboma of optic nerve | PAX6* | Pax6 | Alliance of Genome Resources | ||||
color blindness | BDNF* | Bdnf | Alliance of Genome Resources | ||||
color blindness | GNAT2* | Gnat2 | Alliance of Genome Resources | ||||
color blindness | CNGB3* | Cngb3 | Alliance of Genome Resources | ||||
color blindness | CNGA3* | Cnga3 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | CTNNA2* | Ctnna2 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | CAMSAP1* | Camsap1 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | APC2* | Apc2 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | KIF26A* | Kif26a | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 1 | TUBB3* | Tubb3 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 2 | KIF5C* | Kif5c | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 3 | KIF2A* | Kif2a | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 5 | TUBB2A* | Tubb2a | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 6 | TUBB* | Tubb5 | Alliance of Genome Resources | ||||
cone-rod dystrophy | CRB1* | Crb1 | Alliance of Genome Resources | ||||
cone-rod dystrophy | PDE6C* | Pde6c | Alliance of Genome Resources | ||||
cone-rod dystrophy 10 | SEMA4A* | Sema4a | Alliance of Genome Resources | ||||
cone-rod dystrophy 11 | RAX2* | ||||||
cone-rod dystrophy 12 | PROM1* | Prom1 | Alliance of Genome Resources | ||||
cone-rod dystrophy 13 | RPGRIP1* | Rpgrip1 | Alliance of Genome Resources | ||||
cone-rod dystrophy 14 | GUCA1A* | Guca1a | Alliance of Genome Resources | ||||
cone-rod dystrophy 15 | CDHR1* | Cdhr1 | Alliance of Genome Resources | ||||
cone-rod dystrophy 19 | TTLL5* | Ttll5 | Alliance of Genome Resources | ||||
cone-rod dystrophy 20 | POC1B* | Poc1b | Alliance of Genome Resources | ||||
cone-rod dystrophy 21 | DRAM2* | Dram2 | Alliance of Genome Resources | ||||
cone-rod dystrophy 22 | TLCD3B* | Tlcd3b | Alliance of Genome Resources | ||||
cone-rod dystrophy 24 | UNC119* | Unc119 | Alliance of Genome Resources | ||||
cone-rod dystrophy 5 | PITPNM3* | Pitpnm3 | Alliance of Genome Resources | ||||
congenital central hypoventilation syndrome | BDNF* | Bdnf | Alliance of Genome Resources | ||||
congenital central hypoventilation syndrome | LBX1* | Lbx1 | Alliance of Genome Resources | ||||
congenital central hypoventilation syndrome | MYO1H* | Myo1h | Alliance of Genome Resources | ||||
congenital fibrosis of the extraocular muscles 1 | KIF21A* | Kif21a | Alliance of Genome Resources | ||||
congenital fibrosis of the extraocular muscles 2 | PHOX2A* | Phox2a | Alliance of Genome Resources | ||||
congenital fibrosis of the extraocular muscles 3A | TUBB3* | Tubb3 | Alliance of Genome Resources | ||||
congenital fibrosis of the extraocular muscles 5 | COL25A1* | Col25a1 | Alliance of Genome Resources | ||||
congenital mirror movement disorder | DNAL4* | Dnal4 | Alliance of Genome Resources | ||||
congenital mirror movement disorder | DCC* | Dcc | Alliance of Genome Resources | ||||
congenital mirror movement disorder | RAD51* | Rad51 | Alliance of Genome Resources | ||||
congenital mirror movement disorder | NTN1* | Ntn1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy A14 | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy A7 | CRPPA* | Crppa | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A1 | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A10 | RXYLT1* | Rxylt1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A11 | B3GALNT2* | B3galnt2 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A12 | POMK* | Pomk | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A13 | B4GAT1* | B4gat1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A2 | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A3 | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A5 | FKRP* | Fkrp | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A6 | LARGE1* | Large1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A8 | POMGNT2* | Pomgnt2 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A9 | DAG1* | Dag1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy with cataracts and intellectual disability | INPP5K* | Inpp5k | Alliance of Genome Resources | ||||
congenital myasthenic syndrome | SYT2* | Syt2 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome | VAMP1* | Vamp1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome | MYO9A* | Myo9a | Alliance of Genome Resources | ||||
congenital myasthenic syndrome | CHRNE* | Chrne | Alliance of Genome Resources | ||||
congenital myasthenic syndrome | SLC25A1* | Slc25a1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 13 | DPAGT1* | Dpagt1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 14 | ALG2* | Alg2 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 15 | ALG14* | Alg14 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 16 | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 17 | LRP4* | Lrp4 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 18 | SNAP25* | Snap25 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1A | CAST* | Cast | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1A | CHRNA1* | Chrna1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1B | CHRNA1* | Chrna1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 20 | SLC5A7* | Slc5a7 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 21 | SLC18A3* | Slc18a3 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 22 | PREPL* | Prepl | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 2A | CHRNB1* | Chrnb1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 2C | CHRNB1* | Chrnb1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 3B | CHRND* | Chrnd | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 3C | CHRND* | Chrnd | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 4B | CHRNE* | Chrne | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 7 | SYT2* | Syt2 | Alliance of Genome Resources | ||||
congenital nystagmus | MYO7A* | Myo7a | Alliance of Genome Resources | ||||
congenital nystagmus | PAX6* | Pax6 | Alliance of Genome Resources | ||||
congenital nystagmus | ROBO1* | Robo1 | Alliance of Genome Resources | ||||
congenital nystagmus 6 | GPR143* | Gpr143 | Alliance of Genome Resources | ||||
congenital stationary night blindness | TRPM1* | Trpm1 | Alliance of Genome Resources | ||||
congenital stationary night blindness | TRPV3* | Trpv3 | Alliance of Genome Resources | ||||
congenital stationary night blindness | CACNA1F* | Cacna1f | Alliance of Genome Resources | ||||
congenital stationary night blindness | GUCY2D* | Gucy2e | Alliance of Genome Resources | ||||
congenital stationary night blindness 1G | GNAT1* | Gnat1 | Alliance of Genome Resources | ||||
congenital stationary night blindness 1H | GNB3* | Gnb3 | Alliance of Genome Resources | ||||
congenital stationary night blindness autosomal dominant 3 | GNAT1* | Gnat1 | Alliance of Genome Resources | ||||
conjunctival squamous cell carcinoma | ADAM3A* | Adam3 | Alliance of Genome Resources | ||||
conjunctivitis | PLG* | Plg | Alliance of Genome Resources | ||||
corneal dystrophy | VSX1* | Vsx1 | Alliance of Genome Resources | ||||
corneal dystrophy | TACSTD2* | Tacstd2 | Alliance of Genome Resources | ||||
corneal dystrophy | KRT12* | Krt12 | Alliance of Genome Resources | ||||
corneal dystrophy | KERA* | Kera | Alliance of Genome Resources | ||||
corneal dystrophy | ELOVL4* | Elovl4 | Alliance of Genome Resources | ||||
corneal neovascularization | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
corneal neovascularization | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
corneal neovascularization | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
corneal neovascularization | TNFAIP6* | Tnfaip6 | Alliance of Genome Resources | ||||
Creutzfeldt-Jakob disease | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
Creutzfeldt-Jakob disease | STX1A* | Stx1a | Alliance of Genome Resources | ||||
Cryptococcal meningitis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
cystic echinococcosis | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
cystic echinococcosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
cystic echinococcosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
Cytomegalovirus retinitis | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
dacryocystitis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
degenerative myopia | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
demyelinating disease | KLK6* | Klk6 | Alliance of Genome Resources | ||||
demyelinating disease | MYC* | Bmyc, Myc | Alliance of Genome Resources | ||||
dentatorubral-pallidoluysian atrophy | ATN1* | Atn1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy | DEPDC5* | Depdc5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy | KCNH5* | Kcnh5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy | SLC32A1* | Slc32a1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy | SNF8* | Snf8 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy | SV2A* | Sv2a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 1 | ARX* | Arx | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 100 | FBXO28* | Fbxo28 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 101 | GRIN1* | Grin1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 102 | SLC38A3* | Slc38a3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 103 | KCNC2* | Kcnc2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 104 | ATP6V0A1* | Atp6v0a1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 105 | HID1* | Hid1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 106 | UFSP2* | Ufsp2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 107 | NAPB* | Napb | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 108 | MAST3* | Mast3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 109 | FZR1* | Fzr1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 11 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 110 | CACNA2D1* | Cacna2d1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 116 | GLUL* | Glul | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 12 | PLCB1* | Plcb1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 13 | SCN8A* | Scn8a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 15 | ST3GAL3* | St3gal3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 18 | SZT2* | Szt2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 19 | GABRA1* | Gabra1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 21 | NECAP1* | Necap1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 23 | DOCK7* | Dock7 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 24 | HCN1* | Hcn1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 25 | SLC13A5* | Slc13a5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 26 | KCNB1* | Kcnb1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 27 | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 28 | WWOX* | Wwox | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 29 | AARS1* | Aars1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 3 | SLC25A22* | Slc25a22 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 30 | SIK1* | Sik1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 31A | DNM1* | Dnm1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 31B | DNM1* | Dnm1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 32 | KCNA2* | Kcna2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 33 | EEF1A2* | Eef1a2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 34 | SLC12A5* | Slc12a5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 35 | ITPA* | Itpa | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 36 | ALG13* | Alg13 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 37 | FRRS1L* | Frrs1l | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 38 | ARV1* | Arv1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 4 | STXBP1* | Stxbp1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 40 | GUF1* | Guf1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 41 | SLC1A2* | Slc1a2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 42 | CACNA1A* | Cacna1a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 43 | GABRB3* | Gabrb3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 44 | UBA5* | Uba5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 45 | GABRB1* | Gabrb1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 46 | GRIN2D* | Grin2d | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 47 | FGF12* | Fgf12 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 48 | AP3B2* | Ap3b2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 49 | DENND5A* | Dennd5a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 5 | SPTAN1* | Sptan1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 50 | CAD* | Cad | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 51 | MDH2* | Mdh2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 52 | SCN1B* | Scn1b | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 53 | SYNJ1* | Synj1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 55 | PIGP* | Pigp | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 56 | YWHAG* | Ywhag | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 57 | KCNT2* | Kcnt2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 58 | NTRK2* | Ntrk2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 59 | GABBR2* | Gabbr2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 60 | CNPY3* | Cnpy3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 61 | ADAM22* | Adam22 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 62 | SCN3A* | Scn3a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 63 | CPLX1* | Cplx1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 64 | RHOBTB2* | Rhobtb2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 65 | CYFIP2* | Cyfip2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 66 | PACS2* | Pacs2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 67 | CUX2* | Cux2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 68 | TRAK1* | Trak1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 69 | CACNA1E* | Cacna1e | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 6B | SCN1A* | Scn1a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 70 | PHACTR1* | Phactr1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 71 | GLS* | Gls | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 72 | NEUROD2* | Neurod2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 73 | RNF13* | Rnf13 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 74 | GABRG2* | Gabrg2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 75 | PARS2* | Pars2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 76 | ACTL6B* | Actl6b | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 78 | GABRA2* | Gabra2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 79 | GABRA5* | Gabra5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 8 | ARHGEF9* | Arhgef9 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 80 | PIGB* | Pigb | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 81 | DMXL2* | Dmxl2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 82 | GOT2* | Got2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 83 | UGP2* | Ugp2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 84 | UGDH* | Ugdh | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 85 | SMC1A* | Smc1a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 86 | DALRD3* | Dalrd3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 87 | CDK19* | Cdk19 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 88 | MDH1* | Mdh1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 89 | GAD1* | Gad1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 9 | PCDH19* | Pcdh19 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 90 | FGF13* | Fgf13 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 91 | PPP3CA* | Ppp3ca | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 92 | GABRB2* | Gabrb2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 93 | ATP6V1A* | Atp6v1a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 94 | CHD2* | Chd2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 95 | PIGS* | Pigs | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 96 | NSF* | Nsf | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 97 | CELF2* | Celf2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 98 | ATP1A2* | Atp1a2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 99 | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
diabetic neuropathy | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
diabetic neuropathy | ALDH2* | Aldh2 | Alliance of Genome Resources | ||||
diabetic neuropathy | AKR1B1* | Akr1b1 | Alliance of Genome Resources | ||||
diabetic neuropathy | EPO* | Epo | Alliance of Genome Resources | ||||
diabetic neuropathy | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
diabetic neuropathy | FTO* | Fto | Alliance of Genome Resources | ||||
diabetic neuropathy | GHRL* | Ghrl | Alliance of Genome Resources | ||||
diabetic neuropathy | HGF* | Hgf | Alliance of Genome Resources | ||||
diabetic neuropathy | IFNG* | Ifng | Alliance of Genome Resources | ||||
diabetic neuropathy | PGF* | Pgf | Alliance of Genome Resources | ||||
diabetic neuropathy | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
diabetic neuropathy | UCP2* | Ucp2 | Alliance of Genome Resources | ||||
diabetic neuropathy | UCP3* | Ucp3 | Alliance of Genome Resources | ||||
diabetic neuropathy | ADRA2B* | Adra2b | Alliance of Genome Resources | ||||
diabetic retinopathy | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
diabetic retinopathy | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
diabetic retinopathy | GLO1* | Glo1 | Alliance of Genome Resources | ||||
diabetic retinopathy | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh | Alliance of Genome Resources | ||||
diabetic retinopathy | FLT1* | Flt1 | Alliance of Genome Resources | ||||
diabetic retinopathy | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
diabetic retinopathy | EPO* | Epo | Alliance of Genome Resources | ||||
diabetic retinopathy | ELN* | Eln | Alliance of Genome Resources | ||||
diabetic retinopathy | EDN1* | Edn1 | Alliance of Genome Resources | ||||
diabetic retinopathy | CLU* | Clu | Alliance of Genome Resources | ||||
diabetic retinopathy | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
diabetic retinopathy | CFB* | Cfb | Alliance of Genome Resources | ||||
diabetic retinopathy | CDKAL1* | Cdkal1 | Alliance of Genome Resources | ||||
diabetic retinopathy | APOE* | Apoe | Alliance of Genome Resources | ||||
diabetic retinopathy | APOB* | Apob | Alliance of Genome Resources | ||||
diabetic retinopathy | ANGPT1* | Angpt1 | Alliance of Genome Resources | ||||
diabetic retinopathy | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
diabetic retinopathy | AKR1B1* | Akr1b1 | Alliance of Genome Resources | ||||
diabetic retinopathy | AGER* | Ager | Alliance of Genome Resources | ||||
diabetic retinopathy | ADRB3* | Adrb3 | Alliance of Genome Resources | ||||
diabetic retinopathy | ADIPOQ* | Adipoq | Alliance of Genome Resources | ||||
diabetic retinopathy | ADAMTS9-AS2* | ||||||
diabetic retinopathy | ACP1* | Acp1 | Alliance of Genome Resources | ||||
diabetic retinopathy | ACE2* | Ace2 | Alliance of Genome Resources | ||||
diabetic retinopathy | ACE* | Ace | Alliance of Genome Resources | ||||
diabetic retinopathy | AGT* | Agt | Alliance of Genome Resources | ||||
diabetic retinopathy | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
diabetic retinopathy | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
diabetic retinopathy | VPS26A* | Vps26a | Alliance of Genome Resources | ||||
diabetic retinopathy | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
diabetic retinopathy | VDR* | Vdr | Alliance of Genome Resources | ||||
diabetic retinopathy | TNF* | Tnf | Alliance of Genome Resources | ||||
diabetic retinopathy | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
diabetic retinopathy | SOD3* | Sod3 | Alliance of Genome Resources | ||||
diabetic retinopathy | SOD1* | Sod1 | Alliance of Genome Resources | ||||
diabetic retinopathy | SGF29* | Sgf29 | Alliance of Genome Resources | ||||
diabetic retinopathy | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
diabetic retinopathy | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
diabetic retinopathy | PON1* | Pon1 | Alliance of Genome Resources | ||||
diabetic retinopathy | NOS3* | Nos3 | Alliance of Genome Resources | ||||
diabetic retinopathy | MYSM1* | Mysm1 | Alliance of Genome Resources | ||||
diabetic retinopathy | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
diabetic retinopathy | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
diabetic retinopathy | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
diabetic retinopathy | LTA* | Lta | Alliance of Genome Resources | ||||
diabetic retinopathy | ITGA2* | Itga2 | Alliance of Genome Resources | ||||
diabetic retinopathy | INS* | Ins1, Ins2 | Alliance of Genome Resources | ||||
diabetic retinopathy | IL10* | Il10 | Alliance of Genome Resources | ||||
diabetic retinopathy | IL6* | Il6 | Alliance of Genome Resources | ||||
diabetic retinopathy | IGF1* | Igf1 | Alliance of Genome Resources | ||||
diabetic retinopathy | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
diabetic retinopathy | HFE* | Hfe | Alliance of Genome Resources | ||||
diabetic retinopathy | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
diabetic retinopathy | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
diabetic retinopathy | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
distal myopathy | LDB3* | Ldb3 | Alliance of Genome Resources | ||||
distal myopathy 1 | MYH7* | Myh7 | Alliance of Genome Resources | ||||
distal myopathy 3 | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
distal myopathy 4 | FLNC* | Flnc | Alliance of Genome Resources | ||||
distal myopathy Tateyama type | CAV3* | Cav3 | Alliance of Genome Resources | ||||
distal myopathy with anterior tibial onset | DYSF* | Dysf | Alliance of Genome Resources | ||||
distal myopathy with rimmed vacuoles | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
dopamine beta-hydroxylase deficiency | HSPA5* | Hspa5 | Alliance of Genome Resources | ||||
dopa-responsive dystonia | GCH1* | Gch1 | Alliance of Genome Resources | ||||
dry eye syndrome | IL1B* | Il1b | Alliance of Genome Resources | ||||
dry eye syndrome | MUC1* | Muc1 | Alliance of Genome Resources | ||||
dry eye syndrome | IL6* | Il6 | Alliance of Genome Resources | ||||
Duane retraction syndrome | SALL4* | Sall4 | Alliance of Genome Resources | ||||
Duchenne muscular dystrophy | DAG1* | Dag1 | Alliance of Genome Resources | ||||
Duchenne muscular dystrophy | ITGA7* | Itga7 | 1 model | Alliance of Genome Resources | |||
dysembryoplastic neuroepithelial tumor | BRAF* | Braf | Alliance of Genome Resources | ||||
dystonia | TIMM8A* | Timm8a1 | Alliance of Genome Resources | ||||
dystonia | GCH1* | Gch1 | Alliance of Genome Resources | ||||
dystonia | SPR* | Spr | Alliance of Genome Resources | ||||
dystonia 12 | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
dystonia 12 | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
dystonia 16 | PRKRA* | Prkra | Alliance of Genome Resources | ||||
dystonia 22, adult-onset | TSPOAP1* | Tspoap1 | Alliance of Genome Resources | ||||
dystonia 22, juvenile-onset | TSPOAP1* | Tspoap1 | Alliance of Genome Resources | ||||
dystonia 24 | ANO3* | Ano3 | Alliance of Genome Resources | ||||
dystonia 25 | GNAL* | Gnal | Alliance of Genome Resources | ||||
dystonia 27 | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
dystonia 28, childhood-onset | KMT2B* | Kmt2b | Alliance of Genome Resources | ||||
dystonia 30 | VPS16* | Vps16 | Alliance of Genome Resources | ||||
dystonia 31 | AOPEP* | Aopep | Alliance of Genome Resources | ||||
dystonia 32 | VPS11* | Vps11 | Alliance of Genome Resources | ||||
dystonia 33 | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
dystonia 35, childhood-onset | SHQ1* | Shq1 | Alliance of Genome Resources | ||||
dystonia 37, early-onset with striatal lesions | NUP54* | Nup54 | Alliance of Genome Resources | ||||
dystonia 9 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
early-onset dystonia and/or spastic paraplegia | ATP5MC3* | Atp5mc3 | Alliance of Genome Resources | ||||
early-onset epilepsy 2 | SETD1A* | Setd1a | Alliance of Genome Resources | ||||
early-onset epilepsy 3 | ATP6V0C* | Atp6v0c | Alliance of Genome Resources | ||||
early-onset vitamin B6-dependent epilepsy 1 | PLPBP* | Plpbp | Alliance of Genome Resources | ||||
early-onset vitamin B6-dependent epilepsy 4 | ALDH7A1* | Aldh7a1 | Alliance of Genome Resources | ||||
ectopia lentis with ectopia of pupil | ADAMTSL4* | Adamtsl4 | Alliance of Genome Resources | ||||
Emery-Dreifuss muscular dystrophy | EMD* | Emd | Alliance of Genome Resources | ||||
epilepsy | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
epilepsy | ABCB1* | Abcb1a, Abcb1b | Alliance of Genome Resources | ||||
epilepsy | ACHE* | Ache | Alliance of Genome Resources | ||||
epilepsy | POLG* | Polg | Alliance of Genome Resources | ||||
epilepsy | BCHE* | Bche | Alliance of Genome Resources | ||||
epilepsy | CP* | Cp | Alliance of Genome Resources | ||||
epilepsy | GDNF* | Gdnf | Alliance of Genome Resources | ||||
epilepsy | GRIA1* | Gria1 | Alliance of Genome Resources | ||||
epilepsy | KCNB1* | Kcnb1 | Alliance of Genome Resources | ||||
epilepsy | TBX1* | Tbx1 | Alliance of Genome Resources | ||||
episodic ataxia | CACNB4* | Cacnb4 | Alliance of Genome Resources | ||||
episodic ataxia type 5 | CACNB4* | Cacnb4 | Alliance of Genome Resources | ||||
episodic ataxia type 6 | SLC1A3* | Slc1a3 | Alliance of Genome Resources | ||||
episodic ataxia type 9 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
episodic kinesigenic dyskinesia 3 | TMEM151A* | Tmem151a | Alliance of Genome Resources | ||||
epithelial basement membrane dystrophy | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
epithelial recurrent erosion dystrophy | COL17A1* | Col17a1 | Alliance of Genome Resources | ||||
erythromelalgia | SCN9A* | Scn9a | Alliance of Genome Resources | ||||
essential tremor | HNMT* | Hnmt | Alliance of Genome Resources | ||||
essential tremor | DRD3* | Drd3 | Alliance of Genome Resources | ||||
essential tremor 1 | DRD3* | Drd3 | Alliance of Genome Resources | ||||
essential tremor 4 | FUS* | Fus | Alliance of Genome Resources | ||||
essential tremor 5 | TENM4* | Tenm4 | Alliance of Genome Resources | ||||
essential tremor 6 | NOTCH2NLC* | ||||||
exfoliation syndrome | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
exfoliation syndrome | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
exfoliation syndrome | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
exfoliation syndrome | APOE* | Apoe | Alliance of Genome Resources | ||||
exfoliation syndrome | ACVR1* | Acvr1 | Alliance of Genome Resources | ||||
exfoliation syndrome | CLU* | Clu | Alliance of Genome Resources | ||||
extrapyramidal and movement disease | CYP2D6*, CYP2D7 | Cyp2d9, Cyp2d10, Cyp2d11, Cyp2d12, Cyp2d22, Cyp2d26, Cyp2d34, Cyp2d40 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 1 | FZD4* | Fzd4 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 4 | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 5 | TSPAN12* | Tspan12 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 6 | ZNF408* | Zfp408 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 7 | CTNNB1* | Ctnnb1 | Alliance of Genome Resources | ||||
eye disease | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
eye disease | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
eye disease | IL18* | Il18 | Alliance of Genome Resources | ||||
eye disease | IL1B* | Il1b | Alliance of Genome Resources | ||||
eye disease | F2* | F2 | Alliance of Genome Resources | ||||
facioscapulohumeral muscular dystrophy 2 | SMCHD1* | Smchd1 | Alliance of Genome Resources | ||||
facioscapulohumeral muscular dystrophy 3 | LRIF1* | Lrif1 | Alliance of Genome Resources | ||||
facioscapulohumeral muscular dystrophy 4 | DNMT3B* | Dnmt3b | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 1 | SAMD12* | Samd12 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 2 | STARD7* | Stard7 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 3 | MARCHF6* | Marchf6 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 4 | YEATS2* | Yeats2 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 5 | CNTN2* | Cntn2 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 6 | TNRC6A* | Tnrc6a | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 7 | RAPGEF2* | Rapgef2 | Alliance of Genome Resources | ||||
familial benign fleck retina | PLA2G5* | Pla2g5 | Alliance of Genome Resources | ||||
familial encephalopathy with neuroserpin inclusion bodies | SERPINB7* | Serpinb7 | Alliance of Genome Resources | ||||
familial episodic pain syndrome 1 | TRPA1* | Trpa1 | Alliance of Genome Resources | ||||
familial episodic pain syndrome 2 | SCN10A* | Scn10a | Alliance of Genome Resources | ||||
familial febrile seizures 11 | CPA6* | Cpa6 | Alliance of Genome Resources | ||||
familial febrile seizures 2 | HCN2* | Hcn2 | Alliance of Genome Resources | ||||
familial febrile seizures 4 | ADGRV1* | Adgrv1 | Alliance of Genome Resources | ||||
familial febrile seizures 8 | GABRG2* | Gabrg2 | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 1 | DEPDC5* | Depdc5 | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 2 | NPRL2* | Nprl2 | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 3 | NPRL3* | Nprl3 | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 4 | SCN3A* | Scn3a | Alliance of Genome Resources | ||||
familial hemiplegic migraine 1 | CACNA1A* | Cacna1a | Alliance of Genome Resources | ||||
familial hemiplegic migraine 3 | SCN1A* | Scn1a | Alliance of Genome Resources | ||||
familial meningioma | PTEN* | Pten | Alliance of Genome Resources | ||||
familial meningioma | PDGFB* | Pdgfb | Alliance of Genome Resources | ||||
familial meningioma | NF2* | Nf2 | 1 model | Alliance of Genome Resources | |||
familial meningioma | MN1* | Mn1 | Alliance of Genome Resources | ||||
familial meningioma | SUFU* | Sufu | Alliance of Genome Resources | ||||
familial meningioma | SMARCE1* | Smarce1 | Alliance of Genome Resources | ||||
familial retinoblastoma | RB1* | Rb1 | Alliance of Genome Resources | ||||
familial temporal lobe epilepsy 5 | CPA6* | Cpa6 | Alliance of Genome Resources | ||||
familial temporal lobe epilepsy 7 | RELN* | Reln | Alliance of Genome Resources | ||||
familial temporal lobe epilepsy 8 | GAL* | Gal | Alliance of Genome Resources | ||||
fatal familial insomnia | MIR146A* | Mir146 | Alliance of Genome Resources | ||||
Fazio-Londe disease | SLC52A3* | Slc52a3 | Alliance of Genome Resources | ||||
Finnish type amyloidosis | GSN* | Gsn | Alliance of Genome Resources | ||||
Fleck corneal dystrophy | PIKFYVE* | Pikfyve | Alliance of Genome Resources | ||||
foveal hypoplasia 1 | PAX6* | Pax6 | Alliance of Genome Resources | ||||
Friedreich ataxia | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
Friedreich ataxia | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
Friedreich ataxia 1 | FXN* | Fxn | Alliance of Genome Resources | ||||
frontotemporal dementia | GRN* | Grn | Alliance of Genome Resources | ||||
frontotemporal dementia | MAPT* | Mapt | Alliance of Genome Resources | ||||
frontotemporal dementia | MOBP* | Mobp | Alliance of Genome Resources | ||||
frontotemporal dementia | PSEN1* | Psen1 | Alliance of Genome Resources | ||||
frontotemporal dementia and/or amyotrophic lateral sclerosis 1 | C9orf72* | C9orf72 | Alliance of Genome Resources | ||||
frontotemporal dementia and/or amyotrophic lateral sclerosis 2 | CHCHD10* | Chchd10 | Alliance of Genome Resources | ||||
frontotemporal dementia and/or amyotrophic lateral sclerosis 3 | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
frontotemporal dementia and/or amyotrophic lateral sclerosis 4 | TBK1* | Tbk1 | Alliance of Genome Resources | ||||
frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | VCP* | Vcp | Alliance of Genome Resources | ||||
frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | CHMP2B* | Chmp2b | Alliance of Genome Resources | ||||
Fuchs' endothelial dystrophy | TCF4* | Tcf4 | Alliance of Genome Resources | ||||
Fuchs' endothelial dystrophy | SLC4A11* | Slc4a11 | Alliance of Genome Resources | ||||
Fuchs' endothelial dystrophy | LOXHD1* | Loxhd1 | Alliance of Genome Resources | ||||
Fuchs' endothelial dystrophy | ZEB1* | Zeb1 | Alliance of Genome Resources | ||||
Fuchs' endothelial dystrophy | AGBL1* | Agbl1 | Alliance of Genome Resources | ||||
fundus albipunctatus | PRPH2* | Prph2 | Alliance of Genome Resources | ||||
fundus albipunctatus | RDH5* | Rdh5 | Alliance of Genome Resources | ||||
fundus albipunctatus | RHO* | Rho | Alliance of Genome Resources | ||||
fundus albipunctatus | RLBP1* | Rlbp1 | Alliance of Genome Resources | ||||
fundus dystrophy | ABCA4* | Abca4 | Alliance of Genome Resources | ||||
gelatinous drop-like corneal dystrophy | TACSTD2* | Tacstd2 | Alliance of Genome Resources | ||||
generalized epilepsy with febrile seizures plus | SLC32A1* | Slc32a1 | Alliance of Genome Resources | ||||
generalized epilepsy with febrile seizures plus 1 | SCN1B* | Scn1b | Alliance of Genome Resources | ||||
generalized epilepsy with febrile seizures plus 10 | HCN1* | Hcn1 | Alliance of Genome Resources | ||||
generalized epilepsy with febrile seizures plus 2 | SCN1A* | Scn1a | Alliance of Genome Resources | ||||
generalized epilepsy with febrile seizures plus 9 | STX1B* | Stx1b | Alliance of Genome Resources | ||||
giant axonal neuropathy 2 | DCAF8* | Dcaf8 | Alliance of Genome Resources | ||||
glaucoma | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
glaucoma | WDR36* | Wdr36 | Alliance of Genome Resources | ||||
glaucoma | OPTN* | Optn | Alliance of Genome Resources | ||||
glaucoma | LINGO1* | Lingo1 | Alliance of Genome Resources | ||||
glaucoma | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
glaucoma | FOXC1* | Foxc1 | Alliance of Genome Resources | ||||
glaucoma | EPO* | Epo | Alliance of Genome Resources | ||||
glaucoma | EEF2* | Eef2 | Alliance of Genome Resources | ||||
glaucoma | CNTF* | Cntf | Alliance of Genome Resources | ||||
glaucoma | BDNF* | Bdnf | Alliance of Genome Resources | ||||
glaucoma | AGO2* | Ago2 | Alliance of Genome Resources | ||||
glioblastoma | LZTR1* | Lztr1 | Alliance of Genome Resources | ||||
glioblastoma | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
glioblastoma | DMBT1* | Dmbt1 | Alliance of Genome Resources | ||||
glioblastoma | CDK4* | Cdk4 | Alliance of Genome Resources | ||||
glioblastoma | ARRB2* | Arrb2 | Alliance of Genome Resources | ||||
glioblastoma | AKT3* | Akt3 | Alliance of Genome Resources | ||||
glioblastoma | ADGRB1* | Adgrb1 | Alliance of Genome Resources | ||||
glioblastoma | EGF* | Egf | Alliance of Genome Resources | ||||
glioblastoma | MGMT* | Mgmt | Alliance of Genome Resources | ||||
glioblastoma | MDM2* | Mdm2 | Alliance of Genome Resources | ||||
glioblastoma | MAP1LC3A* | Map1lc3a | Alliance of Genome Resources | ||||
glioblastoma | KDR* | Kdr | Alliance of Genome Resources | ||||
glioblastoma | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
glioblastoma | RPL5* | Rpl5 | Alliance of Genome Resources | ||||
glioblastoma | RB1* | Rb1 | Alliance of Genome Resources | ||||
glioblastoma | PTPRB* | Ptprb | Alliance of Genome Resources | ||||
glioblastoma | EZH2* | Ezh2 | Alliance of Genome Resources | ||||
glioblastoma | PIK3CB* | Pik3cb | Alliance of Genome Resources | ||||
glioblastoma | PGF* | Pgf | Alliance of Genome Resources | ||||
glioblastoma | FLT3LG* | Flt3l | Alliance of Genome Resources | ||||
glioblastoma | FXN* | Fxn | Alliance of Genome Resources | ||||
glioblastoma | IDH1* | Idh1 | Alliance of Genome Resources | ||||
glioblastoma | PDGFRB* | Pdgfrb | Alliance of Genome Resources | ||||
glioblastoma | PDGFB* | Pdgfb | Alliance of Genome Resources | ||||
glioblastoma | NRAS* | Nras | Alliance of Genome Resources | ||||
glioblastoma | NFKBIA* | Nfkbia | Alliance of Genome Resources | ||||
glioblastoma | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
glucose transporter type 1 deficiency syndrome 2 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
granular corneal dystrophy 1 | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
granular corneal dystrophy 2 | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
Graves ophthalmopathy | IL3* | Il3 | Alliance of Genome Resources | ||||
Graves ophthalmopathy | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
Graves ophthalmopathy | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
Graves ophthalmopathy | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
Graves ophthalmopathy | IL10* | Il10 | Alliance of Genome Resources | ||||
Graves ophthalmopathy | TSHR* | Tshr | Alliance of Genome Resources | ||||
Graves ophthalmopathy | TNF* | Tnf | Alliance of Genome Resources | ||||
Graves ophthalmopathy | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
Graves ophthalmopathy | IL23R* | Il23r | Alliance of Genome Resources | ||||
Graves ophthalmopathy | IL2* | Il2 | Alliance of Genome Resources | ||||
Guillain-Barre syndrome | PMP22* | Pmp22 | Alliance of Genome Resources | ||||
haemophilus meningitis | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
hereditary night blindness | SAG* | Sag | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 1A | SPTLC1* | Sptlc1 | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 1C | SPTLC2* | Sptlc2 | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 2A | WNK1* | Wnk1 | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 2B | RETREG1* | Retreg1 | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 5 | NGF* | Ngf | 2 models | Alliance of Genome Resources | |||
hereditary sensory and autonomic neuropathy type 7 | SCN11A* | Scn11a | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 8 | PRDM12* | Prdm12 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy | KIF1A* | Kif1a | Alliance of Genome Resources | ||||
hereditary sensory neuropathy | WNK1* | Wnk1 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy | DNMT1* | Dnmt1 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 1D | ATL1* | Atl1 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 1E | DNMT1* | Dnmt1 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 1F | ATL3* | Atl3 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 2C | KIF1A* | Kif1a | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 4 | NTRK1* | Ntrk1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia | L2HGDH* | L2hgdh | Alliance of Genome Resources | ||||
hereditary spastic paraplegia | KIF1A* | Kif1a | Alliance of Genome Resources | ||||
hereditary spastic paraplegia | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia | AP5Z1* | Ap5z1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia | SPG21* | Spg21 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia | HSPD1* | Hspd1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 10 | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 12 | RTN2* | Rtn2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 17 | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 18 | ERLIN2* | Erlin2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 23 | DSTYK* | Dstyk | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 26 | B4GALNT1* | B4galnt1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 28 | DDHD1* | Ddhd1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 39 | PNPLA6* | Pnpla6 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 3A | ATL1* | Atl1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 42 | SLC33A1* | Slc33a1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 43 | C19orf12* | 1600014C10Rik | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 44 | GJC2* | Gjc2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 45 | NT5C2* | Nt5c2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 46 | GBA2* | Gba2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 47 | AP4B1* | Ap4b1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 49 | TECPR2* | Tecpr2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 50 | AP4M1* | Ap4m1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 51 | AP4E1* | Ap4e1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 52 | AP4S1* | Ap4s1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 53 | VPS37A* | Vps37a | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 55 | MTRFR* | Mtrfr | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 56 | CYP2U1* | Cyp2u1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 57 | TFG* | Tfg | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 5A | CYP7B1* | Cyp7b1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 6 | NIPA1* | Nipa1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 61 | ARL6IP1* | Arl6ip1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 62 | ERLIN1* | Erlin1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 63 | AMPD2* | Ampd2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 64 | ENTPD1* | Entpd1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 70 | MARS1* | Mars1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 72A | REEP2* | Reep2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 73 | CPT1C* | Cpt1c | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 74 | IBA57* | Iba57 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 75 | MAG* | Mag | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 76 | CAPN1* | Capn1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 77 | FARS2* | Fars2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 78 | ATP13A2* | Atp13a2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 79A | UCHL1* | Uchl1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 79B | UCHL1* | Uchl1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 8 | WASHC5* | Washc5 | 1 "NOT" model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 81 | SELENOI* | Selenoi | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 82 | PCYT2* | Pcyt2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 83 | HPDL* | Hpdl | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 84 | PI4KA* | Pi4ka | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 85 | RNF170* | Rnf170 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 86 | ABHD16A* | Abhd16a | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 87 | TMEM63C* | Tmem63c | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 88 | KPNA3* | Kpna3 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 89 | AMFR* | Amfr | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 90A | SPTSSA* | Sptssa | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 90B | SPTSSA* | Sptssa | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 9A | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 9B | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
herpes simplex virus keratitis | APOE* | Apoe | Alliance of Genome Resources | ||||
herpes simplex virus keratitis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
herpes zoster | F2* | F2 | Alliance of Genome Resources | ||||
holoprosencephaly | PLCH1* | Plch1 | Alliance of Genome Resources | ||||
holoprosencephaly | SIX3* | Six3 | Alliance of Genome Resources | ||||
holoprosencephaly | SHH* | Shh | Alliance of Genome Resources | ||||
holoprosencephaly | PTCH1* | Ptch1 | Alliance of Genome Resources | ||||
holoprosencephaly | ZIC2* | Zic2 | Alliance of Genome Resources | ||||
holoprosencephaly | TGIF1* | Tgif1 | Alliance of Genome Resources | ||||
holoprosencephaly 12 | CNOT1* | Cnot1 | Alliance of Genome Resources | ||||
Holoprosencephaly 13, X-linked | STAG2* | Stag2 | Alliance of Genome Resources | ||||
holoprosencephaly 4 | TGIF1* | Tgif1 | 1 "NOT" model | Alliance of Genome Resources | |||
holoprosencephaly 7 | PTCH1* | Ptch1 | Alliance of Genome Resources | ||||
holoprosencephaly 9 | GLI2* | Gli2 | Alliance of Genome Resources | ||||
Huntington's disease | TFAM* | Tfam | Alliance of Genome Resources | ||||
Huntington's disease | SIRT1* | Sirt1 | Alliance of Genome Resources | ||||
Huntington's disease | PRKAA1* | Prkaa1 | Alliance of Genome Resources | ||||
Huntington's disease | PPARGC1A* | Ppargc1a | Alliance of Genome Resources | ||||
Huntington's disease | NRF1* | Nrf1 | Alliance of Genome Resources | ||||
Huntington's disease | NPY2R* | Npy2r | Alliance of Genome Resources | ||||
Huntington's disease | NPY* | Npy | Alliance of Genome Resources | ||||
Huntington's disease | NOG* | Nog | Alliance of Genome Resources | ||||
Huntington's disease | MAP3K5* | Map3k5 | Alliance of Genome Resources | ||||
Huntington's disease | IL6R* | Il6ra | Alliance of Genome Resources | ||||
Huntington's disease | IL6* | Il6 | Alliance of Genome Resources | ||||
Huntington's disease | IGF1* | Igf1 | Alliance of Genome Resources | ||||
Huntington's disease | HSF1* | Hsf1 | Alliance of Genome Resources | ||||
Huntington's disease | HAP1* | Hap1 | 2 "NOT" models | Alliance of Genome Resources | |||
Huntington's disease | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
Huntington's disease | GRIN2A* | Grin2a | Alliance of Genome Resources | ||||
Huntington's disease | GRIK2* | Grik2 | Alliance of Genome Resources | ||||
Huntington's disease | GLUL* | Glul | Alliance of Genome Resources | ||||
Huntington's disease | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
Huntington's disease | CNTF* | Cntf | Alliance of Genome Resources | ||||
Huntington's disease | BDNF* | Bdnf | Alliance of Genome Resources | ||||
Huntington's disease | ABAT* | Abat | Alliance of Genome Resources | ||||
Huntington's disease-like 1 | PRNP* | Prnp | Alliance of Genome Resources | ||||
Huntington's disease-like 2 | JPH3* | Jph3 | Alliance of Genome Resources | ||||
hydrocephalus | WDR81* | Wdr81 | Alliance of Genome Resources | ||||
hydrocephalus | SMARCC1* | Smarcc1 | Alliance of Genome Resources | ||||
hydrocephalus | MPDZ* | Mpdz | Alliance of Genome Resources | ||||
hydrocephalus | L1CAM* | L1cam | Alliance of Genome Resources | ||||
hydrocephalus | CCDC88C* | Ccdc88c | Alliance of Genome Resources | ||||
hydrophthalmos | CYP1B1* | Cyp1b1 | Alliance of Genome Resources | ||||
hyperekplexia 4 | ATAD1* | Atad1 | Alliance of Genome Resources | ||||
hyperopia | MYRF* | Myrf | Alliance of Genome Resources | ||||
hyperopia | NOG* | Nog | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy | POLR1A* | Polr1a | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 10 | PYCR2* | Pycr2 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 11 | POLR1C* | Polr1c | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 12 | VPS11* | Vps11 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 13 | HIKESHI* | Hikeshi | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 14 | UFM1* | Ufm1 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 15 | EPRS1* | Eprs1 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 16 | TMEM106B* | Tmem106b | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 17 | AIMP2* | Aimp2 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 18 | DEGS1* | Degs1, Degs1l | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 19 | TMEM63A* | Tmem63a | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 20 | CNP* | Cnp | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 21 | POLR3K* | Polr3k | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 22 | CLDN11* | Cldn11 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 23 | RNF220* | Rnf220 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 24 | ATP11A* | Atp11a | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 25 | TMEM163* | Tmem163 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 26 | SLC35B2* | Slc35b2 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 3 | AIMP1* | Aimp1 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 4 | HSPD1* | Hspd1 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 5 | HYCC1* | Hycc1 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 7 | POLR3A* | Polr3a | 2 "NOT" models | Alliance of Genome Resources | |||
hypomyelinating leukodystrophy 8 | POLR3B* | Polr3b | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 9 | RARS1* | Rars1 | Alliance of Genome Resources | ||||
idiopathic generalized epilepsy | KCNMA1* | Kcnma1 | Alliance of Genome Resources | ||||
idiopathic generalized epilepsy | HCN4* | Hcn4 | Alliance of Genome Resources | ||||
idiopathic generalized epilepsy 10 | GABRD* | Gabrd | Alliance of Genome Resources | ||||
idiopathic generalized epilepsy 11 | CLCN2* | Clcn2 | Alliance of Genome Resources | ||||
idiopathic generalized epilepsy 12 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
idiopathic generalized epilepsy 13 | GABRA1* | Gabra1 | Alliance of Genome Resources | ||||
idiopathic generalized epilepsy 14 | SLC12A5* | Slc12a5 | Alliance of Genome Resources | ||||
idiopathic generalized epilepsy 15 | RORB* | Rorb | Alliance of Genome Resources | ||||
idiopathic generalized epilepsy 8 | CASR* | Casr | Alliance of Genome Resources | ||||
idiopathic generalized epilepsy 9 | CACNB4* | Cacnb4 | Alliance of Genome Resources | ||||
infantile cerebellar-retinal degeneration | ACO2* | Aco2 | Alliance of Genome Resources | ||||
infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly | MED17* | Med17 | Alliance of Genome Resources | ||||
infantile parkinsonism-dystonia 2 | SLC18A2* | Slc18a2 | Alliance of Genome Resources | ||||
inner ear disease | CENPB* | Cenpb | Alliance of Genome Resources | ||||
intermediate spinal muscular atrophy | SMN1*, SMN2 | Smn1 | 1 model | Alliance of Genome Resources | |||
intermediate uveitis | CCR2* | Ccr2 | Alliance of Genome Resources | ||||
intermediate uveitis | TNF* | Tnf | Alliance of Genome Resources | ||||
intracranial aneurysm | SOX17* | Sox17 | Alliance of Genome Resources | ||||
intracranial aneurysm | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
intracranial aneurysm | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
intracranial aneurysm | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
intracranial aneurysm | COL22A1* | Col22a1 | Alliance of Genome Resources | ||||
intracranial aneurysm | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
intracranial aneurysm | KMT2D* | Kmt2d | Alliance of Genome Resources | ||||
intracranial aneurysm | ENG* | Eng | Alliance of Genome Resources | ||||
intracranial aneurysm | IL6* | Il6 | Alliance of Genome Resources | ||||
intracranial aneurysm | PKD1* | Pkd1 | Alliance of Genome Resources | ||||
intracranial aneurysm | VCAN* | Vcan | Alliance of Genome Resources | ||||
intracranial aneurysm | PKD2* | Pkd2 | Alliance of Genome Resources | ||||
intracranial berry aneurysm 12 | THSD1* | Thsd1 | Alliance of Genome Resources | ||||
intracranial embolism | KL* | Kl | Alliance of Genome Resources | ||||
intracranial vasospasm | HMOX1* | Hmox1 | Alliance of Genome Resources | ||||
intracranial vasospasm | RYR1* | Ryr1 | Alliance of Genome Resources | ||||
iridocyclitis | IL1A* | Il1a | Alliance of Genome Resources | ||||
iridocyclitis | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
iridocyclitis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
iridocyclitis | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
isolated microphthalmia 2 | VSX2* | Vsx2 | Alliance of Genome Resources | ||||
isolated microphthalmia 3 | RAX* | Rax | Alliance of Genome Resources | ||||
isolated microphthalmia 4 | GDF6* | Gdf6 | Alliance of Genome Resources | ||||
isolated microphthalmia 5 | MFRP* | Mfrp | Alliance of Genome Resources | ||||
isolated microphthalmia 7 | GDF3* | Gdf3 | Alliance of Genome Resources | ||||
isolated microphthalmia 8 | ALDH1A3* | Aldh1a3 | Alliance of Genome Resources | ||||
Joubert syndrome | KIAA0753* | 4933427D14Rik | Alliance of Genome Resources | ||||
Joubert syndrome | TMEM218* | Tmem218 | Alliance of Genome Resources | ||||
Joubert syndrome | TOGARAM1* | Togaram1 | Alliance of Genome Resources | ||||
Joubert syndrome | IFT74* | Ift74 | Alliance of Genome Resources | ||||
Joubert syndrome | FAM149B1* | Fam149b | Alliance of Genome Resources | ||||
Joubert syndrome | B9D2* | B9d2 | Alliance of Genome Resources | ||||
Joubert syndrome | ARL3* | Arl3 | Alliance of Genome Resources | ||||
Joubert syndrome | TMEM216* | Tmem216 | Alliance of Genome Resources | ||||
Joubert syndrome | TMEM237* | Tmem237 | Alliance of Genome Resources | ||||
Joubert syndrome | INPP5E* | Inpp5e | Alliance of Genome Resources | ||||
Joubert syndrome 1 | INPP5E* | Inpp5e | Alliance of Genome Resources | ||||
Joubert syndrome 10 | OFD1* | Ofd1 | Alliance of Genome Resources | ||||
Joubert syndrome 13 | TCTN1* | Tctn1 | Alliance of Genome Resources | ||||
Joubert syndrome 14 | TMEM237* | Tmem237 | Alliance of Genome Resources | ||||
Joubert syndrome 15 | CEP41* | Cep41 | Alliance of Genome Resources | ||||
Joubert syndrome 16 | TMEM138* | Tmem138 | Alliance of Genome Resources | ||||
Joubert syndrome 18 | TCTN3* | Tctn3 | Alliance of Genome Resources | ||||
Joubert syndrome 2 | TMEM216* | Tmem216 | Alliance of Genome Resources | ||||
Joubert syndrome 20 | TMEM231* | Tmem231 | Alliance of Genome Resources | ||||
Joubert syndrome 21 | CSPP1* | Cspp1 | Alliance of Genome Resources | ||||
Joubert syndrome 22 | PDE6D* | Pde6d | Alliance of Genome Resources | ||||
Joubert syndrome 23 | KIAA0586* | 2700049A03Rik | Alliance of Genome Resources | ||||
Joubert syndrome 24 | TCTN2* | Tctn2 | Alliance of Genome Resources | ||||
Joubert syndrome 25 | CEP104* | Cep104 | Alliance of Genome Resources | ||||
Joubert syndrome 27 | B9D1* | B9d1 | Alliance of Genome Resources | ||||
Joubert syndrome 28 | MKS1* | Mks1 | Alliance of Genome Resources | ||||
Joubert syndrome 30 | ARMC9* | Armc9 | Alliance of Genome Resources | ||||
Joubert syndrome 31 | CEP120* | Cep120 | Alliance of Genome Resources | ||||
Joubert syndrome 32 | SUFU* | Sufu | Alliance of Genome Resources | ||||
Joubert syndrome 33 | PIBF1* | Pibf1 | Alliance of Genome Resources | ||||
Joubert syndrome 4 | AHI1* | Ahi1 | Alliance of Genome Resources | ||||
Joubert syndrome 4 | NPHP1* | Nphp1 | Alliance of Genome Resources | ||||
Joubert syndrome 4 | NPHP4* | Nphp4 | Alliance of Genome Resources | ||||
Joubert syndrome 8 | ARL13B* | Arl13b | Alliance of Genome Resources | ||||
Joubert syndrome 9 | CC2D2A* | Cc2d2a | Alliance of Genome Resources | ||||
Joubert syndrome with orofaciodigital defect | CPLANE1* | Cplane1 | Alliance of Genome Resources | ||||
juvenile absence epilepsy 1 | EFHC1* | Efhc1 | Alliance of Genome Resources | ||||
juvenile amyotrophic lateral sclerosis type 27 | SPTLC1* | Sptlc1 | Alliance of Genome Resources | ||||
juvenile glaucoma | MYOC* | Myoc | Alliance of Genome Resources | ||||
juvenile myoclonic epilepsy | BRD2* | Brd2 | Alliance of Genome Resources | ||||
juvenile myoclonic epilepsy 10 | CILK1* | Cilk1 | Alliance of Genome Resources | ||||
Kennedy's disease | AR* | Ar | 1 model | Alliance of Genome Resources | |||
keratitis | IL6* | Il6 | Alliance of Genome Resources | ||||
keratitis | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
keratoconus | IL1B* | Il1b | Alliance of Genome Resources | ||||
keratoconus | HGF* | Hgf | Alliance of Genome Resources | ||||
keratoconus | IL1A* | Il1a | Alliance of Genome Resources | ||||
keratoconus | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
keratoconus | VSX1* | Vsx1 | 2 "NOT" models | Alliance of Genome Resources | |||
keratoconus | TUBA3D*, TUBA3C, TUBA3E | Tuba3a, Tuba3b | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | PON1* | Pon1 | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | CFI* | Cfi | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | CRP* | Crp | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | NOS3* | Nos3 | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | SOD2* | Sod2 | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | KDR* | Kdr | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | APOE* | Apoe | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | FLT1* | Flt1 | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | LOXL1* | Loxl1 | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | C3* | C3 | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
Kuhnt-Junius degeneration | ELN* | Eln | Alliance of Genome Resources | ||||
kuru | PRNP* | Prnp | Alliance of Genome Resources | ||||
lacrimal duct obstruction | IGSF3* | Igsf3 | Alliance of Genome Resources | ||||
Lambert-Eaton myasthenic syndrome | CACNA1B* | Cacna1b | Alliance of Genome Resources | ||||
Lambert-Eaton myasthenic syndrome | CHRM1* | Chrm1 | Alliance of Genome Resources | ||||
late onset Parkinson's disease | MAPT* | Mapt | Alliance of Genome Resources | ||||
late onset Parkinson's disease | ADH1C*, ADH1A, ADH1B | Adh1 | Alliance of Genome Resources | ||||
late onset Parkinson's disease | ATXN2* | Atxn2 | Alliance of Genome Resources | ||||
late onset Parkinson's disease | ATXN3* | Atxn3 | Alliance of Genome Resources | ||||
late onset Parkinson's disease | ATXN8OS* | ||||||
late onset Parkinson's disease | EIF4G1* | Eif4g1 | Alliance of Genome Resources | ||||
late onset Parkinson's disease | GBA1* | Gba1 | Alliance of Genome Resources | ||||
late onset Parkinson's disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
late onset Parkinson's disease | HLA-DRA* | H2-Ea | Alliance of Genome Resources | ||||
late onset Parkinson's disease | PSAP* | Psap | Alliance of Genome Resources | ||||
late onset Parkinson's disease | TBP* | Tbp | Alliance of Genome Resources | ||||
Leber congenital amaurosis | RD3* | Rd3 | Alliance of Genome Resources | ||||
Leber congenital amaurosis | PRPH2* | Prph2 | Alliance of Genome Resources | ||||
Leber congenital amaurosis | MYO7A* | Myo7a | Alliance of Genome Resources | ||||
Leber congenital amaurosis | IQCB1* | Iqcb1 | Alliance of Genome Resources | ||||
Leber congenital amaurosis | CRB1* | Crb1 | Alliance of Genome Resources | ||||
Leber congenital amaurosis | AIPL1* | Aipl1 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 11 | IMPDH1* | Impdh1 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 13 | RDH12* | Rdh12 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 15 | TULP1* | Tulp1 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 16 | KCNJ13* | Kcnj13 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 17 | GDF6* | Gdf6 | Alliance of Genome Resources | ||||
Leber congenital amaurosis with early-onset deafness | TUBB4B* | Tubb4b | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | TP53* | Trp53 | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | SOD2* | Sod2 | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | RPGRIP1* | Rpgrip1 | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | RDH12* | Rdh12 | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | ATP6* | Atp6-ps, mt-Atp6 | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | PARL* | Parl | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | ND5* | mt-Nd5 | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | ND4L* | mt-Nd4l | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | ND4* | mt-Nd4 | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | ND3* | mt-Nd3 | Alliance of Genome Resources | ||||
Leber hereditary optic neuropathy | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
leukodystrophy | AARS1* | Aars1 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter | EIF2B2* | Eif2b2 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter 1 | EIF2B1* | Eif2b1 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter 2 | EIF2B2* | Eif2b2 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter 3 | EIF2B3* | Eif2b3 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter 4 | EIF2B4* | Eif2b4 | Alliance of Genome Resources | ||||
leukoencephalopathy with vanishing white matter 5 | EIF2B5* | Eif2b5 | Alliance of Genome Resources | ||||
limb-girdle muscular dystrophy | FKRP* | Fkrp | Alliance of Genome Resources | ||||
Lisch epithelial corneal dystrophy | MCOLN1* | Mcoln1 | Alliance of Genome Resources | ||||
lissencephaly | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
lissencephaly | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
lissencephaly | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
lissencephaly 1 | PAFAH1B1* | Pafah1b1 | Alliance of Genome Resources | ||||
lissencephaly 10 | CEP85L* | Cep85l | Alliance of Genome Resources | ||||
lissencephaly 3 | TUBA1A* | Tuba1a | Alliance of Genome Resources | ||||
lissencephaly 4 | NDE1* | Nde1 | Alliance of Genome Resources | ||||
lissencephaly 5 | LAMB1* | Lamb1 | Alliance of Genome Resources | ||||
lissencephaly 6 | KATNB1* | Katnb1 | Alliance of Genome Resources | ||||
lissencephaly 7 with cerebellar hypoplasia | CDK5* | Cdk5 | Alliance of Genome Resources | ||||
lissencephaly 8 | TMTC3* | Tmtc3 | Alliance of Genome Resources | ||||
lissencephaly 9 with complex brainstem malformation | MACF1* | Macf1 | Alliance of Genome Resources | ||||
low tension glaucoma | MYOC* | Myoc | Alliance of Genome Resources | ||||
low tension glaucoma | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
low tension glaucoma | CAV2* | Cav2 | Alliance of Genome Resources | ||||
low tension glaucoma | TP53* | Trp53 | Alliance of Genome Resources | ||||
low tension glaucoma | APOE* | Apoe | Alliance of Genome Resources | ||||
low tension glaucoma | TNF* | Tnf | Alliance of Genome Resources | ||||
low tension glaucoma | ADRB1* | Adrb1 | Alliance of Genome Resources | ||||
Machado-Joseph disease | BECN1* | Becn1 | Alliance of Genome Resources | ||||
Machado-Joseph disease | ATXN3* | Atxn3 | 1 model | Alliance of Genome Resources | |||
macular corneal dystrophy | CHST6*, CHST5 | Chst5 | Alliance of Genome Resources | ||||
macular degeneration | PRPH2* | Prph2 | Alliance of Genome Resources | ||||
macular degeneration | ABCA4* | Abca4 | Alliance of Genome Resources | ||||
macular degeneration | ADIPOR1* | Adipor1 | Alliance of Genome Resources | ||||
macular degeneration | APOE* | Apoe | Alliance of Genome Resources | ||||
macular degeneration | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
macular degeneration | SERPING1* | Serping1 | Alliance of Genome Resources | ||||
macular degeneration | SAMD7* | Samd7 | Alliance of Genome Resources | ||||
macular degeneration | PPARGC1A* | Ppargc1a | Alliance of Genome Resources | ||||
macular degeneration | PON1* | Pon1 | Alliance of Genome Resources | ||||
macular degeneration | NQO1* | Nqo1 | Alliance of Genome Resources | ||||
macular degeneration | NFE2L2* | Nfe2l2 | Alliance of Genome Resources | ||||
macular degeneration | ND4* | mt-Nd4 | Alliance of Genome Resources | ||||
macular degeneration | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
macular degeneration | KDR* | Kdr | Alliance of Genome Resources | ||||
macular degeneration | IL17A* | Il17a | Alliance of Genome Resources | ||||
macular degeneration | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
macular degeneration | GSR* | Gsr | Alliance of Genome Resources | ||||
macular degeneration | ESR1* | Esr1 | Alliance of Genome Resources | ||||
macular degeneration | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
macular degeneration | CX3CR1* | Cx3cr1 | Alliance of Genome Resources | ||||
macular degeneration | CRP* | Crp | Alliance of Genome Resources | ||||
macular degeneration | CFI* | Cfi | Alliance of Genome Resources | ||||
macular degeneration | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
macular degeneration | CFB* | Cfb | Alliance of Genome Resources | ||||
macular degeneration | CACNG3* | Cacng3 | Alliance of Genome Resources | ||||
macular degeneration | C3* | C3 | Alliance of Genome Resources | ||||
macular degeneration | C2* | C2 | Alliance of Genome Resources | ||||
macular degeneration | BEST1* | Best1 | Alliance of Genome Resources | ||||
macular retinal edema | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
macular retinal edema | NOS3* | Nos3 | Alliance of Genome Resources | ||||
malignant astrocytoma | KRAS* | Kras | Alliance of Genome Resources | ||||
malignant astrocytoma | BRAF* | Braf | Alliance of Genome Resources | ||||
malignant astrocytoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
malignant astrocytoma | CADM2* | Cadm2 | Alliance of Genome Resources | ||||
malignant astrocytoma | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
malignant peripheral nerve sheath tumor | KDM4B* | Kdm4b | Alliance of Genome Resources | ||||
Marfan syndrome | TGFBR2* | Tgfbr2 | Alliance of Genome Resources | ||||
McLeod syndrome | XK* | Xk | Alliance of Genome Resources | ||||
medulloblastoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
medulloblastoma | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
medulloblastoma | PTCH2* | Ptch2 | 2 models | Alliance of Genome Resources | |||
medulloblastoma | SUFU* | Sufu | 1 model | Alliance of Genome Resources | |||
medulloblastoma | APC* | Apc | Alliance of Genome Resources | ||||
medulloblastoma | TSC2* | Tsc2 | Alliance of Genome Resources | ||||
medulloblastoma | BRCA2* | Brca2 | 2 models | Alliance of Genome Resources | |||
medulloblastoma | GPR161* | Gpr161 | Alliance of Genome Resources | ||||
medulloblastoma | CTNNB1* | Ctnnb1 | Alliance of Genome Resources | ||||
medulloblastoma | ELP1* | Elp1 | Alliance of Genome Resources | ||||
Meesmann corneal dystrophy 1 | KRT12* | Krt12 | Alliance of Genome Resources | ||||
Meesmann corneal dystrophy 2 | KRT3* | ||||||
megalencephalic leukoencephalopathy with subcortical cysts | GPRC5B* | Gprc5b | Alliance of Genome Resources | ||||
megalencephalic leukoencephalopathy with subcortical cysts | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
megalencephalic leukoencephalopathy with subcortical cysts 2A | HEPACAM* | Hepacam | Alliance of Genome Resources | ||||
megalencephalic leukoencephalopathy with subcortical cysts 2B | HEPACAM* | Hepacam | Alliance of Genome Resources | ||||
megalocornea | LTBP2* | Ltbp2 | Alliance of Genome Resources | ||||
Meniere's disease | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
Meniere's disease | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
Meniere's disease | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
Meniere's disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
Meniere's disease | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
Meniere's disease | HSPA1A*, HSPA1B | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
meningioma | MN1* | Mn1 | Alliance of Genome Resources | ||||
meningioma | GSTM3* | Gstm5 | Alliance of Genome Resources | ||||
meningioma | MTRR* | Mtrr | Alliance of Genome Resources | ||||
meningioma | NF2* | Nf2 | Alliance of Genome Resources | ||||
meningioma | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
meningioma | SMARCE1* | Smarce1 | Alliance of Genome Resources | ||||
meningioma | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
meningioma | XRCC3* | Xrcc3 | Alliance of Genome Resources | ||||
meningococcal meningitis | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
meningococcal meningitis | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
meningococcal meningitis | NOD2* | Nod2 | Alliance of Genome Resources | ||||
meningococcal meningitis | CD46* | Cd46 | Alliance of Genome Resources | ||||
microcephaly | SLC25A19* | Slc25a19 | Alliance of Genome Resources | ||||
microcephaly | TUBA1A* | Tuba1a | Alliance of Genome Resources | ||||
microcephaly | IGF1* | Igf1 | Alliance of Genome Resources | ||||
microcephaly | NSD1* | Nsd1 | Alliance of Genome Resources | ||||
microcephaly | EFTUD2* | Eftud2 | Alliance of Genome Resources | ||||
microcephaly, seizures, and developmental delay | PNKP* | Pnkp | Alliance of Genome Resources | ||||
microphthalmia | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
microphthalmia | MFRP* | Mfrp | Alliance of Genome Resources | ||||
microphthalmia | PAX6* | Pax6 | Alliance of Genome Resources | ||||
middle cerebral artery infarction | CSF3* | Csf3 | Alliance of Genome Resources | ||||
middle cerebral artery infarction | CRP* | Crp | Alliance of Genome Resources | ||||
middle cerebral artery infarction | HMOX1* | Hmox1 | Alliance of Genome Resources | ||||
middle cerebral artery infarction | NCAM1* | Ncam1 | Alliance of Genome Resources | ||||
middle cerebral artery infarction | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
middle cerebral artery infarction | F12* | F12 | Alliance of Genome Resources | ||||
middle cerebral artery infarction | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
middle cerebral artery infarction | PARK7* | Park7 | Alliance of Genome Resources | ||||
middle cerebral artery infarction | SHH* | Shh | Alliance of Genome Resources | ||||
middle cerebral artery infarction | EPO* | Epo | Alliance of Genome Resources | ||||
middle cerebral artery infarction | CXCL10* | Cxcl10 | Alliance of Genome Resources | ||||
middle cerebral artery infarction | ALB* | Alb | Alliance of Genome Resources | ||||
migraine | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
migraine | NOS3* | Nos3 | Alliance of Genome Resources | ||||
migraine | CALCA*, CALCB | Calca, Calcb | Alliance of Genome Resources | ||||
migraine | TRPV1* | Trpv1 | Alliance of Genome Resources | ||||
migraine | EDNRA* | Ednra | Alliance of Genome Resources | ||||
migraine | TNF* | Tnf | Alliance of Genome Resources | ||||
migraine | ESR1* | Esr1 | Alliance of Genome Resources | ||||
migraine | CACNA1A* | Cacna1a | Alliance of Genome Resources | ||||
migraine | KCNK18* | Kcnk18 | Alliance of Genome Resources | ||||
migraine | PHACTR1* | Phactr1 | Alliance of Genome Resources | ||||
migraine with aura | CACNA1A* | Cacna1a | Alliance of Genome Resources | ||||
migraine with aura | ATP1A2* | Atp1a2 | Alliance of Genome Resources | ||||
migraine with aura | DBH* | Dbh | Alliance of Genome Resources | ||||
migraine with aura | TRPV3* | Trpv3 | Alliance of Genome Resources | ||||
migraine with aura | DRD2* | Drd2 | Alliance of Genome Resources | ||||
migraine with aura | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
migraine without aura | LDLR* | Ldlr | Alliance of Genome Resources | ||||
migraine without aura | TNF* | Tnf | Alliance of Genome Resources | ||||
Miyoshi muscular dystrophy 1 | DYSF* | Dysf | Alliance of Genome Resources | ||||
Miyoshi muscular dystrophy 3 | ANO5* | Ano5 | Alliance of Genome Resources | ||||
motor neuron disease | HTRA2* | Htra2 | Alliance of Genome Resources | ||||
motor neuron disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
motor neuron disease | TARDBP* | Tardbp | Alliance of Genome Resources | ||||
motor neuron disease | SOD1* | Sod1 | Alliance of Genome Resources | ||||
motor peripheral neuropathy | EGR2* | Egr2 | Alliance of Genome Resources | ||||
movement disease | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
movement disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
movement disease | DRD2* | Drd2 | Alliance of Genome Resources | ||||
Moyamoya disease | ANO1* | Ano1 | Alliance of Genome Resources | ||||
Moyamoya disease | GUCY1A1* | Gucy1a1 | Alliance of Genome Resources | ||||
Moyamoya disease | HLA-A*, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
Moyamoya disease | PHACTR1* | Phactr1 | Alliance of Genome Resources | ||||
Moyamoya disease | TIMP2* | Timp2 | Alliance of Genome Resources | ||||
Moyamoya disease | RNF213* | Rnf213 | 1 "NOT" model | Alliance of Genome Resources | |||
Moyamoya disease | ACTA2* | Acta2 | Alliance of Genome Resources | ||||
multiple sclerosis | JAG1* | Jag1 | Alliance of Genome Resources | ||||
multiple sclerosis | A2M* | A2m | Alliance of Genome Resources | ||||
multiple sclerosis | AGER* | Ager | Alliance of Genome Resources | ||||
multiple sclerosis | APOC2* | Apoc2, Apoc2l | Alliance of Genome Resources | ||||
multiple sclerosis | ATP6* | Atp6-ps, mt-Atp6 | Alliance of Genome Resources | ||||
multiple sclerosis | CAV1* | Cav1 | Alliance of Genome Resources | ||||
multiple sclerosis | CCL1* | Ccl1 | Alliance of Genome Resources | ||||
multiple sclerosis | CCL2*, CCL13* | Ccl2, Ccl12 | Alliance of Genome Resources | ||||
multiple sclerosis | CCL7* | Ccl7 | Alliance of Genome Resources | ||||
multiple sclerosis | CCR5* | Ccr5 | Alliance of Genome Resources | ||||
multiple sclerosis | CD24* | Cd24a | Alliance of Genome Resources | ||||
multiple sclerosis | CD28* | Cd28 | Alliance of Genome Resources | ||||
multiple sclerosis | CD40* | Cd40 | Alliance of Genome Resources | ||||
multiple sclerosis | CD46* | Cd46 | Alliance of Genome Resources | ||||
multiple sclerosis | CD86* | Cd86 | Alliance of Genome Resources | ||||
multiple sclerosis | CIITA* | Ciita | Alliance of Genome Resources | ||||
multiple sclerosis | CLEC16A* | Clec16a | Alliance of Genome Resources | ||||
multiple sclerosis | CNP* | Cnp | Alliance of Genome Resources | ||||
multiple sclerosis | CNTF* | Cntf | Alliance of Genome Resources | ||||
multiple sclerosis | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
multiple sclerosis | FAS* | Fas | Alliance of Genome Resources | ||||
multiple sclerosis | FASLG* | Fasl | Alliance of Genome Resources | ||||
multiple sclerosis | GABRA3* | Gabra3 | Alliance of Genome Resources | ||||
multiple sclerosis | GC* | Gc | Alliance of Genome Resources | ||||
multiple sclerosis | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
multiple sclerosis | GSTM3* | Gstm5 | Alliance of Genome Resources | ||||
multiple sclerosis | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
multiple sclerosis | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
multiple sclerosis | HLA-DQA1*, HLA-DQA2 | H2-Aa | 1 model | Alliance of Genome Resources | |||
multiple sclerosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | 1 model | Alliance of Genome Resources | |||
multiple sclerosis | HLA-DRA* | H2-Ea | 1 model | Alliance of Genome Resources | |||
multiple sclerosis | HLA-DRB1*, HLA-DRB3*, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | 1 model | Alliance of Genome Resources | |||
multiple sclerosis | H6PD* | H6pd | Alliance of Genome Resources | ||||
multiple sclerosis | HLA-DPB1* | ||||||
multiple sclerosis | HSP90AB1*, HSP90AB2P, HSP90AB3P, HSP90AB4P | Hsp90ab1 | Alliance of Genome Resources | ||||
multiple sclerosis | IFNB1* | Ifnb1 | Alliance of Genome Resources | ||||
multiple sclerosis | IFNG* | Ifng | Alliance of Genome Resources | ||||
multiple sclerosis | IL1B* | Il1b | Alliance of Genome Resources | ||||
multiple sclerosis | IL2RA* | Il2ra | Alliance of Genome Resources | ||||
multiple sclerosis | IL4* | Il4 | Alliance of Genome Resources | ||||
multiple sclerosis | IL4R* | Il4ra | Alliance of Genome Resources | ||||
multiple sclerosis | IL6* | Il6 | Alliance of Genome Resources | ||||
multiple sclerosis | IL21R* | Il21r | Alliance of Genome Resources | ||||
multiple sclerosis | IL23R* | Il23r | Alliance of Genome Resources | ||||
multiple sclerosis | IRF5* | Irf5 | Alliance of Genome Resources | ||||
multiple sclerosis | KIF1B* | Kif1b | Alliance of Genome Resources | ||||
multiple sclerosis | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
multiple sclerosis | MBP* | Mbp | Alliance of Genome Resources | ||||
multiple sclerosis | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
multiple sclerosis | MMP12* | Mmp12 | Alliance of Genome Resources | ||||
multiple sclerosis | MOG* | Mog | 4 models | Alliance of Genome Resources | |||
multiple sclerosis | MPHOSPH9* | Mphosph9 | Alliance of Genome Resources | ||||
multiple sclerosis | ATP8* | mt-Atp8 | Alliance of Genome Resources | ||||
multiple sclerosis | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
multiple sclerosis | NDUFS2* | Ndufs2 | Alliance of Genome Resources | ||||
multiple sclerosis | NECTIN2* | Nectin2 | Alliance of Genome Resources | ||||
multiple sclerosis | NOTCH4* | Notch4 | Alliance of Genome Resources | ||||
multiple sclerosis | PDCD1* | Pdcd1 | Alliance of Genome Resources | ||||
multiple sclerosis | PHACTR2* | Phactr2 | Alliance of Genome Resources | ||||
multiple sclerosis | PNMT* | Pnmt | Alliance of Genome Resources | ||||
multiple sclerosis | POLG* | Polg | Alliance of Genome Resources | ||||
multiple sclerosis | PSMB9* | Psmb9 | Alliance of Genome Resources | ||||
multiple sclerosis | PTPRC* | Ptprc | Alliance of Genome Resources | ||||
multiple sclerosis | RGMA* | Rgma | Alliance of Genome Resources | ||||
multiple sclerosis | SH2D2A* | Sh2d2a | Alliance of Genome Resources | ||||
multiple sclerosis | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
multiple sclerosis | SPP1* | Spp1 | Alliance of Genome Resources | ||||
multiple sclerosis | TAP2* | Tap2 | Alliance of Genome Resources | ||||
multiple sclerosis | TNFRSF1A* | Tnfrsf1a | 1 model | Alliance of Genome Resources | |||
multiple sclerosis | VDR* | Vdr | Alliance of Genome Resources | ||||
multiple system atrophy | KLK6* | Klk6 | Alliance of Genome Resources | ||||
muscular dystrophy | SGCD* | Sgcd | Alliance of Genome Resources | ||||
muscular dystrophy | CAPN3* | Capn3 | Alliance of Genome Resources | ||||
muscular dystrophy | CAV3* | Cav3 | Alliance of Genome Resources | ||||
muscular dystrophy | CHKB* | Chkb | Alliance of Genome Resources | ||||
muscular dystrophy | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
muscular dystrophy | DYSF* | Dysf | Alliance of Genome Resources | ||||
muscular dystrophy | FKTN* | Fktn | Alliance of Genome Resources | ||||
muscular dystrophy | LAMA2* | Lama2 | Alliance of Genome Resources | ||||
muscular dystrophy | MYOT* | Myot | Alliance of Genome Resources | ||||
muscular dystrophy | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
muscular dystrophy | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
muscular dystrophy | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
muscular dystrophy | SGCA* | Sgca | Alliance of Genome Resources | ||||
muscular dystrophy | TRIM32* | Trim32 | Alliance of Genome Resources | ||||
muscular dystrophy | SGCB* | Sgcb | Alliance of Genome Resources | ||||
muscular dystrophy | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B14 | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B15 | DPM3* | Dpm3 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B2 | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B3 | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B4 | FKTN* | Fktn | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type C12 | POMK* | Pomk | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type C8 | POMGNT2* | Pomgnt2 | Alliance of Genome Resources | ||||
myasthenia gravis | ADRB2* | Adrb2 | Alliance of Genome Resources | ||||
myasthenia gravis | IL2RB* | Il2rb | Alliance of Genome Resources | ||||
myasthenia gravis | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
myasthenia gravis | ACHE* | Ache | Alliance of Genome Resources | ||||
myasthenia gravis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
myasthenia gravis | CHRM1* | Chrm1 | Alliance of Genome Resources | ||||
myasthenia gravis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
myasthenia gravis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
myelitis | HLA-DPB1* | ||||||
myelomeningocele | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
myoclonic-atonic epilepsy | SLC6A1* | Slc6a1 | Alliance of Genome Resources | ||||
myoclonic-atonic epilepsy | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
myoclonic dystonia 26 | KCTD17* | Kctd17 | Alliance of Genome Resources | ||||
myoclonic dystonia 34 | KCNN2* | Kcnn2 | Alliance of Genome Resources | ||||
myopia | PRIMPOL* | Primpol | Alliance of Genome Resources | ||||
myopia | LOXL3* | Loxl3 | Alliance of Genome Resources | ||||
myopia | LAMA2* | Lama2 | Alliance of Genome Resources | ||||
myopia | IGF1* | Igf1 | Alliance of Genome Resources | ||||
myopia | SLC39A5* | Slc39a5 | Alliance of Genome Resources | ||||
myopia | VDR* | Vdr | Alliance of Genome Resources | ||||
myopia | ZNF644* | Zfp644 | Alliance of Genome Resources | ||||
myopia | HGF* | Hgf | Alliance of Genome Resources | ||||
myopia | CPSF1* | Cpsf1 | Alliance of Genome Resources | ||||
myopia | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
myopia | ARR3* | Arr3 | Alliance of Genome Resources | ||||
myopia | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
myopia | P4HA2* | P4ha2 | Alliance of Genome Resources | ||||
myopia | PARL* | Parl | Alliance of Genome Resources | ||||
myopia | LRPAP1* | Lrpap1 | Alliance of Genome Resources | ||||
myopia | SCO2* | Sco2 | Alliance of Genome Resources | ||||
myotonic dystrophy type 2 | CNBP* | Cnbp | Alliance of Genome Resources | ||||
nanophthalmos | TMEM98* | Tmem98 | 1 "NOT" model | Alliance of Genome Resources | |||
nanophthalmos | MYRF* | Myrf | Alliance of Genome Resources | ||||
nanophthalmos | MFRP* | Mfrp | Alliance of Genome Resources | ||||
neovascular inflammatory vitreoretinopathy | LTA* | Lta | Alliance of Genome Resources | ||||
neovascular inflammatory vitreoretinopathy | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
neovascular inflammatory vitreoretinopathy | CAPN5* | Capn5 | Alliance of Genome Resources | ||||
neurilemmoma | NF2* | Nf2 | Alliance of Genome Resources | ||||
neurilemmoma | LZTR1* | Lztr1 | Alliance of Genome Resources | ||||
neurilemmoma | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
neuroaxonal dystrophy | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
neuroaxonal dystrophy | NAGA* | Naga | Alliance of Genome Resources | ||||
neuroblastoma | PECAM1* | Pecam1 | Alliance of Genome Resources | ||||
neuroblastoma | ARID1A* | Arid1a | Alliance of Genome Resources | ||||
neuroblastoma | ARID1B* | Arid1b | Alliance of Genome Resources | ||||
neuroblastoma | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
neuroblastoma | CHAF1A* | Chaf1a | Alliance of Genome Resources | ||||
neuroblastoma | IGF1R* | Igf1r | Alliance of Genome Resources | ||||
neuroblastoma | KIF1B* | Kif1b | Alliance of Genome Resources | ||||
neuroblastoma | NME1* | Nme1 | Alliance of Genome Resources | ||||
neuroblastoma | NSD1* | Nsd1 | Alliance of Genome Resources | ||||
neuroblastoma | PHOX2B* | Phox2b | Alliance of Genome Resources | ||||
neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
neurodegeneration with brain iron accumulation | CRAT* | Crat | Alliance of Genome Resources | ||||
neurodegeneration with brain iron accumulation | FTH1* | Fth1 | Alliance of Genome Resources | ||||
neurodegeneration with brain iron accumulation | REPS1* | Reps1 | Alliance of Genome Resources | ||||
neurodegeneration with brain iron accumulation 2b | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
neurodegeneration with brain iron accumulation 3 | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
neurodegeneration with brain iron accumulation 4 | C19orf12* | 1600014C10Rik | Alliance of Genome Resources | ||||
neurodegenerative disease | FUS* | Fus | Alliance of Genome Resources | ||||
neurodegenerative disease | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
neurodegenerative disease | EPO* | Epo | Alliance of Genome Resources | ||||
neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures | IRF2BPL* | Irf2bpl | Alliance of Genome Resources | ||||
neurofibrosarcoma | MXI1* | Mxi1 | Alliance of Genome Resources | ||||
neurogenic-type arthrogryposis multiplex congenita-2 | ERGIC1* | Ergic1 | Alliance of Genome Resources | ||||
neuromuscular disease | GPI* | Gpi1 | Alliance of Genome Resources | ||||
neuromyelitis optica | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
neuromyelitis optica | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
neuromyelitis optica | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
neuronal intranuclear inclusion disease | NOTCH2NLC* | ||||||
neuropathy | CTSS* | Ctss | Alliance of Genome Resources | ||||
Newfoundland cone-rod dystrophy | RLBP1* | Rlbp1 | Alliance of Genome Resources | ||||
night blindness | RLBP1* | Rlbp1 | Alliance of Genome Resources | ||||
night blindness | GRK1* | Grk1 | Alliance of Genome Resources | ||||
night blindness | NYX* | Nyx | Alliance of Genome Resources | ||||
night blindness | RDH5* | Rdh5 | Alliance of Genome Resources | ||||
night blindness | RHO* | Rho | Alliance of Genome Resources | ||||
night blindness | GNAT1* | Gnat1 | Alliance of Genome Resources | ||||
non-arteritic anterior ischemic optic neuropathy | ITGB3* | Itgb3 | Alliance of Genome Resources | ||||
non-arteritic anterior ischemic optic neuropathy | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
non-arteritic anterior ischemic optic neuropathy | ACE* | Ace | Alliance of Genome Resources | ||||
non-arteritic anterior ischemic optic neuropathy | F5* | F5 | Alliance of Genome Resources | ||||
non-arteritic anterior ischemic optic neuropathy | GP1BA* | Gp1ba | Alliance of Genome Resources | ||||
nonprogressive cerebellar ataxia with mental retardation | CAMTA1* | Camta1 | Alliance of Genome Resources | ||||
nonsyndromic deafness | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
nonsyndromic deafness | USH2A* | Ush2a | Alliance of Genome Resources | ||||
Norman-Roberts syndrome | RELN* | Reln | Alliance of Genome Resources | ||||
nuclear senile cataract | FTO* | Fto | Alliance of Genome Resources | ||||
occult macular dystrophy | RP1L1* | Rp1l1 | Alliance of Genome Resources | ||||
ocular albinism 1 | TYR* | Tyr | Alliance of Genome Resources | ||||
ocular hypertension | MYOC* | Myoc | Alliance of Genome Resources | ||||
ocular hypertension | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
ocular hypertension | CDKN1A* | Cdkn1a | Alliance of Genome Resources | ||||
oculopharyngeal muscular dystrophy | PABPN1* | Pabpn1 | 1 model | Alliance of Genome Resources | |||
Oguchi disease-1 | SAG* | Sag | Alliance of Genome Resources | ||||
olivopontocerebellar atrophy | APTX* | Aptx | Alliance of Genome Resources | ||||
open-angle glaucoma | TAP1* | Tap1 | Alliance of Genome Resources | ||||
open-angle glaucoma | TNF* | Tnf | Alliance of Genome Resources | ||||
open-angle glaucoma | ADRB2* | Adrb2 | Alliance of Genome Resources | ||||
open-angle glaucoma | AFAP1* | Afap1 | Alliance of Genome Resources | ||||
open-angle glaucoma | APOE* | Apoe | Alliance of Genome Resources | ||||
open-angle glaucoma | CDKN2B* | Cdkn2b | Alliance of Genome Resources | ||||
open-angle glaucoma | GMDS* | Gmds | Alliance of Genome Resources | ||||
open-angle glaucoma | MEIS2* | Meis2 | Alliance of Genome Resources | ||||
open-angle glaucoma | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
open-angle glaucoma | OPTN* | Optn | Alliance of Genome Resources | ||||
open-angle glaucoma | PON1* | Pon1 | Alliance of Genome Resources | ||||
optic atrophy | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
optic atrophy | MIEF1* | Mief1 | Alliance of Genome Resources | ||||
optic atrophy | SSBP1* | Ssbp1 | Alliance of Genome Resources | ||||
optic atrophy | MCAT* | Mcat | Alliance of Genome Resources | ||||
optic atrophy | MECR* | Mecr | Alliance of Genome Resources | ||||
optic atrophy 1 | OPA1* | Opa1 | Alliance of Genome Resources | ||||
optic atrophy 1 | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
optic atrophy 10 | RTN4IP1* | Rtn4ip1 | Alliance of Genome Resources | ||||
optic atrophy 11 | YME1L1* | Yme1l1 | Alliance of Genome Resources | ||||
optic atrophy 12 | AFG3L2* | Afg3l2 | Alliance of Genome Resources | ||||
optic atrophy 3 | OPA3* | Opa3 | Alliance of Genome Resources | ||||
optic atrophy 5 | DNM1L* | Dnm1l | Alliance of Genome Resources | ||||
optic atrophy 7 | TMEM126A* | Tmem126a | Alliance of Genome Resources | ||||
optic atrophy 9 | ACO2* | Aco2 | Alliance of Genome Resources | ||||
optic disc anomalies with retinal and/or macular dystrophy | SIX6* | Six6 | Alliance of Genome Resources | ||||
optic nerve disease | EDN1* | Edn1 | Alliance of Genome Resources | ||||
optic nerve glioma | NF1* | Nf1 | Alliance of Genome Resources | ||||
optic neuritis | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
optic neuritis | MOG* | Mog | Alliance of Genome Resources | ||||
optic neuritis | CAT* | Cat | Alliance of Genome Resources | ||||
optic neuritis | SOD2* | Sod2 | Alliance of Genome Resources | ||||
optic neuritis | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
optic neuritis | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
optic neuritis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
optic neuritis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
otitis media | A2ML1* | ||||||
otitis media | CX3CR1* | Cx3cr1 | Alliance of Genome Resources | ||||
otitis media | IL6* | Il6 | Alliance of Genome Resources | ||||
otitis media | IL10* | Il10 | Alliance of Genome Resources | ||||
otitis media | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
otosclerosis | VDR* | Vdr | Alliance of Genome Resources | ||||
otosclerosis | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
otosclerosis | AGT* | Agt | Alliance of Genome Resources | ||||
otosclerosis | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
otosclerosis | BMP4* | Bmp4 | Alliance of Genome Resources | ||||
otosclerosis | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
otosclerosis 11 | FOXL1* | Foxl1 | Alliance of Genome Resources | ||||
pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures | TUBGCP2* | Tubgcp2 | Alliance of Genome Resources | ||||
pantothenate kinase-associated neurodegeneration | PANK2* | Pank2 | 1 "NOT" model | Alliance of Genome Resources | |||
panuveitis | IL10* | Il10 | Alliance of Genome Resources | ||||
panuveitis | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
paramyotonia congenita of Von Eulenburg | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
Parkinsonism | GCH1* | Gch1 | Alliance of Genome Resources | ||||
Parkinsonism | GBA1* | Gba1 | Alliance of Genome Resources | ||||
Parkinsonism | TH* | Th | Alliance of Genome Resources | ||||
Parkinsonism | PARK7* | Park7 | Alliance of Genome Resources | ||||
Parkinsonism | TNFRSF1B* | Tnfrsf1b | Alliance of Genome Resources | ||||
Parkinsonism | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
Parkinsonism | MANF* | Manf | Alliance of Genome Resources | ||||
Parkinsonism | LRRK2* | Lrrk2 | Alliance of Genome Resources | ||||
Parkinsonism | BDNF* | Bdnf | Alliance of Genome Resources | ||||
Parkinsonism | HSPA1A*, HSPA1B | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
Parkinsonism | GDNF* | Gdnf | Alliance of Genome Resources | ||||
Parkinson's disease | A2M* | A2m | Alliance of Genome Resources | ||||
Parkinson's disease | AKT1* | Akt1 | Alliance of Genome Resources | ||||
Parkinson's disease | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
Parkinson's disease | ATM* | Atm | Alliance of Genome Resources | ||||
Parkinson's disease | ATP6* | Atp6-ps, mt-Atp6 | Alliance of Genome Resources | ||||
Parkinson's disease | ATP13A2* | Atp13a2 | Alliance of Genome Resources | ||||
Parkinson's disease | CASP3* | Casp3 | Alliance of Genome Resources | ||||
Parkinson's disease | CASP9* | Casp9 | Alliance of Genome Resources | ||||
Parkinson's disease | CAST* | Cast | Alliance of Genome Resources | ||||
Parkinson's disease | CHRNB3* | Chrnb3 | Alliance of Genome Resources | ||||
Parkinson's disease | CREB1* | Creb1 | Alliance of Genome Resources | ||||
Parkinson's disease | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
Parkinson's disease | DBH* | Dbh | Alliance of Genome Resources | ||||
Parkinson's disease | DDC* | Ddc | Alliance of Genome Resources | ||||
Parkinson's disease | DNAJC6* | Dnajc6 | Alliance of Genome Resources | ||||
Parkinson's disease | DNAJC13* | Dnajc13 | Alliance of Genome Resources | ||||
Parkinson's disease | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
Parkinson's disease | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
Parkinson's disease | EPO* | Epo | Alliance of Genome Resources | ||||
Parkinson's disease | ESR2* | Esr2 | Alliance of Genome Resources | ||||
Parkinson's disease | FBXO7* | Fbxo7 | Alliance of Genome Resources | ||||
Parkinson's disease | GBA1* | Gba1 | Alliance of Genome Resources | ||||
Parkinson's disease | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
Parkinson's disease | GIGYF2* | Gigyf2 | Alliance of Genome Resources | ||||
Parkinson's disease | GRK6* | Grk6 | Alliance of Genome Resources | ||||
Parkinson's disease | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
Parkinson's disease | GSTO1* | Gsto1 | Alliance of Genome Resources | ||||
Parkinson's disease | GSTO2* | Gsto2 | Alliance of Genome Resources | ||||
Parkinson's disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
Parkinson's disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
Parkinson's disease | HLA-DRA* | H2-Ea | Alliance of Genome Resources | ||||
Parkinson's disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
Parkinson's disease | HMGCR* | Hmgcr | Alliance of Genome Resources | ||||
Parkinson's disease | HNMT* | Hnmt | Alliance of Genome Resources | ||||
Parkinson's disease | HSPA8* | Hspa8 | Alliance of Genome Resources | ||||
Parkinson's disease | HSPA9* | Hspa9 | Alliance of Genome Resources | ||||
Parkinson's disease | HTRA2* | Htra2 | Alliance of Genome Resources | ||||
Parkinson's disease | HTT* | Htt | Alliance of Genome Resources | ||||
Parkinson's disease | IL1B* | Il1b | Alliance of Genome Resources | ||||
Parkinson's disease | KLK6* | Klk6 | Alliance of Genome Resources | ||||
Parkinson's disease | LRRK2* | Lrrk2 | Alliance of Genome Resources | ||||
Parkinson's disease | MAOB* | Maob | Alliance of Genome Resources | ||||
Parkinson's disease | MAPK1* | Mapk1 | Alliance of Genome Resources | ||||
Parkinson's disease | MAPK3* | Mapk3 | Alliance of Genome Resources | ||||
Parkinson's disease | MAPT* | Mapt | Alliance of Genome Resources | ||||
Parkinson's disease | MAPT-AS1* | ||||||
Parkinson's disease | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
Parkinson's disease | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
Parkinson's disease | ND3* | mt-Nd3 | Alliance of Genome Resources | ||||
Parkinson's disease | ND4* | mt-Nd4 | Alliance of Genome Resources | ||||
Parkinson's disease | MTRR* | Mtrr | Alliance of Genome Resources | ||||
Parkinson's disease | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
Parkinson's disease | NDUFV2* | Ndufv2 | Alliance of Genome Resources | ||||
Parkinson's disease | NOS1* | Nos1 | Alliance of Genome Resources | ||||
Parkinson's disease | NQO2* | Nqo2 | Alliance of Genome Resources | ||||
Parkinson's disease | PARK7* | Park7 | Alliance of Genome Resources | ||||
Parkinson's disease | PARP1* | Parp1 | Alliance of Genome Resources | ||||
Parkinson's disease | PHACTR2* | Phactr2 | Alliance of Genome Resources | ||||
Parkinson's disease | PINK1* | Pink1 | 2 models | Alliance of Genome Resources | |||
Parkinson's disease | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
Parkinson's disease | POLG* | Polg | Alliance of Genome Resources | ||||
Parkinson's disease | PRKN* | Prkn | Alliance of Genome Resources | ||||
Parkinson's disease | PTGIS* | Ptgis | Alliance of Genome Resources | ||||
Parkinson's disease | S100B* | S100b | Alliance of Genome Resources | ||||
Parkinson's disease | SEPTIN14* | Septin14 | Alliance of Genome Resources | ||||
Parkinson's disease | SLC11A2* | Slc11a2 | Alliance of Genome Resources | ||||
Parkinson's disease | SLC18A2* | Slc18a2 | Alliance of Genome Resources | ||||
Parkinson's disease | SNCA* | Snca | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | SNCB* | Sncb | Alliance of Genome Resources | ||||
Parkinson's disease | SOD1* | Sod1 | Alliance of Genome Resources | ||||
Parkinson's disease | SYNJ1* | Synj1 | Alliance of Genome Resources | ||||
Parkinson's disease | TARDBP* | Tardbp | Alliance of Genome Resources | ||||
Parkinson's disease | TCN2* | Tcn2 | Alliance of Genome Resources | ||||
Parkinson's disease | TH* | Th | Alliance of Genome Resources | ||||
Parkinson's disease | UCHL1* | Uchl1 | 1 model | Alliance of Genome Resources | |||
Parkinson's disease | VDR* | Vdr | Alliance of Genome Resources | ||||
Parkinson's disease 15 | FBXO7* | Fbxo7 | Alliance of Genome Resources | ||||
Parkinson's disease 19A | DNAJC6* | Dnajc6 | Alliance of Genome Resources | ||||
Parkinson's disease 20 | SYNJ1* | Synj1 | Alliance of Genome Resources | ||||
Parkinson's disease 22 | CHCHD2*, CHCHD2P9 | Chchd2, Chchd2-ps | Alliance of Genome Resources | ||||
Parkinson's disease 23 | VPS13C* | Vps13c | Alliance of Genome Resources | ||||
Parkinson's disease 25 | PTPA* | Ptpa | Alliance of Genome Resources | ||||
paroxysmal extreme pain disorder | SCN9A* | Scn9a | Alliance of Genome Resources | ||||
paroxysmal nonkinesigenic dyskinesia 3 | KCNMA1* | Kcnma1 | Alliance of Genome Resources | ||||
patterned macular dystrophy | PRPH2* | Prph2 | Alliance of Genome Resources | ||||
patterned macular dystrophy | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
patterned macular dystrophy 3 | MAPKAPK3* | Mapkapk3 | Alliance of Genome Resources | ||||
PEHO syndrome | ZNHIT3* | Znhit3 | Alliance of Genome Resources | ||||
peripheral nervous system disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
peripheral nervous system disease | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
peripheral nervous system disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
peripheral nervous system neoplasm | PTEN* | Pten | Alliance of Genome Resources | ||||
periventricular nodular heterotopia | MAP1B* | Map1b | Alliance of Genome Resources | ||||
periventricular nodular heterotopia | ARF1* | Arf1 | Alliance of Genome Resources | ||||
periventricular nodular heterotopia | NEDD4L* | Nedd4l | Alliance of Genome Resources | ||||
periventricular nodular heterotopia | ARFGEF2* | Arfgef2 | Alliance of Genome Resources | ||||
periventricular nodular heterotopia | ERMARD* | Ermard, Ermardl1, Ermardl2 | Alliance of Genome Resources | ||||
persistent hyperplastic primary vitreous | ATOH7* | Atoh7 | Alliance of Genome Resources | ||||
Peters anomaly | CYP1B1* | Cyp1b1 | Alliance of Genome Resources | ||||
Pick's disease | MAPT* | Mapt | Alliance of Genome Resources | ||||
Pick's disease | MAP2K6* | Map2k6 | Alliance of Genome Resources | ||||
Pick's disease | PSEN1* | Psen1 | Alliance of Genome Resources | ||||
pigmented paravenous chorioretinal atrophy | CRB1* | Crb1 | Alliance of Genome Resources | ||||
pleomorphic xanthoastrocytoma | BRAF* | Braf | Alliance of Genome Resources | ||||
plexiform neurofibroma | NF1* | Nf1 | Alliance of Genome Resources | ||||
polymicrogyria | WDR62* | Wdr62 | Alliance of Genome Resources | ||||
polyneuropathy | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
polyneuropathy | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
polyneuropathy | SOD3* | Sod3 | Alliance of Genome Resources | ||||
polyneuropathy | SOD2* | Sod2 | Alliance of Genome Resources | ||||
polyneuropathy due to drug | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
polyneuropathy due to drug | ERCC4* | Ercc4 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia | PRDM13* | Prdm13 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 11 | TBC1D23* | Tbc1d23 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 12 | COASY* | Coasy | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 13 | VPS51* | Vps51 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 15 | CDC40* | Cdc40 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 16 | MINPP1* | Minpp1 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1A | VRK1* | Vrk1 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1B | EXOSC3* | Exosc3 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1C | EXOSC8* | Exosc8 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1D | EXOSC9* | Exosc9 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1E | SLC25A46* | Slc25a46 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 1F | EXOSC1* | Exosc1 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2A | TSEN54* | Tsen54 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2B | TSEN2* | Tsen2 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2C | TSEN34* | Tsen34 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2D | SEPSECS* | Sepsecs | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2E | VPS53* | Vps53 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 2F | TSEN15* | Tsen15 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 3 | PCLO* | Pclo | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 4 | TSEN54* | Tsen54 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 5 | TSEN54* | Tsen54 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 6 | RARS2* | Rars2 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 7 | TOE1* | Toe1 | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 8 | CHMP1A* | Chmp1a | Alliance of Genome Resources | ||||
pontocerebellar hypoplasia type 9 | AMPD2* | Ampd2 | Alliance of Genome Resources | ||||
porencephaly | COL4A2* | Col4a2 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 1 | VSX1* | Vsx1 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 1 | OVOL2* | Ovol2 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 2 | COL8A2* | Col8a2 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 3 | ZEB1* | Zeb1 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 4 | GRHL2* | Grhl2 | Alliance of Genome Resources | ||||
posterior uveitis | CCR2* | Ccr2 | Alliance of Genome Resources | ||||
posterior uveitis | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
posterior uveitis | CCR5* | Ccr5 | Alliance of Genome Resources | ||||
primary angle-closure glaucoma | COL18A1* | Col18a1 | Alliance of Genome Resources | ||||
primary angle-closure glaucoma | MYRF* | Myrf | Alliance of Genome Resources | ||||
primary angle-closure glaucoma | ACVR1* | Acvr1 | Alliance of Genome Resources | ||||
primary autosomal dominant microcephaly 18 | WDFY3* | Wdfy3 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | PDCD6IP* | Pdcd6ip | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | WDR62* | Wdr62 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | TRAPPC14* | Trappc14 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | RRP7A*, RRP7BP | Rrp7a | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | NUP37* | Nup37 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | NCAPH* | Ncaph | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | NCAPD3* | Ncapd3 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | NCAPD2* | Ncapd2 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | MCPH1* | Mcph1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | LMNB2* | Lmnb2 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | LMNB1* | Lmnb1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | KNL1* | Knl1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | KIF14* | Kif14 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | CPAP* | Cpap | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | BUB1* | Bub1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly | ASPM* | Aspm | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 1 | MCPH1* | Mcph1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 10 | ZNF335* | Zfp335 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 11 | PHC1* | Phc1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 12 | CDK6* | Cdk6 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 13 | CENPE* | Cenpe | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 14 | SASS6* | Sass6 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 15 | MFSD2A* | Mfsd2a | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 16 | ANKLE2* | Ankle2 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 17 | CIT* | Cit | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 19 | COPB2* | Copb2 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 3 | CDK5RAP2* | Cdk5rap2 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 4 | KNL1* | Knl1 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 5 | ASPM* | Aspm | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 6 | CPAP* | Cpap | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 7 | STIL* | Stil | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 8 | CEP135* | Cep135 | Alliance of Genome Resources | ||||
primary autosomal recessive microcephaly 9 | CEP152* | Cep152 | Alliance of Genome Resources | ||||
primary cerebellar degeneration | SIL1* | Sil1 | Alliance of Genome Resources | ||||
primary microcephaly | CIT* | Cit | Alliance of Genome Resources | ||||
primary open angle glaucoma | ADRB2* | Adrb2 | Alliance of Genome Resources | ||||
primary open angle glaucoma | CYP1B1* | Cyp1b1 | Alliance of Genome Resources | ||||
primary open angle glaucoma | MYOC* | Myoc | Alliance of Genome Resources | ||||
primary open angle glaucoma | APOE* | Apoe | Alliance of Genome Resources | ||||
primary open angle glaucoma | SOD2* | Sod2 | Alliance of Genome Resources | ||||
primary open angle glaucoma | LAMB2* | Lamb2 | Alliance of Genome Resources | ||||
primary open angle glaucoma | LOXL1* | Loxl1 | Alliance of Genome Resources | ||||
primary open angle glaucoma | THBS1* | Thbs1 | Alliance of Genome Resources | ||||
primary open angle glaucoma | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
primary open angle glaucoma | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
primary open angle glaucoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
primary open angle glaucoma | OPTN* | Optn | Alliance of Genome Resources | ||||
primary open angle glaucoma | TP53* | Trp53 | Alliance of Genome Resources | ||||
primary open angle glaucoma | CAV1* | Cav1 | Alliance of Genome Resources | ||||
primary open angle glaucoma | PON1* | Pon1 | Alliance of Genome Resources | ||||
primary open angle glaucoma | CAV2* | Cav2 | Alliance of Genome Resources | ||||
primary open angle glaucoma | CDKN1A* | Cdkn1a | Alliance of Genome Resources | ||||
primary open angle glaucoma | WDR36* | Wdr36 | Alliance of Genome Resources | ||||
primary open angle glaucoma | ACVR1* | Acvr1 | Alliance of Genome Resources | ||||
primary open angle glaucoma | ESR2* | Esr2 | Alliance of Genome Resources | ||||
primary open angle glaucoma | ADIPOQ* | Adipoq | Alliance of Genome Resources | ||||
primary open angle glaucoma | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
primary open angle glaucoma | NOS3* | Nos3 | Alliance of Genome Resources | ||||
primary open angle glaucoma | TNF* | Tnf | Alliance of Genome Resources | ||||
primary open angle glaucoma | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
primary open angle glaucoma | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
primary progressive multiple sclerosis | IL4R* | Il4ra | Alliance of Genome Resources | ||||
primary progressive multiple sclerosis | GRN* | Grn | Alliance of Genome Resources | ||||
primary progressive multiple sclerosis | ADAMTS14* | Adamts14 | Alliance of Genome Resources | ||||
primary progressive multiple sclerosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
primary progressive multiple sclerosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
prion disease | SOD1* | Sod1 | Alliance of Genome Resources | ||||
progressive leukoencephalopathy with ovarian failure | AARS2* | Aars2 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy | SLC7A6OS* | Slc7a6os | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy | EPM2A* | Epm2a | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy | SEMA6B* | Sema6b | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 10 | PRDM8* | Prdm8 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 1A | CSTB* | Cstb | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 3 | KCTD7* | Kctd7 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 4 | SCARB2* | Scarb2 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 6 | GOSR2* | Gosr2 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 7 | KCNC1* | Kcnc1 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 8 | CERS1* | Cers1 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 9 | LMNB2* | Lmnb2 | Alliance of Genome Resources | ||||
progressive supranuclear palsy | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
progressive supranuclear palsy | MAPT* | Mapt | Alliance of Genome Resources | ||||
progressive supranuclear palsy | MAP2K6* | Map2k6 | Alliance of Genome Resources | ||||
proliferative diabetic retinopathy | CCL2*, CCL13 | Ccl2, Ccl12 | Alliance of Genome Resources | ||||
proliferative diabetic retinopathy | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
proliferative diabetic retinopathy | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
proliferative diabetic retinopathy | SRSF6* | Srsf6 | Alliance of Genome Resources | ||||
proliferative diabetic retinopathy | BCOR*, BCORP1 | Bcor | Alliance of Genome Resources | ||||
proliferative diabetic retinopathy | PPARG* | Pparg | Alliance of Genome Resources | ||||
pterygium | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
pterygium | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
pterygium | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
ptosis | FOXC2* | Foxc2 | Alliance of Genome Resources | ||||
quadriplegia | IL6* | Il6 | Alliance of Genome Resources | ||||
red color blindness | OPN1LW*, OPN1MW, OPN1MW2, OPN1MW3 | Opn1mw | Alliance of Genome Resources | ||||
red-green color blindness | OPN1MW*, OPN1LW, OPN1MW2, OPN1MW3 | Opn1mw | Alliance of Genome Resources | ||||
Reis-Bucklers corneal dystrophy | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
relapsing-remitting multiple sclerosis | CSPG4* | Cspg4 | Alliance of Genome Resources | ||||
relapsing-remitting multiple sclerosis | FAS* | Fas | Alliance of Genome Resources | ||||
relapsing-remitting multiple sclerosis | KLC1* | Klc1 | Alliance of Genome Resources | ||||
relapsing-remitting multiple sclerosis | NOD2* | Nod2 | Alliance of Genome Resources | ||||
relapsing-remitting multiple sclerosis | ADAMTS14* | Adamts14 | Alliance of Genome Resources | ||||
restless legs syndrome | TF* | Trf | Alliance of Genome Resources | ||||
retinal artery occlusion | IL10* | Il10 | Alliance of Genome Resources | ||||
retinal artery occlusion | IL6* | Il6 | Alliance of Genome Resources | ||||
retinal cone dystrophy 3A | PDE6H* | Pde6h | Alliance of Genome Resources | ||||
retinal cone dystrophy 3B | KCNV2* | Kcnv2 | Alliance of Genome Resources | ||||
retinal cone dystrophy 4 | CACNA2D4* | Cacna2d4 | Alliance of Genome Resources | ||||
retinal degeneration | PRPH2* | Prph2 | Alliance of Genome Resources | ||||
retinal degeneration | PKD2* | Pkd2 | Alliance of Genome Resources | ||||
retinal degeneration | HGF* | Hgf | Alliance of Genome Resources | ||||
retinal degeneration | HDAC4* | Hdac4 | Alliance of Genome Resources | ||||
retinal degeneration | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
retinal degeneration | ABCA4* | Abca4 | Alliance of Genome Resources | ||||
retinal degeneration | TFPI2* | Tfpi2 | Alliance of Genome Resources | ||||
retinal degeneration | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
retinal degeneration | RD3* | Rd3 | Alliance of Genome Resources | ||||
retinal detachment | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
retinal detachment | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
retinal disease | APOE* | Apoe | Alliance of Genome Resources | ||||
retinal drusen | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
retinal macular dystrophy 2 | PROM1* | Prom1 | Alliance of Genome Resources | ||||
retinal macular dystrophy 4 | CLEC3B* | Clec3b | Alliance of Genome Resources | ||||
retinal vasculitis | CX3CR1* | Cx3cr1 | Alliance of Genome Resources | ||||
retinal vasculitis | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
retinal vein occlusion | ITGA2* | Itga2 | Alliance of Genome Resources | ||||
retinal vein occlusion | F2* | F2 | Alliance of Genome Resources | ||||
retinal vein occlusion | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
retinal vein occlusion | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
retinal vein occlusion | PON1* | Pon1 | Alliance of Genome Resources | ||||
retinal vein occlusion | F5* | F5 | Alliance of Genome Resources | ||||
retinal vein occlusion | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | IMPDH1* | Impdh1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | CC2D2A* | Cc2d2a | Alliance of Genome Resources | ||||
retinitis pigmentosa | CAT* | Cat | Alliance of Genome Resources | ||||
retinitis pigmentosa | CA4* | Car4 | Alliance of Genome Resources | ||||
retinitis pigmentosa | ARHGEF18* | Arhgef18 | Alliance of Genome Resources | ||||
retinitis pigmentosa | LRAT* | Lrat | Alliance of Genome Resources | ||||
retinitis pigmentosa | IMPG1* | Impg1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | ABCA4* | Abca4 | Alliance of Genome Resources | ||||
retinitis pigmentosa | IFT140* | Ift140 | Alliance of Genome Resources | ||||
retinitis pigmentosa | HKDC1* | Hkdc1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | HK1* | Hk1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | GUCY2D* | Gucy2e | Alliance of Genome Resources | ||||
retinitis pigmentosa | FSCN2* | Fscn2 | Alliance of Genome Resources | ||||
retinitis pigmentosa | CRB1* | Crb1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | CNGA1* | Cnga1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | AIPL1* | Aipl1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | CERKL* | Cerkl | Alliance of Genome Resources | ||||
retinitis pigmentosa | WDR19* | Wdr19 | Alliance of Genome Resources | ||||
retinitis pigmentosa | USH2A* | Ush2a | Alliance of Genome Resources | ||||
retinitis pigmentosa | TULP1* | Tulp1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | SOD1* | Sod1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | SNRNP200* | Snrnp200 | Alliance of Genome Resources | ||||
retinitis pigmentosa | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | SAG* | Sag | Alliance of Genome Resources | ||||
retinitis pigmentosa | RPGRIP1* | Rpgrip1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | RPGR* | Rpgr | Alliance of Genome Resources | ||||
retinitis pigmentosa | RPE65* | Rpe65 | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa | RP2* | Rp2 | Alliance of Genome Resources | ||||
retinitis pigmentosa | RLBP1* | Rlbp1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | RHO* | Rho | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa | RGR* | Rgr | Alliance of Genome Resources | ||||
retinitis pigmentosa | RAX2* | ||||||
retinitis pigmentosa | PRPS1* | Prps1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | PRPH2* | Prph2 | Alliance of Genome Resources | ||||
retinitis pigmentosa | PRPF8* | Prpf8 | Alliance of Genome Resources | ||||
retinitis pigmentosa | PRPF3* | Prpf3 | Alliance of Genome Resources | ||||
retinitis pigmentosa | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | OFD1* | Ofd1 | Alliance of Genome Resources | ||||
retinitis pigmentosa | NRL* | Nrl | Alliance of Genome Resources | ||||
retinitis pigmentosa | MFRP* | Mfrp | Alliance of Genome Resources | ||||
retinitis pigmentosa 10 | IMPDH1* | Impdh1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 23 | OFD1* | Ofd1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 25 | EYS* | ||||||
retinitis pigmentosa 27 | NRL* | Nrl | Alliance of Genome Resources | ||||
retinitis pigmentosa 3 | RPGRIP1L* | Rpgrip1l | Alliance of Genome Resources | ||||
retinitis pigmentosa 3 | IQCB1* | Iqcb1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 31 | TOPORS* | Topors | Alliance of Genome Resources | ||||
retinitis pigmentosa 32 | CLCC1* | Clcc1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 33 | SNRNP200* | Snrnp200 | Alliance of Genome Resources | ||||
retinitis pigmentosa 35 | SEMA4A* | Sema4a | Alliance of Genome Resources | ||||
retinitis pigmentosa 36 | PRCD* | Prcd | Alliance of Genome Resources | ||||
retinitis pigmentosa 37 | NR2E3* | Nr2e3 | Alliance of Genome Resources | ||||
retinitis pigmentosa 38 | MERTK* | Mertk | Alliance of Genome Resources | ||||
retinitis pigmentosa 39 | USH2A* | Ush2a | Alliance of Genome Resources | ||||
retinitis pigmentosa 42 | KLHL7* | Klhl7 | Alliance of Genome Resources | ||||
retinitis pigmentosa 43 | PDE6A* | Pde6a | Alliance of Genome Resources | ||||
retinitis pigmentosa 44 | RGR* | Rgr | Alliance of Genome Resources | ||||
retinitis pigmentosa 45 | CNGB1* | Cngb1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 46 | IDH3B* | Idh3b | Alliance of Genome Resources | ||||
retinitis pigmentosa 47 | SAG* | Sag | Alliance of Genome Resources | ||||
retinitis pigmentosa 48 | GUCA1B* | Guca1b | Alliance of Genome Resources | ||||
retinitis pigmentosa 50 | BEST1* | Best1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 51 | TTC8* | Ttc8 | Alliance of Genome Resources | ||||
retinitis pigmentosa 55 | ARL6* | Arl6 | Alliance of Genome Resources | ||||
retinitis pigmentosa 57 | PDE6G* | Pde6g | Alliance of Genome Resources | ||||
retinitis pigmentosa 58 | ZNF513* | Zfp513 | Alliance of Genome Resources | ||||
retinitis pigmentosa 60 | PRPF6* | Prpf6 | Alliance of Genome Resources | ||||
retinitis pigmentosa 61 | CLRN1* | Clrn1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 62 | MAK* | Mak | Alliance of Genome Resources | ||||
retinitis pigmentosa 66 | RBP3* | Rbp3 | Alliance of Genome Resources | ||||
retinitis pigmentosa 67 | NEK2* | Nek2 | Alliance of Genome Resources | ||||
retinitis pigmentosa 68 | SLC7A14* | Slc7a14 | Alliance of Genome Resources | ||||
retinitis pigmentosa 69 | KIZ* | Kiz | Alliance of Genome Resources | ||||
retinitis pigmentosa 7 | ROM1* | Rom1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 70 | PRPF4* | Prpf4 | Alliance of Genome Resources | ||||
retinitis pigmentosa 71 | IFT172* | Ift172 | Alliance of Genome Resources | ||||
retinitis pigmentosa 72 | ZNF408* | Zfp408 | Alliance of Genome Resources | ||||
retinitis pigmentosa 73 | HGSNAT* | Hgsnat | Alliance of Genome Resources | ||||
retinitis pigmentosa 74 | BBS2* | Bbs2 | Alliance of Genome Resources | ||||
retinitis pigmentosa 75 | AGBL5* | Agbl5 | Alliance of Genome Resources | ||||
retinitis pigmentosa 81 | IFT43* | Ift43 | Alliance of Genome Resources | ||||
retinitis pigmentosa 83 | ARL3* | Arl3 | Alliance of Genome Resources | ||||
retinitis pigmentosa 84 | DHX38* | Dhx38 | Alliance of Genome Resources | ||||
retinitis pigmentosa 85 | AHR* | Ahr | Alliance of Genome Resources | ||||
retinitis pigmentosa 86 | KIAA1549* | D630045J12Rik | Alliance of Genome Resources | ||||
retinitis pigmentosa 87 | RPE65* | Rpe65 | Alliance of Genome Resources | ||||
retinitis pigmentosa 88 | RP1L1* | Rp1l1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 89 | KIF3B* | Kif3b | Alliance of Genome Resources | ||||
retinitis pigmentosa 9 | RP9* | Rp9 | Alliance of Genome Resources | ||||
retinitis pigmentosa 90 | IDH3A* | Idh3a | Alliance of Genome Resources | ||||
retinoblastoma | IFNB1* | Ifnb1 | Alliance of Genome Resources | ||||
retinoblastoma | MGMT* | Mgmt | Alliance of Genome Resources | ||||
retinoblastoma | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
retinoblastoma | MTR* | Mtr | Alliance of Genome Resources | ||||
retinoblastoma | RB1* | Rb1 | 3 models | Alliance of Genome Resources | |||
retinopathy of prematurity | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
retinopathy of prematurity | NOS3* | Nos3 | Alliance of Genome Resources | ||||
retinopathy of prematurity | NDP* | Ndp | Alliance of Genome Resources | ||||
retinopathy of prematurity | SOD1* | Sod1 | Alliance of Genome Resources | ||||
retinopathy of prematurity | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
retinopathy of prematurity | IHH* | Ihh | Alliance of Genome Resources | ||||
retinopathy of prematurity | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
retinoschisis | RS1* | Rs1 | Alliance of Genome Resources | ||||
retinoschisis | TYR* | Tyr | Alliance of Genome Resources | ||||
ring dermoid of cornea | PITX2* | Pitx2 | Alliance of Genome Resources | ||||
RNASET2-deficient cystic leukoencephalopathy | RNASET2* | Rnaset2a, Rnaset2b | Alliance of Genome Resources | ||||
Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
scapuloperoneal spinal muscular atrophy | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
sciatic neuropathy | LRP1* | Lrp1 | Alliance of Genome Resources | ||||
sciatic neuropathy | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
sciatic neuropathy | HGF* | Hgf | Alliance of Genome Resources | ||||
sciatic neuropathy | SOD1* | Sod1 | Alliance of Genome Resources | ||||
sciatic neuropathy | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
scleritis | TNF* | Tnf | Alliance of Genome Resources | ||||
senile cataract | ATM* | Atm | Alliance of Genome Resources | ||||
senile cataract | CAT* | Cat | Alliance of Genome Resources | ||||
senile cataract | HSPA1B*, HSPA1A | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
senile cataract | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
senile cataract | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
senile cataract | WRN* | Wrn | Alliance of Genome Resources | ||||
senile cataract | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
senile cataract | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
senile cataract | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
senile cataract | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
senile cataract | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
sensorineural hearing loss | MYO1A* | Myo1a | Alliance of Genome Resources | ||||
sensorineural hearing loss | WHRN* | Whrn | Alliance of Genome Resources | ||||
sensorineural hearing loss | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
sensorineural hearing loss | TNF* | Tnf | Alliance of Genome Resources | ||||
sensorineural hearing loss | TMPRSS3* | Tmprss3 | Alliance of Genome Resources | ||||
sensorineural hearing loss | TMIE* | Tmie | Alliance of Genome Resources | ||||
sensorineural hearing loss | TMC1* | Tmc1 | Alliance of Genome Resources | ||||
sensorineural hearing loss | TECTA* | Tecta | Alliance of Genome Resources | ||||
sensorineural hearing loss | TBX1* | Tbx1 | Alliance of Genome Resources | ||||
sensorineural hearing loss | STRC*, STRCP1 | Strc | Alliance of Genome Resources | ||||
sensorineural hearing loss | MYO15A* | Myo15a | Alliance of Genome Resources | ||||
sensorineural hearing loss | MYO7A* | Myo7a | Alliance of Genome Resources | ||||
sensorineural hearing loss | MYO6* | Myo6 | Alliance of Genome Resources | ||||
sensorineural hearing loss | MYH14* | Myh14 | Alliance of Genome Resources | ||||
sensorineural hearing loss | MYH9* | Myh9 | Alliance of Genome Resources | ||||
sensorineural hearing loss | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
sensorineural hearing loss | KCNQ4* | Kcnq4 | Alliance of Genome Resources | ||||
sensorineural hearing loss | ITGA2* | Itga2 | Alliance of Genome Resources | ||||
sensorineural hearing loss | IL2* | Il2 | Alliance of Genome Resources | ||||
sensorineural hearing loss | IFNG* | Ifng | Alliance of Genome Resources | ||||
sensorineural hearing loss | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
sensorineural hearing loss | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
sensorineural hearing loss | GSDME* | Gsdme | Alliance of Genome Resources | ||||
sensorineural hearing loss | GPSM2* | Gpsm2 | Alliance of Genome Resources | ||||
sensorineural hearing loss | GATA3* | Gata3 | Alliance of Genome Resources | ||||
sensorineural hearing loss | F5* | F5 | Alliance of Genome Resources | ||||
sensorineural hearing loss | F2* | F2 | Alliance of Genome Resources | ||||
sensorineural hearing loss | EYA4* | Eya4 | Alliance of Genome Resources | ||||
sensorineural hearing loss | DIAPH1* | Diaph1 | Alliance of Genome Resources | ||||
sensorineural hearing loss | CLCNKA*, CLCNKB | Clcnka, Clcnkb | Alliance of Genome Resources | ||||
sensorineural hearing loss | BSND* | Bsnd | Alliance of Genome Resources | ||||
sensorineural hearing loss | BCAP31* | Bcap31 | Alliance of Genome Resources | ||||
sensorineural hearing loss | APOE* | Apoe | Alliance of Genome Resources | ||||
sepiapterin reductase deficiency | SPR* | Spr | Alliance of Genome Resources | ||||
severe congenital encephalopathy due to MECP2 mutation | MECP2* | Mecp2 | Alliance of Genome Resources | ||||
snowflake vitreoretinal degeneration | KCNJ13* | Kcnj13 | Alliance of Genome Resources | ||||
spastic ataxia | COQ4* | Coq4 | Alliance of Genome Resources | ||||
spastic ataxia | AFG3L2* | Afg3l2 | Alliance of Genome Resources | ||||
spastic ataxia | CHP1* | Chp1 | Alliance of Genome Resources | ||||
spastic ataxia 1 | VAMP1* | Vamp1 | Alliance of Genome Resources | ||||
spastic ataxia 2 | KIF1C* | Kif1c | Alliance of Genome Resources | ||||
spastic ataxia 3 | MARS2* | Mars2 | Alliance of Genome Resources | ||||
spastic ataxia 4 | MTPAP* | Mtpap | Alliance of Genome Resources | ||||
spastic ataxia 5 | AFG3L2* | Afg3l2 | Alliance of Genome Resources | ||||
spastic ataxia 8 | NKX6-2* | Nkx6-2 | Alliance of Genome Resources | ||||
spastic quadriplegic cerebral palsy 2 | KANK1* | Kank1 | Alliance of Genome Resources | ||||
spastic quadriplegic cerebral palsy 3 | ADD3* | Add3 | Alliance of Genome Resources | ||||
spinal muscular atrophy | ANKRD1* | Ankrd1 | Alliance of Genome Resources | ||||
spinal muscular atrophy | SMN1*, SMN2 | Smn1 | Alliance of Genome Resources | ||||
spinal muscular atrophy | HEXB* | Hexb | Alliance of Genome Resources | ||||
spinal muscular atrophy | DPP6* | Dpp6 | Alliance of Genome Resources | ||||
spinal muscular atrophy | AR* | Ar | Alliance of Genome Resources | ||||
spinal muscular atrophy | VAPB* | Vapb | Alliance of Genome Resources | ||||
spinal muscular atrophy, Jokela type | CHCHD10* | Chchd10 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 1 | DYNC1H1* | Dync1h1 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 2A | BICD2* | Bicd2 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 2B | ND6* | mt-Nd6 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 2B | BICD2* | Bicd2 | Alliance of Genome Resources | ||||
spinal muscular atrophy with progressive myoclonic epilepsy | ASAH1* | Asah1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia 44 | GRM1* | Grm1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia 45 | FAT2* | Fat2 | Alliance of Genome Resources | ||||
spinocerebellar ataxia 46 | PLD3* | Pld3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 10 | ATXN10* | Atxn10 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 11 | TTBK2* | Ttbk2 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 12 | PPP2R2B* | Ppp2r2b | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 13 | KCNC3* | Kcnc3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 15 | ITPR1* | Itpr1 | 2 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 19/22 | KCND3* | Kcnd3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 21 | TMEM240* | Tmem240 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 23 | PDYN* | Pdyn | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 25 | PNPT1* | Pnpt1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 26 | EEF2* | Eef2 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 29 | ITPR1* | Itpr1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 31 | BEAN1* | Bean1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 34 | ELOVL4* | Elovl4 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 35 | TGM6* | Tgm6 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 36 | NOP56* | Nop56 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 37 | DAB1* | Dab1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 38 | ELOVL5* | Elovl5 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 4 | ZFHX3* | Zfhx3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 40 | CCDC88C* | Ccdc88c | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 8 | ATXN8* | ||||||
spinocerebellar ataxia type 8 | ATXN8OS* | ||||||
spinocerebellar ataxia with axonal neuropathy 2 | SETX* | Setx | Alliance of Genome Resources | ||||
spinocerebellar ataxia with axonal neuropathy type 3 | COA7* | Coa7 | Alliance of Genome Resources | ||||
SPOAN syndrome | KLC2* | Klc2 | Alliance of Genome Resources | ||||
status epilepticus | BDNF* | Bdnf | Alliance of Genome Resources | ||||
Stiff-Person syndrome | HSD17B4* | Hsd17b4 | Alliance of Genome Resources | ||||
stress-induced childhood-onset neurodegeneration with variable ataxia and seizures | ADPRS* | Adprs | Alliance of Genome Resources | ||||
striatonigral degeneration | NUP62* | Nup62 | Alliance of Genome Resources | ||||
striatonigral degeneration | VAC14* | Vac14 | Alliance of Genome Resources | ||||
subcortical band heterotopia | DCX* | Dcx | Alliance of Genome Resources | ||||
Sveinsson chorioretinal atrophy | TEAD1* | Tead1 | Alliance of Genome Resources | ||||
sympathetic ophthalmia | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
syndromic microphthalmia 1 | NAA10* | Naa10 | Alliance of Genome Resources | ||||
syndromic microphthalmia 1 | BCOR*, BCORP1 | Bcor | Alliance of Genome Resources | ||||
syndromic microphthalmia 11 | VAX1* | Vax1 | Alliance of Genome Resources | ||||
syndromic microphthalmia 12 | RARB* | Rarb | Alliance of Genome Resources | ||||
syndromic microphthalmia 13 | HMGB3* | Hmgb3 | Alliance of Genome Resources | ||||
syndromic microphthalmia 14 | MAB21L2* | Mab21l2 | Alliance of Genome Resources | ||||
syndromic microphthalmia 3 | SOX2* | Sox2 | Alliance of Genome Resources | ||||
syndromic microphthalmia 5 | OTX2* | Otx2 | Alliance of Genome Resources | ||||
syndromic microphthalmia 6 | BMP4* | Bmp4 | Alliance of Genome Resources | ||||
syndromic microphthalmia 9 | STRA6* | Stra6 | Alliance of Genome Resources | ||||
tauopathy | MAPT* | Mapt | Alliance of Genome Resources | ||||
temporal arteritis | IL4* | Il4 | Alliance of Genome Resources | ||||
temporal arteritis | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
temporal arteritis | IFNG* | Ifng | Alliance of Genome Resources | ||||
temporal arteritis | IL17A* | Il17a | Alliance of Genome Resources | ||||
temporal arteritis | IL18* | Il18 | Alliance of Genome Resources | ||||
temporal arteritis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
temporal arteritis | IL21R* | Il21r | Alliance of Genome Resources | ||||
temporal arteritis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
temporal arteritis | MFGE8* | Mfge8 | Alliance of Genome Resources | ||||
temporal arteritis | ELN* | Eln | Alliance of Genome Resources | ||||
temporal arteritis | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
temporal arteritis | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
temporal arteritis | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
temporal arteritis | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
temporal arteritis | CCL2*, CCL13 | Ccl2, Ccl12 | Alliance of Genome Resources | ||||
temporal arteritis | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
temporal lobe epilepsy | PDYN* | Pdyn | Alliance of Genome Resources | ||||
temporal lobe epilepsy | KCNAB1* | Kcnab1 | Alliance of Genome Resources | ||||
temporal lobe epilepsy | NPY* | Npy | Alliance of Genome Resources | ||||
temporal lobe epilepsy | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
temporal lobe epilepsy | MAPT* | Mapt | Alliance of Genome Resources | ||||
Thiel-Behnke corneal dystrophy | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
torsion dystonia 2 | HPCA* | Hpca | Alliance of Genome Resources | ||||
torsion dystonia 4 | TUBB4A* | Tubb4a | Alliance of Genome Resources | ||||
toxic encephalopathy | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
toxic encephalopathy | ABCB1* | Abcb1a, Abcb1b | Alliance of Genome Resources | ||||
toxic encephalopathy | ABCG2* | Abcg2, Abcg3 | Alliance of Genome Resources | ||||
toxic encephalopathy | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
toxic encephalopathy | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
toxic encephalopathy | IGF1R* | Igf1r | Alliance of Genome Resources | ||||
trachoma | TNF* | Tnf | Alliance of Genome Resources | ||||
trachoma | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
trachoma | IL10* | Il10 | Alliance of Genome Resources | ||||
trachoma | CXCL8* | ||||||
transient cerebral ischemia | BCL2L2*, BCL2L2-PABPN1 | Bcl2l2 | Alliance of Genome Resources | ||||
transient cerebral ischemia | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
transient cerebral ischemia | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
transient cerebral ischemia | NAMPT* | Nampt | Alliance of Genome Resources | ||||
transient cerebral ischemia | GOT1* | Got1 | Alliance of Genome Resources | ||||
transient cerebral ischemia | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
transient cerebral ischemia | EPO* | Epo | Alliance of Genome Resources | ||||
transient cerebral ischemia | CSF3* | Csf3 | Alliance of Genome Resources | ||||
transient cerebral ischemia | F12* | F12 | Alliance of Genome Resources | ||||
transient cerebral ischemia | SOD1* | Sod1 | Alliance of Genome Resources | ||||
transient cerebral ischemia | TFPI* | Tfpi | Alliance of Genome Resources | ||||
transient cerebral ischemia | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
transverse myelitis | AQP4* | Aqp4 | Alliance of Genome Resources | ||||
traumatic brain injury | APP* | App | Alliance of Genome Resources | ||||
tropical spastic paraparesis | KLRK1*, KLRC4-KLRK1 | Klrk1 | Alliance of Genome Resources | ||||
tropical spastic paraparesis | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
tropical spastic paraparesis | NFKB1* | Nfkb1 | Alliance of Genome Resources | ||||
tropical spastic paraparesis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
tympanosclerosis | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1A | COL6A1* | Col6a1 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1B | COL6A2* | Col6a2 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1C | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 2 | COL12A1* | Col12a1 | Alliance of Genome Resources | ||||
uveal melanoma | BRCA2* | Brca2 | Alliance of Genome Resources | ||||
uveal melanoma | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
uveal melanoma | MBD4* | Mbd4 | Alliance of Genome Resources | ||||
uveal melanoma | BAP1* | Bap1 | Alliance of Genome Resources | ||||
uveitis | TNFRSF1A* | Tnfrsf1a | Alliance of Genome Resources | ||||
uveitis | IL1B* | Il1b | Alliance of Genome Resources | ||||
uveitis | TGFB1* | Tgfb1 | Alliance of Genome Resources | ||||
uveitis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
uveitis | TNF* | Tnf | Alliance of Genome Resources | ||||
uveitis | IL6* | Il6 | Alliance of Genome Resources | ||||
uveitis | GC* | Gc | Alliance of Genome Resources | ||||
uveitis | IL13* | Il13 | Alliance of Genome Resources | ||||
uveitis | IL10* | Il10 | Alliance of Genome Resources | ||||
uveitis | HSPA1L* | Hspa1l | Alliance of Genome Resources | ||||
uveitis | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
uveitis | HLA-A*, HLA-B*, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
uveitis | IL23R* | Il23r | Alliance of Genome Resources | ||||
viral encephalitis | CXCL8* | ||||||
visual epilepsy | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
visual epilepsy | APP* | App | Alliance of Genome Resources | ||||
visual epilepsy | ASPM* | Aspm | Alliance of Genome Resources | ||||
visual epilepsy | CDKL5* | Cdkl5 | Alliance of Genome Resources | ||||
visual epilepsy | CNTNAP2* | Cntnap2 | Alliance of Genome Resources | ||||
visual epilepsy | TUBA1A* | Tuba1a | Alliance of Genome Resources | ||||
visual epilepsy | TNF* | Tnf | Alliance of Genome Resources | ||||
visual epilepsy | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
visual epilepsy | NPY* | Npy | Alliance of Genome Resources | ||||
visual epilepsy | L2HGDH* | L2hgdh | Alliance of Genome Resources | ||||
visual epilepsy | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
visual impairment and progressive phthisis bulbi | MARK3* | Mark3 | Alliance of Genome Resources | ||||
vitelliform macular dystrophy | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
vitelliform macular dystrophy | PRPH2* | Prph2 | Alliance of Genome Resources | ||||
vitelliform macular dystrophy | IMPG1* | Impg1 | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | FKTN* | Fktn | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | FKRP* | Fkrp | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
West syndrome | STXBP1* | Stxbp1 | Alliance of Genome Resources | ||||
West syndrome | MC2R* | Mc2r | Alliance of Genome Resources | ||||
X-linked atrophic macular degeneration | RPGR* | Rpgr | Alliance of Genome Resources | ||||
X-linked cone-rod dystrophy 3 | CACNA1F* | Cacna1f | Alliance of Genome Resources | ||||
X-linked deafness 1 | PRPS1* | Prps1 | Alliance of Genome Resources | ||||
X-linked deafness 2 | POU3F4* | Pou3f4 | Alliance of Genome Resources | ||||
X-linked deafness 5 | AIFM1* | Aifm1 | Alliance of Genome Resources | ||||
X-linked deafness 6 | COL4A6* | Col4a6 | Alliance of Genome Resources | ||||
X-linked deafness 7 | GPRASP2*, ARMCX5-GPRASP2, GPRASP3 | Bhlhb9, Gprasp2 | Alliance of Genome Resources | ||||
X-linked dystonia-parkinsonism | TAF1*, TAF1L | Taf1 | Alliance of Genome Resources | ||||
X-linked Emery-Dreifuss muscular dystrophy 1 | EMD* | Emd | Alliance of Genome Resources | ||||
X-linked Emery-Dreifuss muscular dystrophy 6 | FHL1* | Fhl1 | Alliance of Genome Resources | ||||
X-linked epilepsy with variable learning disabilities and behavior disorders | SYN1* | Syn1 | Alliance of Genome Resources | ||||
X-linked exudative vitreoretinopathy 2 | NDP* | Ndp | Alliance of Genome Resources | ||||
X-linked lissencephaly 1 | DCX* | Dcx | Alliance of Genome Resources | ||||
X-linked lissencephaly 2 | ARX* | Arx | Alliance of Genome Resources | ||||
X-linked parkinsonism-spasticity syndrome | ATP6AP2* | Atp6ap2 | Alliance of Genome Resources | ||||
X-linked spinal muscular atrophy 2 | UBA1* | Uba1 | Alliance of Genome Resources | ||||
X-linked spinocerebellar ataxia 1 | ATP2B3* | Atp2b3 | Alliance of Genome Resources | ||||
Y-linked deafness 2 | TBL1Y*, TBL1X | Tbl1x | Alliance of Genome Resources |
Transgenes and other genome features developed in mice to model this disease.
|
|||
Disease Term | Transgenes and Other Genome Features | Mouse Models | |
adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Plp1-Lmnb1)#Yfu | 1 model | |
adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Plp1-LMNB1)1108Qsp | 1 model | |
adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Lmnb1)1Yfu | 1 model | |
age related macular degeneration 1 | Tg(APOB)1102Sgy | 1 model | |
Alexander disease | Tg(GFAP)7Mes | 1 model | |
Alexander disease | Tg(Gfap-GFAP*R239H)60TMIke | 1 model | |
Alexander disease | Tg(GFAP)10Mes | 3 models | |
Alzheimer's disease | Tg(Prnp-MAPT*K274Q*K281Q)286Lgn | 1 model | |
Alzheimer's disease | Tg(Prnp-MAPT)43Vle | 1 model | |
Alzheimer's disease | Tg(Prnp-MAPT)7Vle | 1 model | |
Alzheimer's disease | Tg(Prnp-ITM2B/APP695*42)A12Emcg | 1 model | |
Alzheimer's disease | Tg(Prnp-ITM2B/APP695*40)1Emcg | 1 model | |
Alzheimer's disease | Tg(PRNP-APPSweInd)19959Dwst | 1 model | |
Alzheimer's disease | Tg(PRNP-APPSweInd)8Dwst | 3 models | |
Alzheimer's disease | Tg(Prnp-APPSweArc)#Rmni | 1 model | |
Alzheimer's disease | Tg(Prnp-App/APPswe)E1-2Dbo | 1 model | |
Alzheimer's disease | Tg(Prnp-APP*)1Hmor | 1 model | |
Alzheimer's disease | Tg(PDGFB-MAPT*V337M)1Atak | 1 model | |
Alzheimer's disease | Tg(PDGFB-APPSwInd)J9Lms | 1 model | |
Alzheimer's disease | Tg(PDGFB-APPSwDutLon)46Lpr | 2 models | |
Alzheimer's disease | Tg(PDGFB-APPInd)F17Plhn | 1 model | |
Alzheimer's disease | Tg(NEFL-APP)#Nalb | 1 model | |
Alzheimer's disease | Tg(Mapt-MAPT*)#Hanr | 1 model | |
Alzheimer's disease | Tg(Eno2-PSEN2*)1480Ykk | 1 model | |
Alzheimer's disease | Tg(Eno2-PSEN2)2348Ykk | 1 model | |
Alzheimer's disease | Tg(Eno2-APP*Ind)#Kakiz | 1 model | |
Alzheimer's disease | Tg(DMD-APP*)18Neve | 1 model | |
Alzheimer's disease | Tg(DMD-APP*)7Neve | 1 model | |
Alzheimer's disease | Tg(CMV-IgkvaD11)BCat | 2 models | |
Alzheimer's disease | Tg(Camk2a-App*,-Apbb1)25Spim | 1 model | |
Alzheimer's disease | Tg(APPV717F)109Ili | 9 models | |
Alzheimer's disease | Tg(APPSwLon)96Btla | 1 model | |
Alzheimer's disease | Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas | 8 models | |
Alzheimer's disease | Tg(APPswe,PSEN1dE9)85Dbo | 6 models | |
Alzheimer's disease | Tg(APPSWE)2576Kha | 13 models | |
Alzheimer's disease | Tg(APPSw)40Btla | 2 models | |
Alzheimer's disease | Tg(APP)8.9Btla | 1 model | |
Alzheimer's disease | Tg(APP695)3Dbo | 8 models | |
Alzheimer's disease | Tg(ACTB-APP*V717F)1Colm | 1 model | |
Alzheimer's disease | Tg(Thy1-MAPT)2Vln | 2 models | |
Alzheimer's disease | Tg(Thy1-MAPT)1Vln | 2 models | |
Alzheimer's disease | Tg(Thy1-APPSweLon)41Ema | 1 model | |
Alzheimer's disease | Tg(Thy1-APPSweAut)A7Tiwa | 1 model | |
Alzheimer's disease | Tg(Thy1-APPSweArc)BLngn | 1 model | |
Alzheimer's disease | Tg(Thy1-APPSwDutIowa)BWevn | 3 models | |
Alzheimer's disease | Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr | 3 models | |
Alzheimer's disease | Tg(Thy1-APPSw)10Jiri | 3 models | |
Alzheimer's disease | Tg(Thy1-APPLon)2Vln | 4 models | |
Alzheimer's disease | Tg(Thy1-APPArc)M8Cagr | 2 models | |
Alzheimer's disease | Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte | 1 model | |
Alzheimer's disease | Tg(Thy1-MAPT*P301L)2Vln | 1 model | |
Alzheimer's disease | Tg(Thy1-MAPT)22Schd | 2 models | |
Alzheimer's disease | Tg(Thy1-APPSL)28Lpr | 4 models | |
Alzheimer's disease | Tg(Thy1-APP*Swe*Ind)fAccu | 1 model | |
Alzheimer's disease | Tg(Thy1-APP*)2Tbay | 1 model | |
Alzheimer's disease | Tg(Thy1-APP)3Somm | 3 models | |
Alzheimer's disease | Tg(tetO/Prnp-APP*Swe*Lon)9191Krz | 1 model | |
Alzheimer's disease | Tg(tetO-MAPT*K280,-luc)#Eman | 1 model | |
Alzheimer's disease | Tg(tetO-HMOX1)6Hyms | 1 model | |
Alzheimer's disease | Tg(tetO-CDK5R1/GFP)337Lht | 1 model | |
Alzheimer's disease | Tg(tetO-APPSwInd)Dbo | 2 models | |
Alzheimer's disease | Tg(tetO-APPSwInd)107Dbo | 1 model | |
Alzheimer's disease | Tg(tetO-APPSwInd)102Dbo | 1 model | |
Alzheimer's disease | Tg(tetO-APPSwInd)18Dbo | 1 model | |
Alzheimer's disease | Tg(PSEN1H163R)G9Btla | 1 model | |
Alzheimer's disease | Tg(PSEN1dE9)S9Dbo | 4 models | |
Alzheimer's disease | Tg(Prnp-MAPT*P301S)PS19Vle | 3 models | |
Alzheimer's disease | Tg(Prnp-MAPT*P301L)JNPL3Hlmc | 2 models | |
Alzheimer's disease 3 | Tg(APPswe,PSEN1dE9)85Dbo | 2 models | |
Alzheimer's disease 3 | Tg(PSEN1dE9)S9Dbo | 4 models | |
Alzheimer's disease 3 | Tg(PSEN1H163R)G9Btla | 1 model | |
Alzheimer's disease 3 | Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas | 1 model | |
Alzheimer's disease 4 | Tg(APP695)3Dbo | 3 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)42Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)106Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)148Dwc | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)#Roos | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R/EYFP)737Alho | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Sod1*G86R)M1Jwg | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R/EYFP)641Alho | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)1Gur | 6 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)2Gur | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)dl1Gur | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)29Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)9Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)1Dwc | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*)DF7Yaw | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*)D-14Dbo | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*)125Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Prnp-SOD1*G37R,-PSEN1)110Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Prnp-Immt/SOD1*G93A)7Gmnf | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(NFH)120Jpj | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(NEFH)200Jpj | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(Myl1-SOD1*G93A)#Amu | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G127X)716Mrkl | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)#Maw | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)IAra | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)LAra | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R*H48Q)58Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R*H48Q)139Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*L126Z)45Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*L126Z)#Deng | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(Thy1-DCTN1*G59S)M2Pcw | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Thy1-Sncg)HvP36Putt | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Thy1-SOD1*G93A)T3Hgrd | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)74Dwc | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP*A315T)23Jlel | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP)4Jlel | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP)3cPtrc | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(CAG-dsRed2/RNAi:Tardbp)6Zxu | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(Thy1-TARDBP*)BOddo | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(Thy1-TARDBP)6Singh | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(Thy1-TARDBP)4Singh | 2 models | |
amyotrophic lateral sclerosis type 10 | Tg(tetO-TARDBP*A315T)13Lmit | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(tetO-TARDBP*)4Vle | 2 models | |
amyotrophic lateral sclerosis type 10 | Tg(tetO-TARDBP)12Vle | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(TARDBP*G348C)#Jpj | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(TARDBP*A315T)#Jpj | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(TARDBP)#Jpj | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP*Q331K)103Dwc | 1 model | |
amyotrophic lateral sclerosis type 10 | Tg(Prnp-TARDBP*A315T)95Balo | 1 model | |
amyotrophic lateral sclerosis type 15 | Tg(Thy1-UBQLN2*P506T)6Mont | 1 model | |
amyotrophic lateral sclerosis type 15 | Tg(Thy1-UBQLN2*P497S)3Mont | 1 model | |
amyotrophic lateral sclerosis type 4 | Tg(Prnp-SETX*R2136H)1920Als | 1 model | |
amyotrophic lateral sclerosis type 6 | Tg(CAG-lacZ,-FUS,-EGFP)629Gyu | 1 model | |
amyotrophic lateral sclerosis type 6 | Tg(CAG-lacZ,-FUS*R521G,-EGFP)682Gyu | 1 model | |
amyotrophic lateral sclerosis type 6 | Tg(Prnp-FUS*R521C)3313Ejh | 1 model | |
amyotrophic lateral sclerosis type 6 | Tg(Thy1-FUS*)19Vlb | 1 model | |
amyotrophic lateral sclerosis type 6 | Tg(Thy1-FUS*)1Dit | 1 model | |
amyotrophic lateral sclerosis type 6 | Tg(Prnp-FUS)WT3Cshw | 1 model | |
amyotrophic lateral sclerosis type 8 | Tg(Thy1-VAPB*P56S,-EGFP)D3Cai | 1 model | |
arteriovenous malformations of the brain | Tg(tetO-Notch4*)1Rwng | 1 model | |
autosomal dominant auditory neuropathy 1 | Tg(CAG-Diaph3)771Lesp | 1 model | |
autosomal dominant auditory neuropathy 1 | Tg(CAG-Diap3)924Lesp | 1 model | |
autosomal dominant limb-girdle muscular dystrophy type 1 | Tg(Ckm-DNAJB6_ib*F93L)#Ccwe | 1 model | |
autosomal dominant nocturnal frontal lobe epilepsy 3 | Tg(tetO-Chrnb2*V287L)H3Gica | 1 model | |
autosomal recessive nonsyndromic deafness 1A | Del(14Gjb6-Cryl1)1Lmon | 1 model | |
autosomal recessive nonsyndromic deafness 38 | Phl1 | 2 models | |
Axenfeld-Rieger syndrome type 1 | Tg(KRT14-Hmgn2)#Baam | 1 model | |
Axenfeld-Rieger syndrome type 1 | Tg(Kera-PITX2*A)BHjal | 1 model | |
Axenfeld-Rieger syndrome type 1 | Tg(Kera-PITX2*A)AHjal | 1 model | |
birdshot chorioretinopathy | Tg(H2-K1-HLA-A*)28Mpla | 1 model | |
brain ischemia | Tg(Notch3*R169C)88Bbb | 1 model | |
CADASIL 1 | Tg(Notch3*R169C)88Bbb | 1 model | |
cataract | Tg(Cryaa-APEH)KKS4Kksha | 1 model | |
cataract 19 multiple types | Tg(Lim2*G15V)1Rlc | 2 models | |
cataract 2 multiple types | Tg(CRYBB1-CRYGC*)#Jfhe | 1 model | |
cataract 30 | Tg(Vim*R113C)1Tmm | 1 model | |
cataract 5 multiple types | Tg(Hsf4/EGFP)N7Spbh | 1 model | |
Charcot-Marie-Tooth disease axonal type 2F | Tg(Thy1-HSPB1*S135F)#Lvdb | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(tetO/CMV-Pmp22)JP18Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(Pmp22)My41Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C61Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(Pmp22)247Ueli | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C3Fbas | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C22Clh | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.4Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.2Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.1Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz*S63X)30Mes | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz*S63X)31Mes | 2 models | |
Charcot-Marie-Tooth disease type 1C | Tg(CMV-LITAF*W116G)#Lli | 1 model | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Eno2-MFN2*R94Q)L51Ugfm | 2 models | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Eno2-MFN2*R94Q)L87Ugfm | 1 model | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc | 1 model | |
Charcot-Marie-Tooth disease type 2E | Tg(NEFL*E397K)#Milg | 1 model | |
Charcot-Marie-Tooth disease type 2E | Tg(tetO-NEFL)173.2Jpj | 1 model | |
Charcot-Marie-Tooth disease type 3 | Tg(Mpz*S63C)33Mes | 1 model | |
Charcot-Marie-Tooth disease type 3 | Tg(Mpz*S63C)32Mes | 1 model | |
Charcot-Marie-Tooth disease type 4J | Tg(ACTB-Fig4*I41T)705Mm | 1 model | |
cone-rod dystrophy 14 | Tg(Rho-GUCA1A*Y99C)L53Amd | 1 model | |
cone-rod dystrophy 6 | Tg(Rho-GUCY2D*R838S)379Amd | 1 model | |
cone-rod dystrophy 6 | Tg(Rho-GUCY2D*R838S)362Amd | 1 model | |
congenital myasthenic syndrome 3A | Tg(Ckm-Chrnd*S262T)40Cgz | 1 model | |
congenital myasthenic syndrome 4A | Tg(Ckm-Chrne*L269F)5Cgz | 1 model | |
congenital stationary night blindness autosomal dominant 1 | Tg(Rho*G90D*A337V)202Sie | 1 model | |
congenital stromal corneal dystrophy | Tg(CAG-cat,-Dcn*)#Debi | 1 model | |
Creutzfeldt-Jakob disease | Tg(Prnp*D177N*M128V)A21Rchi | 4 models | |
Creutzfeldt-Jakob disease | Tg(Prnp*)#Rgab | 2 models | |
dentatorubral-pallidoluysian atrophy | Tg(Eno2-ATN1)3Tx | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Eno2-ATN1)14Tx | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Prnp-ATN1)124Dbo | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(ATN1*)Q129Stsu | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Prnp-ATN1)150Dbo | 1 model | |
Duchenne muscular dystrophy | Tg(ACTA1-Ctss)1Jmol | 1 model | |
epilepsy | Tg(RP23-65I14)2Jno | 1 model | |
epilepsy | Tg(RP23-65I14)1Jno | 1 model | |
epilepsy | Tg(Eno2-Scn2a1*)Q54Mm | 3 models | |
epilepsy | Tg(Camk2a-Bdnf)A9Stl | 1 model | |
facioscapulohumeral muscular dystrophy | Tg(ACTA1-FRG1)medRotu | 1 model | |
facioscapulohumeral muscular dystrophy | Tg(ACTA1-FRG1)highRotu | 1 model | |
familial encephalopathy with neuroserpin inclusion bodies | Tg(Thy1-SERPINI1*G392E)333Icka | 2 models | |
familial temporal lobe epilepsy 1 | Tg(Lgi1*)#Mpan | 1 model | |
Finnish type amyloidosis | Tg(Ckm-GSN*D187N)AJewe | 2 models | |
fragile X-associated tremor/ataxia syndrome | Tg(Pcp2-FMR1*)1Dln | 1 model | |
fragile X-associated tremor/ataxia syndrome | Tg(tetO-FMR1*,-EGFP)#Rkhu | 2 models | |
frontotemporal dementia | Tg(Thy1-TARDBP)6Singh | 1 model | |
frontotemporal dementia | Tg(Thy1-MAPT*)1Avil | 1 model | |
frontotemporal dementia | Tg(Thy1-MAPT*K369I)K3Gotz | 1 model | |
frontotemporal dementia | Tg(Thy1-MAPT*P301S)2541Godt | 1 model | |
frontotemporal dementia | Tg(Thy1-MAPT*V337M)1Godt | 1 model | |
frontotemporal dementia | Tg(Thy1-TARDBP)4Singh | 2 models | |
frontotemporal dementia | Tg(tetO-CHMP2B*)3Fbga | 1 model | |
frontotemporal dementia | Tg(Prnp-TARDBP*A315T)95Balo | 1 model | |
frontotemporal dementia | Tg(Camk2a-MAPT)601Ymot | 1 model | |
frontotemporal dementia | Tg(Camk2a-MAPT*P301L)D35Jiri | 1 model | |
frontotemporal dementia | Tg(Camk2a-MAPT*R406W)748Atak | 1 model | |
frontotemporal dementia | Tg(MAPT*V337M)1Gds | 1 model | |
frontotemporal dementia | Tg(Prnp-MAPT*R406W)21807Dwst | 1 model | |
frontotemporal dementia | Tg(Prnp-MAPT*P301S)50Hiw | 1 model | |
frontotemporal dementia | Tg(PDGFB-MAPT*V337M)1Atak | 1 model | |
frontotemporal dementia | Tg(Prnp-MAPT)7Vle | 1 model | |
frontotemporal dementia | Tg(Tuba1-MAPT)14Vle | 1 model | |
frontotemporal dementia | Tg(Prnp-MAPT)43Vle | 1 model | |
frontotemporal dementia | Tg(Prnp-MAPT*P301L)JNPL3Hlmc | 1 model | |
frontotemporal dementia and/or amyotrophic lateral sclerosis 1 | Tg(C9orf72)500Lpwr | 1 model | |
generalized epilepsy with febrile seizures plus | Tg(Scn1a*)RH9Aesc | 1 model | |
Gerstmann-Straussler-Scheinker syndrome | Tg(Prnp*P101L)174Sbp | 1 model | |
Gerstmann-Straussler-Scheinker syndrome | Tg(Prnp*P101L)2862Sbp | 1 model | |
Gerstmann-Straussler-Scheinker syndrome | Tg(Prnp*A116V*M128V)1309Jama | 1 model | |
Gerstmann-Straussler-Scheinker syndrome | Tg(Prnp*P101L)2247Sbp | 1 model | |
Gerstmann-Straussler-Scheinker syndrome | Tg(Prnp*P101L)2866Sbp | 3 models | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Thy1-TARDBP*)BOddo | 2 models | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP*G348C)#Jpj | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP*A315T)#Jpj | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP)#Jpj | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Prnp-TARDBP)3cPtrc | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Camk2a-Tardbp)#Ckjs | 1 model | |
hereditary sensory neuropathy | Tg(CAG-SPTLC1*C133W)8EAmcc | 1 model | |
Huntington's disease | Tg(YAC128)#Hay | 1 model | |
Huntington's disease | Tg(YAC128)55Hay | 2 models | |
Huntington's disease | Tg(YAC128)53Hay | 1 model | |
Huntington's disease | Tg(YAC72)2511Hay | 2 models | |
Huntington's disease | Tg(UBC-GFP/HTT*84Q)22Shya | 1 model | |
Huntington's disease | Tg(tetO-HTT*94Q,-lacZ)1Rhn | 1 model | |
Huntington's disease | Tg(Prnp-SNAP25/HTT*150Q)8Xjl | 1 model | |
Huntington's disease | Tg(Prnp-HTT*82Q,KRT14-EGFP)C63Dbo | 1 model | |
Huntington's disease | Tg(Prnp-HTT*82Q)61Gschi | 1 model | |
Huntington's disease | Tg(Prnp-HTT*82Q)52Caro | 1 model | |
Huntington's disease | Tg(Prnp-HTT*82Q)8AGschi | 1 model | |
Huntington's disease | Tg(Ppp1r1b-HTT*)1Meeh | 1 model | |
Huntington's disease | Tg(Plp1-HTT*150Q)4aXjl | 1 model | |
Huntington's disease | Tg(HTT*/EGFP)190Nn | 1 model | |
Huntington's disease | Tg(HTT*/EGFP)150Nn | 1 model | |
Huntington's disease | Tg(HTT*)NXwy | 1 model | |
Huntington's disease | Tg(HTT*)LXwy | 1 model | |
Huntington's disease | Tg(HTT*)1Xwy | 1 model | |
Huntington's disease | Tg(HTT*97Q)IXwy | 2 models | |
Huntington's disease | Tg(HDexon1)62Gpb | 3 models | |
Huntington's disease | Tg(HDexon1)61Gpb | 1 model | |
Huntington's disease | Tg(HD)63Aron | 1 model | |
Huntington's disease | Tg(HD82Gln)81Gschi | 3 models | |
Huntington's disease | Tg(GFAP-HTT*160Q)31Xjl | 1 model | |
Huntington's disease | Tg(GFAP-HTT*160Q)1Xjl | 1 model | |
Huntington's disease | Tg(CMV-HTT*89Q)ATag | 2 models | |
Huntington's disease | Tg(CMV-HTT*48Q)BTag | 2 models | |
Huntington's disease | Tg(CAG-Ppard*E411P)#Als | 1 model | |
Huntington's disease-like 2 | Tg(JPH3*)CXwy | 1 model | |
Huntington's disease-like 2 | Tg(JPH3-GFP,-JPH3*)GXwy | 1 model | |
hydrocephalus | Tg(Sox3)1Pqt | 1 model | |
hyperekplexia 1 | Tg(Thy1-GLRA1*R271Q)382Wha | 1 model | |
hyperekplexia 1 | Tg(Thy1-GLRA1*R271Q)300Wha | 1 model | |
Kennedy's disease | Tg(AR*100Q)#Als | 1 model | |
Kennedy's disease | Tg(AR*100Q)C25Als | 1 model | |
Kennedy's disease | Tg(AR*100Q)C32Als | 1 model | |
Kennedy's disease | Tg(CAG-AR*97Q)7-8Sobue | 1 model | |
Kennedy's disease | Tg(Prnp-AR*112Q)#Deme | 1 model | |
Kennedy's disease | Tg(ACTA1-Ar)141Kyjo | 1 model | |
Lafora disease | Tg(CAG-EPM2A*C266S)1Bmin | 1 model | |
Leber hereditary optic neuropathy | Tg(LONP1-mt-ND4*,-mCherry*)#Jguy | 1 model | |
leukoencephalopathy with vanishing white matter | Tg(Plp1-Eif2ak3*)18Pop | 1 model | |
limb-girdle muscular dystrophy | Tg(Ckm-Sgcg)4Mcn | 1 model | |
low tension glaucoma | Tg(TBK1)#Andm | 2 models | |
Machado-Joseph disease | Tg(ATXN3*)67.2Cce | 2 models | |
Machado-Joseph disease | Tg(ATXN3*)84.2Cce | 3 models | |
Machado-Joseph disease | Tg(Htt-ATXN3*148Q)3746Thsc | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*148Q)NLS.28Olri | 1 model | |
Machado-Joseph disease | Tg(Pcp2-ATXN3*69Q)bHirai | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*148Q)148.19Olri | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*70Q)70.61Olri | 1 model | |
Machado-Joseph disease | Tg(CMV-ATXN3*135Q)CPama | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*79Q)#Hlw | 1 model | |
Machado-Joseph disease | Tg(CMV-ATXN3*94Q)94Pama | 2 models | |
malignant astrocytoma | Tg(GFAP-TAg121)1Tvd | 2 models | |
malignant astrocytoma | Tg(GFAP-SRC)2Aag | 1 model | |
malignant astrocytoma | Tg(GFAP-SRC)1Aag | 1 model | |
malignant astrocytoma | Tg(GFAP-Hras1)2Agu | 1 model | |
medulloblastoma | Tg(tetO-Ifng)184Pop | 2 models | |
medulloblastoma | Tg(Neurod2-Smo*A2)#Jols | 1 model | |
medulloblastoma | Tg(Neurod2-Smo*A1)199Jols | 3 models | |
medulloblastoma | Tg(tetO-MYCN,-luc)#Waw | 2 models | |
medulloblastoma | Tg(tetO-TAg,CMV-rtTA)123Yihu | 1 model | |
microphthalmia | Tg(ASL1/Cryaa-Ralbp1)24Yca | 1 model | |
motor neuron disease | Tg(Thy1-BSCL2*N88S)1Dit | 1 model | |
multiple sclerosis | Tg(Tnf)6074Gkl | 2 models | |
multiple sclerosis | Tg(PLP1*)4Rsj | 1 model | |
multiple sclerosis | Tg(Mbp-Pad2)28Fgm | 2 models | |
multiple sclerosis | Tg(H2-Kb-Tcra,-Tcrb)1640Kurs | 1 model | |
multiple sclerosis | Tg(Gfap-TNF*)K21Gkl | 2 models | |
multiple system atrophy | Tg(Mbp-SNCA)1Ema | 1 model | |
multiple system atrophy | Tg(Cnp-SNCA)M2Vle | 1 model | |
multiple system atrophy | Tg(Plp1-SNCA)1Haa | 1 model | |
multiple system atrophy | Tg(Mbp-SNCA)29Ema | 1 model | |
myopia | Tg(Eif1a-LUM*L199P,-hrGFP)#Fzha | 1 model | |
myotonic dystrophy type 1 | Tg(HSA*LR)41Cath | 1 model | |
myotonic dystrophy type 1 | Tg(HSA*LR)32bCath | 1 model | |
myotonic dystrophy type 1 | Tg(CAG-DMPK*)1323Coop | 2 models | |
myotonic dystrophy type 1 | Tg(HSA*LR)32aCath | 1 model | |
myotonic dystrophy type 1 | Tg(DM15)26Bew | 1 model | |
myotonic dystrophy type 1 | Tg(Ckm-CUGBP1)1039Coop | 1 model | |
myotonic dystrophy type 1 | Tg(tetO-CUGBP1)3413Coop | 1 model | |
myotonic dystrophy type 1 | Tg(HSA*LR)21Cath | 1 model | |
myotonic dystrophy type 1 | Tg(HSA*LR)20bCath | 1 model | |
myotonic dystrophy type 1 | Tg(HSA*LR)20aCath | 1 model | |
myotonic dystrophy type 1 | Tg(DMWD,DMPK*,SIX5)1177Ggo | 1 model | |
myotonic dystrophy type 1 | Tg(DMWD,DMPK*,SIX5)328Ggo | 1 model | |
myotonic dystrophy type 1 | Tg(DMPK/tetO-EGFP/DMPK)5-313Masm | 1 model | |
neuroblastoma | Tg(CAG-Alk*F1174L,-luc)60Jhsc | 3 models | |
neuroblastoma | Tg(OMP-SV40T)13Bse | 1 model | |
neuroblastoma | Tg(rTH-Tag)20Dmc | 1 model | |
neuroblastoma | Tg(tetO-TAg)2-5Hiwa | 1 model | |
neuroblastoma | Tg(Th-MYCN)41Waw | 14 models | |
neurodegeneration with brain iron accumulation 3 | Tg(PGK1-FTL*)#Sle | 1 model | |
neurodegeneration with brain iron accumulation 3 | Tg(Prnp-FTL*)4Ruvi | 1 model | |
neuropathy | Tg(Mpz)80.2Wra | 1 model | |
oculopharyngeal muscular dystrophy | Tg(ACTA1-PABPN1*A17)1Drub | 1 model | |
open-angle glaucoma | Tg(MYOC*Y437H)#Sit | 1 model | |
open-angle glaucoma | Tg(Myoc*Y423H)#Sit | 1 model | |
Parkinson's disease | Tg(CAG-SNCA*)1.1Ccs | 1 model | |
Parkinson's disease | Tg(DBH-SNCA)#Dwei | 1 model | |
Parkinson's disease | Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan | 1 model | |
Parkinson's disease | Tg(PDGF-S100B)36Cqin | 1 model | |
Parkinson's disease | Tg(Snca-SNCA/GFP)#Jyl | 1 model | |
Parkinson's disease | Tg(tetO-HMOX1)6Hyms | 1 model | |
Parkinson's disease | Tg(tetO-SNCA)0Olri | 1 model | |
Parkinson's disease | Tg(Th-SNCA)5Eric | 2 models | |
Parkinson's disease | Tg(Th-SNCA*)1.2Ccs | 1 model | |
Parkinson's disease | Tg(Th-SNCA*A30P*A53T)39Eric | 1 model | |
Parkinson's disease | Tg(Th-Twnk*,-EGFP)2Gcor | 1 model | |
Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)83Vle | 2 models | |
Parkinson's disease 1 | Tg(Snca-SNCA)#Galt | 1 model | |
Parkinson's disease 1 | Tg(SNCA*E46K)3Elan | 1 model | |
Parkinson's disease 1 | Tg(SNCA)ARyot | 1 model | |
Parkinson's disease 1 | Tg(PDGFB-SNCA*A53T)8Ema | 1 model | |
Parkinson's disease 1 | Tg(PDGFB-SNCA/EGFP)78Ema | 1 model | |
Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)25Mkle | 1 model | |
Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)AAub | 2 models | |
Parkinson's disease 1 | Tg(Thy1-SNCA*A30P)18Pjk | 1 model | |
Parkinson's disease 1 | Tg(THY1-SNCA*A53T)M53Sud | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA*E57K)16Ema | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA*)#Ztzh | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA)61Ema | 1 model | |
Parkinson's disease 1 | Tg(PDGFB-SNCA)4Ema | 1 model | |
Parkinson's disease 1 | Tg(Th-SNCA*)1702Yosh | 1 model | |
Parkinson's disease 2 | Tg(Slc6a3-PARK2*Q311X)AXwy | 1 model | |
Parkinson's disease 4 | Tg(Thy1-Snca)1S13Putt | 1 model | |
Parkinson's disease 8 | Tg(PDGFB-LRRK2*G2019S)32Hlw | 1 model | |
Parkinson's disease 8 | Tg(PDGFB-LRRK2*R1441C)31Hlw | 1 model | |
Parkinson's disease 8 | Tg(Lrrk2*G2019S)2Yue | 1 model | |
paroxysmal nonkinesigenic dyskinesia 1 | Tg(Pnkd*A7V*A9V,-DsRed)671Ljp | 1 model | |
paroxysmal nonkinesigenic dyskinesia 1 | Tg(Pnkd*A7V*A9V,-DsRed)704Ljp | 1 model | |
Pelizaeus-Merzbacher disease | Tg(Plp)66Kan | 2 models | |
Pelizaeus-Merzbacher disease | Dp(XTceal3-Plp1)1Gmh | 1 model | |
Pelizaeus-Merzbacher disease | Tg(Plp)72Kan | 1 model | |
persistent hyperplastic primary vitreous | Tg(NES/TK-PDGFB,-lacZ)310Kfn | 1 model | |
Pick's disease | Tg(Thy1-MAPT*L266V*G272V)13Ema | 1 model | |
primary open angle glaucoma | Tg(OPTN*E50K,-EGFP)1Mde | 1 model | |
primary open angle glaucoma | Tg(CMV-MYOC*Y437H)#Vcs | 1 model | |
retinal cancer | Tg(Tyrp1-TAg)3434Bee | 1 model | |
retinitis pigmentosa 2 | Tg(Rho-Arl3*Q71L)#Visu | 1 model | |
retinitis pigmentosa 3 | Tg(CAG-Rpgr)mRDefWrght | 2 models | |
retinitis pigmentosa 4 | Tg(RHO*P347S)A1Tili | 3 models | |
retinitis pigmentosa 4 | Tg(Rho)1Wbae | 1 model | |
retinitis pigmentosa 4 | Tg(RHO-P23H)DTpd | 1 model | |
retinoblastoma | Tg(TagRb)1Plm | 1 model | |
retinoblastoma | Tg(Rbp3-SV40)IT-2Jjw | 1 model | |
retinoblastoma | Tg(Pax6-TAg)1796Hur | 1 model | |
spinocerebellar ataxia type 1 | Tg(tetO-ATXN1*82Q)#Horr | 1 model | |
spinocerebellar ataxia type 1 | Tg(Pcp2-ATXN1*82Q)5Horr | 1 model | |
spinocerebellar ataxia type 10 | Tg(Prnp-lacZ/ATXN10*)#Teas | 1 model | |
spinocerebellar ataxia type 14 | Tg(tetO-PRKCG*S361G,-GFP)3Jpka | 1 model | |
spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)71-27Xjl | 1 model | |
spinocerebellar ataxia type 17 | Tg(Pcp2-TBP*)69Hmhl | 1 model | |
spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)71-16Xjl | 1 model | |
spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)105Xjl | 1 model | |
spinocerebellar ataxia type 2 | Tg(Pcp2-ATXN2*127Q)#Plt | 1 model | |
spinocerebellar ataxia type 2 | Tg(ATXN2*72Q)#Plt | 1 model | |
spinocerebellar ataxia type 5 | Tg(tetO-SPTBN2*)#Lpwr | 1 model | |
spinocerebellar ataxia type 7 | Tg(Pcp2-SCA7)P7EJman | 1 model | |
spinocerebellar ataxia type 7 | Tg(GFAP-ATXN7*92Q)2521Als | 1 model | |
spinocerebellar ataxia type 7 | Tg(GFAP-ATXN7*92Q)2542Als | 1 model | |
spinocerebellar ataxia type 7 | Tg(Prnp-ATXN7*92Q)1963Als | 1 model | |
spinocerebellar ataxia type 7 | Tg(Prnp-ATXN7*92Q)6076Als | 1 model | |
spinocerebellar ataxia type 7 | Tg(RHO-SCA7)R7EJman | 1 model | |
Stargardt disease | Tg(RBP3-ELOVL4*)2Kzh | 1 model | |
Stargardt disease | Tg(RBP3-ELOVL4*)1Kzh | 1 model | |
Stargardt disease | Tg(RBP3-ELOVL4*)3Kzh | 1 model | |
tauopathy | Tg(Prnp-MAPT*P301S)50Hiw | 1 model | |
tauopathy | Tg(Mapt-MAPT*)#Hanr | 1 model | |
tauopathy | Tg(Prnp-MAPT*)2652Gds | 1 model | |
torsion dystonia 1 | Tg(Eno2-TOR1A*)13Shas | 1 model | |
torsion dystonia 1 | Tg(CMV-TOR1A*)2Nush | 1 model | |
torsion dystonia 1 | Tg(CMV-TOR1A*)1Nush | 1 model | |
uveal melanoma | Tg(Dct-Grm1)ESzc | 1 model | |
X-linked cone-rod dystrophy 1 | Tg(CMV-Rpgr)1Tili | 1 model |